type sequence filename description exhibit text html head title title licensed summit financial printing document created using edgarfilings profile copyright summit financial printing right reserved head body style font size font family time roman bgcolor ffffff text style height color text align center margin left auto background color margin right auto noshade noshade table style font size font family time roman border collapse collapse width cellspacing cellpadding style vertical align width style font size font family time roman font variant small font weight bold text align left confidential style vertical align width style font size font family time roman font variant small font weight bold font style italic text align right margin left execution copy table style font size font family time roman font variant small text align right confidential treatment requested style font size font family time roman font variant small text align right under style font size font family time roman font weight bold text align right style font size font family time roman font weight bold text align right exhibit style font size font family time roman font variant small font weight bold text align center strategic collaboration agreement style font size font family time roman font variant small font weight bold text align center between style font size font family time roman font variant small font weight bold text align center pharmaceutical style font size font family time roman font variant small font weight bold text align center style font size font family time roman font variant small font weight bold text align center astrazeneca style font size font family time roman font variant small font weight bold text align center dspfpagebreakarea style margin bottom clear both margin dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight bold text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center table content table style font size font family time roman border collapse collapse width cellspacing cellpadding border style vertical align background color cceeff colspan style font size font family time roman text align left article research collaboration right obtain exclusive license style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left research collaboration overview style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left research program style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left core research term disease research term style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left collaborative process identify potentially eligible target overview style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left eligible target style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left exclusion criterion style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left high interest target list reserved target list style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left activity support target sanction under disease research program style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left target that outside collaboration style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left process designating high interest target collaboration target style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left core research term style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left disease research term style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left collaboration program activity term style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left process designating development candidate style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left expiration collaboration program term style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left exclusive right obtain maintain exclusive license development candidate style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff colspan style font size font family time roman text align left article collaboration management administration cost expense manufacturing style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left collaboration management style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left alliance manager style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left disclosure result style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left material transfer style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left collaboration cost style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left collaboration manufacturing supply style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left collaboration summary work plan report style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left applicable bioethics style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article exclusivity covenant style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left exclusivity covenant style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left additional exclusivity covenant style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left corporate transaction style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left effect exclusivity indication style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff colspan style font size font family time roman text align left article license grant technology transfer support style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left product license grant astrazeneca style vertical align text align right width background color ffffff style font size font family time roman table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left table style font size font family time roman border collapse collapse width cellspacing cellpadding style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left assignment product specific patent grant back style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left exclusive technology license grant astrazeneca style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left cross license under collaboration intellectual property style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left subcontracting style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left technology transfer style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article development manufacturing commercialization style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left astrazeneca diligence style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left competitive product style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left regulatory interaction style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left antisense safety database style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left manufacturing supply style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article financial provision style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left front style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left product license style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left candidate drug designation milestone style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left milestone payment achievement milestone event product style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left limitation milestone payment exception notice style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left credit case termination program style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left royalty payment style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left third party payment obligation style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left payment style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left audit style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left interest style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff colspan style font size font family time roman text align left article intellectual property style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left ownership style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left prosecution maintenance patent style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left patent cost style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left defense claim brought third party style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left enforcement patent against competitive infringement style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left other infringement style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left patent listing style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left joint research agreement under leahy smith america invents style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left obligation third party style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left additional right exception style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left patent term extension style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff colspan style font size font family time roman text align left article representation warranty style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left representation warranty covenant both party style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left representation warranty covenant style vertical align text align right width background color cceeff style font size font family time roman table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left table zfee style font size font family time roman border collapse collapse width cellspacing cellpadding style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left update warranty style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left additional covenant style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left disclaimer warranty style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article indemnification insurance style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left indemnification astrazeneca style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left indemnification style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left notice claim style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left defense settlement cooperation expense style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left insurance style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left limitation consequential damage style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left anti bribery corruption compliance style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article term termination style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left agreement term expiration style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left termination agreement style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left consequence expiration termination this agreement style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article confidentiality style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left confidentiality exception style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left prior confidentiality agreement style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left authorized disclosure style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left licensed know style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left press release publication disclosure agreement style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff colspan style font size font family time roman text align left article miscellaneous style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style vertical align width background color ffffff style vertical align text align right width background color ffffff style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left dispute resolution style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left governing jurisdiction equitable relief loss remedy style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left assignment successor style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left change control event involving astrazeneca style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left antitrust filing style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left force majeure style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left notice style vertical align text align right width background color cceeff style font size font family time roman table table style font size font family time roman border collapse collapse width cellspacing cellpadding border style vertical align width style font size font family time roman text align left style vertical align width style font size font family time roman text align left export clause style vertical align text align right width style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left waiver style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left severability style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left entire agreement modification style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left relationship party style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left interpretation style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left book record style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left further action style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left construction agreement style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left supremacy style vertical align text align right width background color cceeff style font size font family time roman table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential table style font size font family time roman border collapse collapse width cellspacing cellpadding border style vertical align width background color cceeff style font size font family time roman text align left style vertical align width background color cceeff style font size font family time roman text align left counterpart style vertical align text align right width background color cceeff style font size font family time roman style vertical align width background color ffffff style font size font family time roman text align left style vertical align width background color ffffff style font size font family time roman text align left compliance with style vertical align text align right width background color ffffff style font size font family time roman style vertical align width background color cceeff style vertical align width background color cceeff style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left list appendix schedule exhibt style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix definition style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix lead candidate checklist style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix license agreement style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix core technology patent style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix manufacturing analytical patent style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix product specific patent style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left appendix prior agreement style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule preliminary core research plan style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule outline preliminary disease research plan style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule criterion activity achieve target sanction style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule draft drug discovery plan style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule criterion activity development candidate designation style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule development pipeline effective date style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule governance style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule alliance management activity style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule work plan report style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule astrazeneca bioethics policy style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule specific performance milestone event style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left schedule fully absorbed cost good methodology style vertical align text align right width background color ffffff style font size font family time roman style vertical align background color cceeff colspan style vertical align text align right width background color cceeff style vertical align background color ffffff colspan style font size font family time roman text align left exhibit astrazeneca framework style vertical align text align right width background color ffffff style font size font family time roman table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center strategic collaboration agreement style font size font family time roman text align justify text indent this strategic collaboration agreement font style font size font family time roman font weight bold font style italic agreement font entered into style vertical align text line height font size smaller font size smaller vertical align text line height july font style font size font family time roman font weight bold font style italic execution date font between font style font size font family time roman font variant small font weight bold pharmaceutical font delaware corporation having principal place business gazelle court carlsbad font style font size font family time roman font weight bold font style italic font font style font size font family time roman font variant small font weight bold astrazeneca font company incorporated sweden under with registered office dert sweden font style font size font family time roman font weight bold font style italic astrazeneca font astrazeneca each referred herein individually font style font size font family time roman font weight bold font style italic party font collectively font style font size font family time roman font weight bold font style italic party font capitalized term used this agreement whether used singular plural have meaning forth font style font size font family time roman font variant small appendix font font style font size font family time roman font attached appendix exhibit schedule part this agreement style font size font family time roman font weight bold text align center recital style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font posse certain patent right know technology expertise with respect antisense therapeutic novel valuable capability research discovery identification synthesis development antisense therapeutic style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font astrazeneca expertise developing commercializing human therapeutic interested entering into strategic relationship with explore potential target treatment metabolic disorder cardiovascular disease kidney disease collectively font style font size font family time roman font weight bold font style italic primary disease font create antisense drug such target style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font astrazeneca desire enter into strategic collaboration primary disease include core technology research program focused growing party collective knowledge interaction tissue cell type relevant primary disease disease research program focused identification validation application novel target treat primary disease drug discovery program focused additional collaboration target that have certain target sanction success criterion style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font with regard target selected collaboration target development using astrazeneca desire identify lead candidate consider designating development candidate astrazeneca consider designating candidate drug each collaboration target with respect collaboration target that provide astrazeneca exclusive right obtain exclusive license under this agreement research develop manufacture commercialize product field style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font desire grant astrazeneca astrazeneca desire accept from effective date exclusive license research develop manufacture commercialize product style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font also desire grant astrazeneca astrazeneca desire accept from exclusive license under program technology made under this agreement background technology necessary practice such program technology astrazeneca certain field style font size font family time roman text align justify text indent dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify text indent font style font size font family time roman font weight bold whereas font astrazeneca have other going agreement including collaboration license development agreement effective december amended research collaboration license agreement effective october strategic collaboration forth this agreement independent from such other agreement style font size font family time roman text align justify text indent font style font size font family time roman font weight bold therefore font consideration respective covenant representation warranty agreement forth herein party hereto agree follows style text align justify margin left style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center research collaboration right obtain exclusive license style font size font family time roman font weight bold text align center style text align justify table zdaa class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold research collaboration overview font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto intent research collaboration party conduct core technology research program focused growing party collective knowledge systemic delivery interaction tissue cell type relevant primary disease disease research program focused identification validation application certain novel target treat primary disease drug discovery program focused target that meet certain target sanction success criterion disease research program table style text align justify table zdaea class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto beginning throughout term disease research program party including through will collaboratively discus identify target that party potentially interested pursuing disease research program treat primary disease when target interest identified will determine which target eligible inclusion disease research program astrazeneca either such eligible target directly high interest target list commence work necessary validate such target hold limited number such eligible target reserve period time before deciding whether such target high interest target list table style text align justify table bcbf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto some case together with astrazeneca will perform target validation activity under disease research program eligible target that astrazeneca added list high interest target once high interest target reach target sanction select such target subject collaboration program under this agreement table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each collaboration program will commercially reasonable effort conduct drug discovery activity generate lead candidate consider designating development candidate table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each collaboration program that program collaboration target collaboration target basis after astrazeneca determines that lead compound success criterion such lead compound designated development candidate astrazeneca will have right obtain exclusive license further research develop manufacture ultimately commercialize such development candidate other compound designed bind such collaboration target table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto collaboration target will deemed have been designated effective date drug discovery program will first collaboration program under this agreement astrazeneca exclusive license from further research develop manufacture ultimately commercialize compound table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto purpose this font style font size font family time roman section font provide high level overview role responsibility right obligation each party under this agreement with respect research collaboration therefore this font style font size font family time roman section font qualified entirety more detailed provision this agreement forth below table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold research program font subject accordance with term this agreement astrazeneca will conduct research program each under separate mutually agreed plan data generated from these research program will inform drug discovery program table style text align justify margin left text indent style text align justify table zede class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic core research program font core research program will cover research focused growing party collective knowledge systemic delivery interaction tissue cell type relevant primary disease such program font style font size font family time roman font weight bold font style italic core research program font plan such program font style font size font family time roman font weight bold font style italic core research plan font party will base core research plan preliminary plan attached font style font size font family time roman font variant small schedule font font style font size font family time roman font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic disease research program font disease research program will focus identification validation high interest target that designated collaboration target such program font style font size font family time roman font weight bold font style italic disease research program font plan such program font style font size font family time roman font weight bold font style italic disease research plan font disease research plan will include minimum item forth font style font size font family time roman font variant small schedule font font style font size font family time roman font approval will attached minute astrazeneca supplement effort disease research program with astrazeneca scientist various point throughout disease research term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic updating research plan font core research plan based preliminary plan attached font style font size font family time roman font variant small schedule font font style font size font family time roman font disease research plan will mutually agreed within after effective date approval will attached minute thereafter party will update such plan needed updated plan will reviewed approved least before beginning each calendar year facilitate each party budgeting first update disease research plan will occur after first high interest target selected each update disease research plan will include minimum high interest target worked disease research plan each calendar year remaining portion thereof already commenced date which anticipates that work each high interest target will commence activity support target sanction high interest target included disease research plan including work high interest target that ongoing table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic feasibility font neither party will required complete activity under core research plan disease research plan such party good faith belief that such activity technically feasible given then current state table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold core research term disease research term font table style text align justify margin left text indent style text align justify table addb fcbf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic core research term font term conduct core research program will begin effective date will anniversary effective date font style font size font family time roman font weight bold font style italic core research term font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic disease research term font term conduct disease research program will begin effective date will anniversary effective date font style font size font family time roman font weight bold font style italic disease research term font font style font size font family time roman font style italic provided however font anniversary effective date completed activity forth disease research plan support target sanction high interest target table style text align justify margin left text indent style text align justify table zfaef feba class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaborative process identify potentially eligible target overview font throughout disease research term including first meeting party will collaboratively discus identify target that party potentially interested pursuing disease research program treat primary disease potential target identified through this collaborative process using step identified font style font size font family time roman section font through font style font size font family time roman font below will first determine whether target being considered eligible possible inclusion disease research plan astrazeneca designate eligible target that interest astrazeneca high interest target which activity support target sanction will conducted choose hold limited number such eligible target reserve before deciding whether such target high interest target list table style text align justify margin left text indent style text align justify table zeac class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold eligible target font astrazeneca through consider designation high interest target target that excluded exclusion criterion forth font style font size font family time roman section font each font style font size font family time roman font weight bold font style italic eligible target font various source potential eligible target that designated high interest target include eligible target have primary disease association disease that primary disease focus each disease research plan will primary disease that each meeting will review with astrazeneca obligation under this paragraph will earlier table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exclusion criterion font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold list exclusion criterion consider proposed target font target proposed designated reserved target high interest target meet following criterion listed item through such criterion listed item through font style font size font family time roman font weight bold font style italic exclusion criterion font such target eligible target will added reserved target list high interest target list table style font size font family time roman text align justify margin left style font size font family time roman text align justify margin left font style font size font family time roman font style italic provided that font font style font size font family time roman font style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold notice applicable exclusion criterion font will through notify astrazeneca exclusion criterion apply target astrazeneca request consideration reserved target high interest target shall provide such information reasonably necessary allow discus verify such conclusion font style font size font family time roman font style italic provided that font upon requesting that target considered reserved target target that reserved target considered high interest target astrazeneca will also notify writing astrazeneca internal program regardless therapeutic modality such target protein product thereof table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold high interest target list reserved target list font with respect eligible target astrazeneca either eligible target directly high interest target list described under font style font size font family time roman section font hold limited number such eligible target reserve reserved target list period time further described font style font size font family time roman section font while astrazeneca considers whether designate such eligible target high interest target table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold high interest target font table style text align justify margin left text indent style text align justify table caec class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic high interest target list font under disease research plan will establish prioritized list eligible target form basis disease research program each such target font style font size font family time roman font weight bold font style italic high interest target font such list font style font size font family time roman font weight bold font style italic high interest target list font will regularly discus eligible target belief designated high interest target will establish criterion process selection prioritization high interest target which include during disease research term eligible target included high interest target list time such inclusion separate from decision commence work such high interest target under disease research plan table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic schedule populating high interest target list font font style font size font family time roman font weight bold font given time needed research each high interest target party intend that will name least high interest target within disease research term least additional high interest target during each consecutive period thereafter during disease research term font style font size font family time roman font style italic provided font number high interest target exceed each party propose update high interest target list each meeting table style text align justify table bfce class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic substituting removing high interest target font prior high interest target eligible target high interest target list substitution such target addition high interest target invalidated font style font size font family time roman font published scientific literature demonstrates invalidity high interest target prior such target determined then will replace such invalidated high interest target high interest target list with another eligible target selected table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold reserved target font table style text align justify margin left text indent style text align justify table bede class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic reserved target list font under disease research plan astrazeneca determines that certain eligible target should held reserve consideration potential high interest target will establish maintain minute such list eligible target font style font size font family time roman font weight bold font style italic reserved target list font each such listed eligible target font style font size font family time roman font weight bold font style italic reserved target font astrazeneca eligible target such list time during disease research term eligible target added reserved target list virtue such addition number eligible target reserved target list will exceed number open high interest target slot remaining high interest target list given time reserved target list will include date that each such reserved target added reserved target list each reserved target will automatically removed from reserved target list will longer reserved target after such list time number target reserved target list exceeds maximum number allowed reserved target virtue decrease number open slot remaining high interest target list target will required removed from reserved target list except virtue passage time astrazeneca will precluded from adding additional eligible target reserved target list virtue such addition would increase size reserved target list above maximum permitted number reserved target table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic designation reserved target font subject font style font size font family time roman section font with respect maximum number reserved target previously removed target reserved target list such target still eligible target either data changed materially such target based either laboratory work information discovered literature have passed from time such target removed from reserved target list such addition eligible target shall once again reserved target until automatically removed from reserved target list accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic restriction reserved target font during disease research term until high interest target have been selected included high interest target list will will ensure that affiliate will offer reserved target third party grant such third party right such reserved target asos designed bind such reserved target long such target remains reserved target table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic dissolution reserved target list font once substantial activity initiated under disease research plan high interest target additional target added substituted high interest target list reserved target list will dissolved obligation astrazeneca right under this agreement with respect eligible target that were reserved target list such dissolution will terminate table style text align justify margin left text indent style text align justify table fabd ffdd class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold activity support target sanction under disease research program font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will prepare disease research plan update such plan which will include target sanction criterion each high interest target will agree disease research plan astrazeneca will provide input disease research plan through criterion activity conducted high interest target achieve target sanction will include criterion activity forth font style font size font family time roman font variant small schedule font font style font size font family time roman font table style text align justify table ccbe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will determine number high interest target which activity support target sanction will conducted during each calendar year portion thereof initial final period disease research term which number will approximately high interest target during first whole calendar year disease research term high interest target calendar year during remainder disease research term total high interest target font style font size font family time roman font style italic provided however font that with approval conduct such activity support target sanction more high interest target calendar year than otherwise planned hereunder identifies that certain high interest target require work achieve target sanction long disease research term conducted activity support target sanction high interest target conduct activity support target sanction fewer high interest target calendar year than otherwise planned hereunder more high interest target require unusually large amount work table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto disease research plan will identify which party will responsible each activity related such target accordance with disease research plan will commercially reasonable effort perform conducted activity designated under such plan accordance with timeline specified therein agrees that astrazeneca will conduct activity under disease research plan supplement effort achieve target sanction then will update disease research plan accordingly astrazeneca will commercially reasonable effort conduct such astrazeneca conducted activity designated under disease research plan accordance with timeline specified therein each party will responsible cost work conduct under disease research program unless otherwise mutually agreed neither party will required conduct work using that similar cost technical feasibility model such party other program table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold target that outside collaboration font during disease research term either party work outside research collaboration target protein product thereof that reserved target high interest target collaboration target table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold process designating high interest target collaboration target font table style text align justify style text align justify style text align justify table ffed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold review target sanction data package font upon completion activity disease research plan support target sanction particular high interest target will deliver target sanction data package such high interest target review soon reasonably practicable determine whether such high interest target achieved target sanction thus eligible become collaboration target each time delivers target sanction data package high interest target under this font style font size font family time roman section font party will schedule meeting occur within following delivery such target sanction data package such meeting possible within after such meeting agree astrazeneca will determine record minute whether such high interest target achieved target sanction agree astrazeneca determines that such high interest target achieved target sanction astrazeneca designates such high interest target collaboration target then will promptly commence collaboration program such collaboration target under font style font size font family time roman section font below table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional work achieve target sanction font determines that such high interest target achieved target sanction status then will decide whether revise target sanction criterion determine whether additional work will conducted such high interest target achieve target sanction will update disease research plan accordingly allocation expense budget such additional work party best positioned conduct such work will discussed agreed cost such additional work incurred will billed astrazeneca will invoiced astrazeneca calendar quarter basis paid astrazeneca within astrazeneca receipt such invoice extent such invoiced cost within budget approved such activity conclusion additional work shall provide revised data package font style font size font family time roman section font shall apply table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold failure achieve target sanction font high interest target high interest target basis first completion activity disease research plan support target sanction agrees that further work will undertaken with respect such target following completion agreed additional work agree astrazeneca determines that high interest target achieved target sanction then date such determination font style font size font family time roman font weight bold font style italic target failure date font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto such high interest target will designated collaboration target will longer high interest target under this agreement will still count against maximum limit high interest target under this agreement table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto when astrazeneca timely delivers release notice astrazeneca will free exploit asos designed bind such former high interest target astrazeneca timely deliver release notice then period from target failure date astrazeneca affiliate will exploit asos designed bind such former high interest target other than research tool connection with internal program table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will free exploit asos designed bind such former high interest target font style font size font family time roman font style italic provided however font that astrazeneca timely deliver release notice period after target failure date work conduct such former high interest target will undertaken itself collaboration with third party partner other than subcontractor acting behalf academic collaborator such former high interest target achieves target sanction which shall deemed have occurred with respect such former high interest target within such period then will provide written notice astrazeneca when within following receipt such notice astrazeneca delivers written notice that astrazeneca desire such former high interest target restored this agreement designated collaboration target agrees reimburse within incurred achieve target sanction such target after target failure date through date delivers such notice that initiated drug discovery activity then such target will collaboration target hereunder will promptly commence drug discovery work such collaboration target under font style font size font family time roman section font below table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto without limiting font style font size font family time roman section font will have exclusive right astrazeneca will hereby grant exclusive license data result information generated with respect such former high interest target research develop manufacture commercialize asos such high interest target astrazeneca will promptly transfer copy such data result information astrazeneca possession generated under disease research program table style text align justify table adff class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold timing font process forth this font style font size font family time roman section font agree astrazeneca make determination regarding whether high interest target achieved target sanction status whether such high interest target designated collaboration target whether target sanction criterion will revised whether additional work will conducted such high interest target achieve target sanction will event exceed after date first meet discus target sanction data package agrees that additional work should undertaken revised target sanction data package table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold core research term font core research term neither astrazeneca will have obligation perform activity under core research program each party will promptly transfer other extent previously provided copy data result information that generated under core research program each party shall entitled exclusively disclose such data result information accordance with font style font size font family time roman section font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold disease research term font disease research term neither astrazeneca will have obligation perform activity under disease research program high interest target list will dissolved will deliver astrazeneca target sanction data package completed extent possible with generated prior expiration disease research term high interest target that achieved target sanction will consider whether such high interest target achieved target sanction astrazeneca designate such high interest target collaboration target delivering written notice such designation within after astrazeneca receipt such target sanction data package will deemed have determined that high interest target that have been designated collaboration target such expiry such period have achieved target sanction font style font size font family time roman section font shall apply each such target clarity expiration disease research term will affect astrazeneca right obligation with respect collaboration program under this agreement including case collaboration program obligation under font style font size font family time roman section font commercially reasonable effort identify lead candidate each applicable collaboration program that satisfies development candidate success criterion table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zdfeb class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program activity term font table style text align justify margin left text indent style text align justify table bfea class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold drug discovery plan font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto initial draft drug discovery plan attached this agreement font style font size font family time roman font variant small schedule font font style font size font family time roman font each additional collaboration program within after designation applicable collaboration target will provide initial draft drug discovery plan applicable collaboration target each such draft plan will detail drug discovery activity identify development candidate under applicable collaboration program approval will attached minute each such plan font style font size font family time roman font weight bold font style italic drug discovery plan font each drug discovery plan will include success criterion activity that will performed achieve development candidate designation forth font style font size font family time roman font variant small schedule font font style font size font family time roman font will consistent with scope timeframe other similar program table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will provide input each drug discovery plan including additional success criterion development candidate that astrazeneca would like propose consideration font style font size font family time roman font style italic provided that font event each drug discovery plan will include project transition criterion consistent with internal criterion extent applicable asos consistent with scope standard drug discovery activity will endeavor conduct conducted activity under each drug discovery plan consistent with astrazeneca framework notified from time time such framework consistent with framework astrazeneca other drug applicable astrazeneca franchise current version astrazeneca framework attached font style font size font family time roman font variant small exhibit font font style font size font family time roman font will review such plan agree final drug discovery plan each collaboration program table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will review update approve drug discovery plan will initiate drug discovery plan soon practicable later than following effective date estimate conducted activity under drug discovery plan will completed within after such activity initiated table style text align justify table cffb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will commercially reasonable effort carry drug discovery activity each collaboration program pursuant applicable drug discovery plan accordance with timeline specified therein manner consistent with internal practice other target with goal identifying development candidate applicable collaboration program soon practicable will update each drug discovery plan needed submit review approval table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zdaa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto agrees that astrazeneca will conduct activity under particular drug discovery plan then party will update such drug discovery plan accordingly approval following such approval astrazeneca will commercially reasonable effort conduct such astrazeneca conducted activity designated under such drug discovery plan accordance with timeline specified therein table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party mutually agree final drug discovery plan given collaboration program such matter will resolved senior representative accordance with font style font size font family time roman section font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold third party obligation applicable compound font while party reviewing technology option used under drug discovery plan potential development candidate party will discus existing potential third party obligation they believe apply apply such technology will disclose astrazeneca such existing potential third party obligation known that apply technology under consideration party will identify which technology such font style font size font family time roman font weight bold font style italic third party compound technology font subject either license agreement existence such time agreement that anticipates will entered into such third party font style font size font family time roman section font will apply such agreement subject prior agreement otherwise subject license agreement where astrazeneca agrees incorporate technology subject license agreement into under drug discovery plan astrazeneca will such agreement will update font style font size font family time roman font variant small appendix font include such license agreement table style text align justify margin left text indent style text align justify table ebdae babe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program term font period during which party will conduct collaboration program under drug discovery plan such period font style font size font family time roman font weight bold font style italic collaboration program term font will begin effective date will anniversary effective date font style font size font family time roman font style italic provided that font disease research term extended under font style font size font family time roman section font there uncompleted activity performed collaboration program under drug discovery plan under this font style font size font family time roman section font then order provide sufficient time perform such additional activity with respect such collaboration program collaboration program term uncompleted collaboration program will extended anniversary effective date target restored collaboration accordance with font style font size font family time roman section font then provision this agreement that were operative during collaboration program term will apply solely with respect such target such period necessary enable activity specified drug discovery plan such target performed table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table dadd class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold process designating development candidate font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold review lead candidate data package font after activity forth applicable drug discovery plan completed particular collaboration program will deliver applicable lead candidate data package review soon reasonably practicable determine whether lead candidate applicable development candidate success criterion whether astrazeneca wish designate development candidate each time delivers lead candidate data package collaboration program under this font style font size font family time roman section font party will schedule meeting occur within following delivery such lead candidate data package such meeting possible within after such meeting agree astrazeneca will determine record minute determination whether such lead candidate applicable development candidate success criterion agree astrazeneca determines such lead candidate other compound included lead candidate data package font style font size font family time roman font weight bold font style italic other lead font together with lead candidate font style font size font family time roman font weight bold font style italic lead compound font such criterion designates lead compound development candidate then astrazeneca will have right undertake evaluation pursuant font style font size font family time roman section font determine whether astrazeneca wish designate such development candidate candidate drug obtain exclusive license from compound from applicable collaboration program accordance with font style font size font family time roman section font below with respect maintain exclusive license product accordance with font style font size font family time roman section font belief that compound identified lead candidate data package satisfies success criterion fails designate such compound development candidate matter shall resolved accordance with font style font size font family time roman section font applicable font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional work achieve development candidate status font with respect collaboration program determines that none lead compound applicable development candidate success criterion then will decide whether revise such success criterion designate development candidate based such revised criterion determine whether additional work will conducted more lead compound meet development candidate success criterion will update drug discovery plan accordingly allocation expense budget such additional work party best positioned conduct such work will discussed agreed cost such additional work incurred will billed astrazeneca will invoiced astrazeneca calendar quarter basis paid astrazeneca within astrazeneca receipt such invoice conclusion additional work shall provide revised data package font style font size font family time roman section font shall apply table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table dafb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold failure achieve development candidate status font collaboration target collaboration target basis following completion activity forth applicable drug discovery plan agree astrazeneca with respect unless otherwise agreed party expert accordance with font style font size font family time roman section font determines that none lead compound have applicable development candidate success criterion determines that such success criterion will revised that additional work will conducted such lead compound then date such determination font style font size font family time roman font weight bold font style italic candidate failure date font table style text align justify margin left text indent style text align justify table eeed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto none such lead compound other compound included applicable collaboration program each font style font size font family time roman font weight bold font style italic failed candidate font will designated development candidate applicable collaboration target will longer collaboration target under this agreement table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will have right obtain exclusive license from failed candidate accordance with font style font size font family time roman section font below table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto failed candidate compound license granted astrazeneca under font style font size font family time roman section font with respect will automatically terminate table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto when astrazeneca timely delivers release notice astrazeneca will free exploit asos designed bind such former collaboration target astrazeneca timely deliver release notice then period case case other failed candidate each case after candidate failure date each case font style font size font family time roman font weight bold font style italic carryover period font astrazeneca affiliate will exploit asos designed bind such former collaboration target other than research tool connection with internal program table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will free exploit asos designed bind such former collaboration target font style font size font family time roman font style italic provided however font that astrazeneca timely deliver release notice then table style text align justify table zfec class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto during carryover period work conduct failed candidate other designed bind former collaboration target will undertaken itself collaboration with third party other than subcontractor acting behalf academic collaborator except permitted this font style font size font family time roman section font will offer failed candidate third party table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto within carryover period intends commence failed candidate different designed bind applicable former collaboration target shall notify astrazeneca will provide astrazeneca with lead candidate data package such astrazeneca will have exclusive option font style font size font family time roman font weight bold font style italic carryover option font obtain from license under font style font size font family time roman section font with respect such former collaboration target within following receipt such data package astrazeneca delivers written notice that astrazeneca desire such target restored this agreement such will deemed have been designated development candidate astrazeneca exercise right under font style font size font family time roman section font development candidate compound license granted astrazeneca product under font style font size font family time roman section font will automatically restored effective astrazeneca elect make such designation exercise applicable collaboration program license right without limiting astrazeneca obligation license under font style font size font family time roman section font astrazeneca obligation milestone applicable astrazeneca will reimburse within such exercise incurred with respect such development candidate from candidate failure date date delivered astrazeneca applicable lead candidate data package under this font style font size font family time roman section font table style text align justify margin left text indent style text align justify table fcefd faee class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto subject restoration pursuant font style font size font family time roman section font without limiting font style font size font family time roman section font will have exclusive right astrazeneca will hereby grant exclusive license practice under astrazeneca collaboration technology with respect such collaboration target exploit asos designed bind such former collaboration target clarity such grant shall affect astrazeneca right practice under astrazeneca collaboration technology exploit compound product astrazeneca field targeting such former collaboration target exploit compound that designed bind remaining exclusive target table style text align justify style text align justify table bbcc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto with regard jointly owned collaboration technology such collaboration program astrazeneca will assign astrazeneca right title interest jointly owned product specific patent that claim compound designed bind remaining exclusive target such other jointly owned product specific patent agreed party such transferred jointly owned product specific patent will included license granted astrazeneca under font style font size font family time roman section font they relevant remaining exclusive target font style font size font family time roman section font restoration pursuant font style font size font family time roman section font interest assigned pursuant this font style font size font family time roman section font will astrazeneca request assigned back astrazeneca table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will promptly transfer other extent previously provided copy data result information relating such former collaboration target that generated under drug discovery plan other party shall entitled exclusively disclose such data result information accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold process font process forth this font style font size font family time roman section font determine whether lead compound development candidate success criterion whether lead compound will designated development candidate whether applicable success criterion will revised whether additional work will conducted lead compound designated development candidate will event exceed after date first convenes meeting discus lead candidate data package applicable revised lead candidate data package table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold expiration collaboration program term font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold failure designate development candidate font collaboration program collaboration program basis despite party commercially reasonable effort expiration collaboration program term delivered lead candidate data package particular collaboration target astrazeneca designated development candidate particular collaboration target then table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party will longer have obligation perform activity under this font style font size font family time roman article font with respect such collaboration program table style text align justify margin left text indent style text align justify table fede class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will deliver lead candidate data package completed extent possible with data result information generated prior expiration collaboration program term will consider whether lead compound from such collaboration program applicable development candidate success criterion whether such criterion astrazeneca designate such compound development candidate delivering written notice such designation within after astrazeneca receipt such lead candidate data package table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto unless astrazeneca designates development candidate particular collaboration program pursuant font style font size font family time roman section font compound from such collaboration program will deemed failed candidate font style font size font family time roman section font will apply table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold status other collaboration program font clarity expiration collaboration program term will affect party respective right obligation with respect collaboration program that collaboration program term licensed program being evaluated astrazeneca pursuant font style font size font family time roman section font until expiry applicable collaboration program license right deadline table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exclusive right obtain maintain exclusive license development candidate font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program license right font collaboration target collaboration target basis astrazeneca exclusive right which exercise time before pacific time each font style font size font family time roman font weight bold font style italic collaboration program license right deadline font such period font style font size font family time roman font weight bold font style italic evaluation period font following date each font style font size font family time roman font weight bold font style italic collaboration program license right font with respect collaboration target that obtain from license forth font style font size font family time roman section font below with respect maintain exclusive license forth font style font size font family time roman section font table style text align justify margin left text indent style text align justify table cdaa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca evaluation font during prior evaluation period astrazeneca conduct other activity expense supplement information determine wish designate development candidate candidate drug accordance with astrazeneca internal procedure exercise collaboration program license right after designation development candidate will provide astrazeneca promptly practicable with research grade such development candidate applicable rodent designed under applicable drug discovery plan font style font size font family time roman font style italic provided that font provide such research grade astrazeneca within after designation such development candidate applicable collaboration program license right deadline evaluation period will extended amount time equal number thereafter that take deliver such research grade astrazeneca requested astrazeneca during evaluation period possession will supply further quantity research grade astrazeneca will notify whether astrazeneca exercising collaboration program license right license applicable collaboration target maintain license each case product included applicable collaboration program notifying writing before applicable collaboration program license right deadline during such evaluation period astrazeneca will keep apprised astrazeneca progress making decision regarding such exercise enable plan early possible manufacturing under font style font size font family time roman section font relevant development candidate each collaboration program being evaluated during such evaluation period will provide such information astrazeneca reasonably request connection with such evaluation table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exercise font astrazeneca notifies writing collaboration program license right deadline that astrazeneca exercising collaboration program license right collaboration program collaboration program basis date such notice font style font size font family time roman font weight bold font style italic collaboration program exercise date font astrazeneca will license forth font style font size font family time roman section font milestone forth font style font size font family time roman section font applicable within after astrazeneca receipt invoice from such payment collaboration program license font style font size font family time roman section font shall continue case collaboration program that program will hereby grant astrazeneca license forth font style font size font family time roman section font below with respect such collaboration program table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exercise font collaboration program collaboration program basis astrazeneca provide timely written notice under font style font size font family time roman section font then table style text align justify table fbbda class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca collaboration program license right will expire license payable under font style font size font family time roman section font astrazeneca will have further right will have further obligation with respect such collaboration target including development candidate other compound included applicable collaboration program table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto target which such compound directed will cease collaboration target table style text align justify table bebacdb dfdcc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto collaboration target milestone payable license granted astrazeneca under font style font size font family time roman section font product will automatically terminate table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will have exclusive right astrazeneca will hereby grant exclusive license astrazeneca collaboration intellectual property generated astrazeneca under this agreement such collaboration target exploit asos designed bind such collaboration target clarity such grant will affect astrazeneca right practice under astrazeneca collaboration technology exploit compound product astrazeneca field targeting such former collaboration target exploit compound that designed bind remaining exclusive target table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto with regard jointly owned collaboration technology such collaboration program astrazeneca will assign astrazeneca right title interest jointly owned product specific patent that claim compound designed bind remaining exclusive target such other jointly owned product specific patent agreed party such transferred jointly owned product specific patent will included license granted astrazeneca under font style font size font family time roman section font they relevant remaining exclusive target font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will promptly transfer other extent previously provided copy data result information relating such former collaboration target that generated under drug discovery plan other party shall entitled exclusively disclose such data result information accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto period thereafter astrazeneca affiliate will develop commercialize designed bind applicable former collaboration target other than research tool connection with internal program table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto extent previously provided astrazeneca will promptly transfer copy data result information generated astrazeneca related testing study with respect applicable collaboration target undertaken astrazeneca during prior evaluation period table style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center collaboration management administration cost expense manufacturing style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration management font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font party will establish joint steering committee font style font size font family time roman font weight bold font style italic font collaboration program within effective date finalize update collaboration plan oversee conduct activity under respective collaboration plan will consist four representative appointed four representative appointed astrazeneca each member will senior research development leader have similar experience expertise senior research development leader each party will designate four representative empowered such party make decision related performance such party obligation under this agreement chair each chair will responsible overseeing activity consistent with responsibility forth font style font size font family time roman section font font style font size font family time roman font variant small schedule font font style font size font family time roman font forth certain governance matter agreed execution date will determine operating procedure first meeting including policy replacement member policy participation additional representative consultant invited attend meeting location meeting which will codified written minute first meeting each party will responsible cost employee consultant attending meeting table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold role font without limiting foregoing will perform following function accordance with this agreement some which addressed directly given meeting table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto review agree core research plan amendment thereto table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto review agree disease research plan amendment thereto taking into account outline font style font size font family time roman font variant small schedule font font style font size font family time roman font requirement achieve criterion perform activity listed font style font size font family time roman font variant small schedule font font style font size font family time roman font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto regularly discus potential eligible target application exclusion criterion such target maintain reserved target list minute table style text align justify table fbff cdaf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto establish criterion process selecting prioritizing high interest target table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto maintain list high interest target minute table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto determine high interest target worked disease research plan when work high interest target commence table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto target sanction criterion each high interest target under disease research plan font style font size font family time roman font style italic provided that font unless otherwise agreed such criterion shall include criterion listed font style font size font family time roman font variant small schedule font font style font size font family time roman font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto evaluate each target sanction data package make determination regarding whether high interest target achieved target sanction status whether high interest target will designated collaboration target whether target sanction criterion will revised whether additional work will conducted such high interest target achieve target sanction further provided font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto maintain list collaboration target that subject collaboration program table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto agree drug discovery plan each collaboration program table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto prepare work plan report accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto evaluate each lead candidate data package make determination regarding whether lead compound development candidate success criterion whether lead compound will designated development candidate whether such success criterion will revised whether additional work will conducted such lead compound designated development candidate further provided font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto review overall progress activity under applicable collaboration plan table style text align justify margin left text indent style text align justify table faef class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto review provide advice amend applicable collaboration plan table style text align justify table abbad class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto such other review approval advisory responsibility assigned pursuant this agreement table style text align justify margin left text indent style text align justify table cfda class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program decision making font table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto unanimously agree matter decided then either party shall have right refer such dispute senior representative resolution good faith negotiation accordance with font style font size font family time roman section font party shall implement proposed activity change pending such decision senior representative font style font size font family time roman font style italic provided that font dispute relates proposed change collaboration plan previously agreed continue conducted activity accordance with such plan pending resolution dispute senior representative table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto notwithstanding provision contrary herein will have obligation perform activity that after having consulted good faith belief that continuing such activity would table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold term font obligation participate relation collaboration plan will terminate date completes conducted activity under such collaboration plan thereafter will have right obligation participate meeting relation such collaboration plan upon request after licensed program will cease responsible making decision with respect such licensed program avoidance doubt without limiting foregoing provision font style font size font family time roman section font will cease apply astrazeneca will have full decision making authority with respect such licensed program subject astrazeneca continuing obligation commercially reasonable effort under this agreement will become forum party share information regarding licensed program party will decide number frequency meeting required respect such licensed program role table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zeef class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold alliance manager font promptly after effective date each party will appoint representative alliance manager each font style font size font family time roman font weight bold font style italic alliance manager font each alliance manager will permitted attend meeting participate such meeting voting observer unless party appointing alliance manager also appoints such person member alliance manager will responsible supporting performing activity listed font style font size font family time roman font variant small schedule font font style font size font family time roman font font style font size font family time roman font each party replace alliance manager time upon written notice other party accordance with font style font size font family time roman section font during collaboration program term alliance manager will meet monthly basis more frequently they determine person telephonically discus progress various activity under collaboration plan table style text align justify margin left text indent style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold disclosure result font table style text align justify table fdee class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold result under collaboration plan font each party will promptly disclose other party result work performed party under collaboration plan reasonable manner such result obtained astrazeneca will provide report analysis each meeting more frequently reasonable request member detailing current status each collaboration plan table style text align justify margin left text indent style text align justify table zbed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold reporting astrazeneca licensed program font each licensed program astrazeneca will prepare maintain reasonably complete accurate record regarding development each product will provide reasonably detailed summary report such activity least sooner font style font size font family time roman font material interaction with regulatory authority occurs with respect product astrazeneca shall prepare such report accordance with internal procedure astrazeneca obligation provide such information shall cease accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold information font result report analysis other information regarding collaboration plan disclosed party other party pursuant hereto used only accordance with right granted other term condition under this agreement table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold format reporting font report required under this font style font size font family time roman section font take form recorded minute which will contain copy slide relating result presented table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table dfca class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold material transfer font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto order facilitate activity under collaboration plan either party provide other party certain material other party furtherance collaboration plan such material will used receiving party accordance with term condition this agreement solely purpose exercising right performing obligation under this agreement receiving party will transfer such material third party unless expressly contemplated this agreement upon written consent supplying party table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party acknowledge agree that they will exchange information regarding material used generated connection with research collaboration requested other party each will reasonable endeavor subject requirement obligation owed third party provide assist other obtain case astrazeneca material that collaboration intellectual property case material that astrazeneca collaboration intellectual property each case accordance with font style font size font family time roman section font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto except expressly forth herein material provided without representation warranty express implied including implied warranty merchantability fitness particular purpose warranty that material will infringe violate patent other proprietary right third party table style text align justify table fccccabb class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration cost font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold core research program cost disease research program cost font during core research term disease research term subject font style font size font family time roman section font will responsible cost associated with conducted activity designated under core research plan disease research plan astrazeneca will responsible cost associated with astrazeneca conducted activity designated under core research plan disease research plan table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program cost font table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold drug discovery plan cost paid font until astrazeneca exercise collaboration program license right particular collaboration program unless otherwise specified font style font size font family time roman section font except otherwise provided under font style font size font family time roman section font will responsible cost associated with conducted activity designated under each drug discovery plan table style text align justify margin left text indent style text align justify table accf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold drug discovery plan other cost paid astrazeneca font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold before exercising collaboration program license right font until astrazeneca exercise collaboration program license right particular collaboration program unless otherwise specified font style font size font family time roman section font astrazeneca will responsible cost associated with astrazeneca conducted activity designated under each drug discovery plan table style text align justify style text align justify table zcdacf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold after exercising collaboration program license right font after astrazeneca exercise collaboration program license right particular collaboration program astrazeneca will solely responsible cost related research development manufacture commercialization product including astrazeneca conducted activity table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration manufacturing supply font will supply font style font size font family time roman font sufficient support conducted activity astrazeneca conducted activity designated under given collaboration plan table style text align justify style text align justify table bede badc class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration summary work plan report font calendar quarter calendar quarter basis beginning with within after most recent calendar quarter with assistance alliance manager will deliver written report astrazeneca which identifies each collaboration target each font style font size font family time roman font weight bold font style italic work plan report font agreed where planned activity under collaboration plan collaboration target have been agreed data will provided report template included font style font size font family time roman font variant small schedule font font style font size font family time roman font information report will provide basis such report will prepared throughout collaboration program term until astrazeneca will notify work plan report longer required during collaboration program term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold applicable bioethics font research conducted each party including subcontractor pursuant this agreement will carried good scientific manner compliance with applicable addition each collaboration program will carried compliance with astrazeneca bioethics policy attached font style font size font family time roman font variant small schedule font font style font size font family time roman font attempt achieve efficiently expeditiously objective applicable collaboration plan respect conducted activity initiated under collaboration program after effective date astrazeneca will mutually agree prior award work will work together secure compliance with astrazeneca bioethics policy where party will discus agree whether such insofar requirement complying with such policy will result additional cost being charged work conducted activity compared astrazeneca agrees responsible such additional cost party will agree when such cost will invoiced astrazeneca will such cost within after astrazeneca receipt invoice from party discussion agreement under this font style font size font family time roman section font through table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center exclusivity covenant style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exclusivity covenant font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca exclusivity covenant font font style font size font family time roman font exclusive target exclusive target basis except performance obligation exercise right under case astrazeneca font style font size font family time roman section font case font style font size font family time roman section font forth font style font size font family time roman section font font style font size font family time roman section font astrazeneca will font style font size font family time roman work independently font font style font size font family time roman with font affiliate font style font size font family time roman third font party font style font size font family time roman font including font style font size font family time roman grant license third font party font style font size font family time roman with respect font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic high interest target font discovery research development that designed bind high interest target from date each such target becomes high interest target under font style font size font family time roman section font until table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic collaboration target during collaboration program license right period font discovery research development that designed bind collaboration target from date each collaboration target deemed have been designated until table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic collaboration target after exercising collaboration program license right font development commercialization field that designed bind collaboration target which astrazeneca exercised collaboration program license right accordance with this agreement with respect development that designed bind such collaboration target until country country basis with respect commercialization that designed bind such collaboration target field until table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table fadba class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold follow product font notwithstanding provision font style font size font family time roman section font exclusive target exclusive target basis astrazeneca identify follow product exclusive target product identifies follow product exclusive target astrazeneca request thereafter astrazeneca commercially reasonable effort continue develop commercialize such follow compound then itself with third party will permitted discover research develop designed bind such exclusive target that product being developed astrazeneca font style font size font family time roman font weight bold font style italic follow product font after product commercialize such follow product table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold limitation exception font font style font size font family time roman font weight bold each party exclusivity covenant font font style font size font family time roman font table style text align justify style text align justify table acecdddbf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold limitation exception exclusivity covenant font font style font size font family time roman font notwithstanding anything contrary this agreement practice following will violate font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto performance conducted activity table style text align justify style text align justify table ccfbac class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto with respect collaboration target activity permitted under prior agreement such agreement effect date target high interest target list have been disclosed astrazeneca such prior agreement amended thereafter table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto granting performance obligation under permitted license table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold other limitation exception font font style font size font family time roman font weight bold astrazeneca font font style font size font family time roman font weight bold exclusivity covenant font font style font size font family time roman font notwithstanding anything contrary this agreement astrazeneca performance astrazeneca conducted activity will violate font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional exclusivity covenant font party acknowledge agree that exclusivity covenant forth font style font size font family time roman section font above addition limit astrazeneca covenant forth font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold corporate transaction font notwithstanding anything contrary this agreement will breach font style font size font family time roman section font font style font size font family time roman section font astrazeneca will breach font style font size font family time roman section font covenant forth font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font result activity relating designed bind exclusive target each font style font size font family time roman font weight bold font style italic competitive font program relating competitive asos each case resulting from direct indirect acquisition third party party direct indirect acquisition party affiliate third party including through acquisition substantially business each case after execution date font style font size font family time roman font style italic long font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto case where party acquired third party font style font size font family time roman font weight bold font style italic acquiring party font with competitive activity relating discovery research development commercialization competitive acquiring party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto case where party affiliate acquires third party font style font size font family time roman font weight bold font style italic acquisition target font with competitive acquiring party affiliate acquisition target either case astrazeneca table style font size font family time roman text align justify margin left style font size font family time roman text align justify margin left party acquired involved acquisition competitive font style font size font family time roman section font will apply pending case font style font size font family time roman section font such style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold effect exclusivity indication font font style font size font family time roman font compound designed bind exclusive target field font style font size font family time roman which font known play role more primary disease astrazeneca subject exclusivity obligation under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman font style italic however font party acknowledge agree that each party with third party continue discover research develop manufacture commercialize product that designed bind target that font style font size font family time roman font style italic font exclusive target indication even such product designed treat primary disease table style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center license grant technology transfer support style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold product license grant astrazeneca font table style text align justify style text align justify table feeead class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration target development commercialization license font collaboration target collaboration target basis subject term condition this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto hereby grant astrazeneca worldwide exclusive including with regard affiliate perpetual irrevocable except otherwise expressly provided this agreement royalty bearing sublicensable accordance with font style font size font family time roman section font below license under licensed technology research develop manufacture have manufactured accordance with font style font size font family time roman section font below commercialize product field table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto case collaboration target that grant astrazeneca effective upon astrazeneca exercise collaboration program license right such collaboration target accordance with font style font size font family time roman section font worldwide exclusive including with regard affiliate perpetual irrevocable except otherwise expressly provided this agreement royalty bearing sublicensable accordance with font style font size font family time roman section font below license under licensed technology research develop manufacture have manufactured accordance with font style font size font family time roman section font below commercialize product with respect such collaboration target field table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold sublicense right font table style text align justify style text align justify table ddeb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold right grant sublicenses font subject term condition this agreement astrazeneca will have right grant sublicenses through multiple tier sublicenses under license granted under font style font size font family time roman section font above table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto under licensed technology other than manufacturing analytical patent manufacturing analytical know affiliate astrazeneca third party table style text align justify style text align justify table zccd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto under manufacturing analytical patent manufacturing analytical know solely affiliate astrazeneca third party with valid license granted under manufacturing analytical patent manufacturing analytical know manufacture product manufacturing facility owned operated such third party each font style font size font family time roman font weight bold font style italic licensed font table style text align justify style font size font family time roman text align justify margin left font style font size font family time roman font style italic provided that font each such sublicense continued development manufacture commercialization product subject consistent with term condition this agreement astrazeneca will reasonable effort ensure that person which grant sublicenses comply with such term condition extent applicable such sublicense clarity restriction this font style font size font family time roman section font shall apply appointment third party undertake additional manufacturing activity including testing fill finish using supplied behalf astrazeneca font style font size font family time roman font style italic provided that font such third party undertaking such activity astrazeneca affiliate sublicensees licensed know transferred such third party style font size font family time roman text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align left style text align justify table cecbf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold enforcing sublicense agreement font either party learns sublicensee breach term sublicense granted astrazeneca such party will promptly notify other party writing will provide such other party with available evidence such breach party will discus good faith applicable cure astrazeneca will have first right enforce term sublicense against such sublicensee demand sublicensee cure such breach within after discussion with regarding applicable cure astrazeneca fails take action discussed astrazeneca enforce sublicense term sublicense granted pursuant this font style font size font family time roman section font effect applicable cure which failure good faith determination notified astrazeneca writing might reasonably expected cause astrazeneca hereby grant right enforce such sublicense term astrazeneca behalf will cooperate with which cooperation will astrazeneca sole expense will include astrazeneca joining action before court administrative body filed against such sublicensee extent necessary have legal standing before such court administrative body connection with enforcing such term astrazeneca will provide with written notice sublicense granted pursuant this font style font size font family time roman section font that grant third party right commercialize manufacture product within after execution thereof requested true complete copy such sublicense sublicense that subject breach term sublicensed under this agreement within request subject astrazeneca being entitled make appropriate redaction commercially sensitive information provided relevant enforcement reasonably necessary determine astrazeneca compliance with term this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold request grant sublicenses cmos font addition astrazeneca provides with written request that grant license under manufacturing analytical patent manufacturing analytical know designated astrazeneca that licensed solely such manufacture product astrazeneca affiliate sublicensee manufacturing facility owned operated such will offer grant such license such term that substantially similar term previously agreed with licensed cmos entering into such agreement with such shall become licensed purpose font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold effect termination sublicenses font this agreement terminates reason sublicensee will from effective date such termination automatically become direct licensee with respect right sublicensed sublicensee astrazeneca font style font size font family time roman font style italic long font such sublicensee breach sublicense agreement such sublicensee agrees writing comply with term this agreement extent applicable right originally sublicensed astrazeneca such sublicensee agrees directly such sublicensee payment under this agreement extent applicable right sublicensed astrazeneca astrazeneca agrees that will confirm knowledge clause foregoing writing request benefit requested sublicensee table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table abeb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold master service agreement material transfer agreement font this font style font size font family time roman section font intended require astrazeneca amend standard term condition master service agreement with third party place execution date conduct preclinical clinical research development astrazeneca behalf material transfer agreement with academic collaborator profit institution entered into after execution date astrazeneca connection with licensed technology however agreement entered into after execution date will subject approval long decision making authority such approval unreasonably withheld delayed font style font size font family time roman font style italic provided that font such approval will required given until after effective date table style text align justify style text align justify table bbab class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold payable cmos font hereby agrees that licensed cmos licensed pursuant request astrazeneca pursuant font style font size font family time roman section font shall required license royalty connection with manufacture product astrazeneca that licensed astrazeneca under font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold consequence natural expiration this agreement font product product basis with respect particular product which astrazeneca exercised applicable collaboration program license right this agreement expires font style font size font family time roman font terminated early particular country accordance with font style font size font family time roman section font then addition term forth font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font applicable license under font style font size font family time roman section font licensed know such product will automatically convert into perpetual exclusive worldwide royalty free fully paid sublicensable license under licensed know manufacture research develop commercialize product that subject such expiration such country table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold implied license font right licensed technology expressly licensed astrazeneca under this agreement hereby retained affiliate right astrazeneca technology expressly licensed assigned under this agreement hereby retained astrazeneca affiliate except expressly provided this agreement party will deemed estoppel implication have granted other party license other right with respect intellectual property table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold license condition limitation font subject font style font size font family time roman section font font style font size font family time roman section font collaboration target collaboration target basis license granted under font style font size font family time roman section font sublicense right under font style font size font family time roman section font subject limited prior agreement such agreement effect date such collaboration target designated high interest target placed high interest target list with respect execution date have been disclosed astrazeneca prior such date such prior agreement amended thereafter license agreement such agreement effect date identified license agreement added font style font size font family time roman font variant small appendix font font style font size font family time roman font provided font style font size font family time roman section font form disclosed astrazeneca prior such date such license agreement amended thereafter unless such amendment made with astrazeneca prior written consent granting performance obligation under permitted license table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table decbb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold trademark product font extent that owns trademark specific product licensed under font style font size font family time roman section font astrazeneca reasonably belief such trademark necessary useful such product then upon astrazeneca request astrazeneca sole cost expense will assign right title such trademark astrazeneca sufficiently advance first commercial sale product font style font size font family time roman font weight bold font other than such trademark astrazeneca solely responsible trademark trade dress logo slogan design copyright domain name used connection with product licensed under font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold distributorships promotion font avoidance doubt astrazeneca affiliate will have right their sole discretion except limited this section grant third party right import market distribute promote sell product licensed astrazeneca under section field where such product such third party right granted consistent with scope license granted astrazeneca hereunder with without right each such third party distributor provided that such grant include grant sublicense under develop manufacture other than product appointed distributor product from astrazeneca affiliate otherwise other astrazeneca with respect product such arrangement between astrazeneca affiliate such distributor consistent with distribution arrangement astrazeneca enters into astrazeneca table style text align justify style text align justify table abfd ffbe class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold assignment product specific patent grant back font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto collaboration target collaboration target basis with respect collaboration target which astrazeneca exclusive license under font style font size font family time roman section font time after completion first phase study applicable product after discussion manager will assign astrazeneca astrazeneca will accept from ownership interest product specific patent within licensed patent that owned whether solely owned jointly owned with more third party font style font size font family time roman font style italic provided that font either party reasonably determines that such assignment would likely adversely affect applicable licensed patent including diminishing scope term validity enforceability such licensed patent then table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca grant worldwide exclusive sublicensable license under patent right assigned astrazeneca under font style font size font family time roman section font purpose outside field except license commercialize compound claimed product specific patent that specifically claim product being developed commercialized astrazeneca research develop manufacture have manufactured register market commercialize follow product accordance with font style font size font family time roman section font each case extent permitted this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exclusive technology license grant astrazeneca font effective date subject term condition this agreement hereby grant astrazeneca worldwide exclusive sublicenseable transferrable royalty free fully paid license under collaboration intellectual property background intellectual property sole purpose astrazeneca performing astrazeneca conducted activity effectively participating under this agreement understand retain some capability with regard technology furtherance astrazeneca continuation development product under this agreement after expiration input font style font size font family time roman font post astrazeneca exercise each collaboration program license right expressly excluding right manufacture commercialize such product conducting research activity outside scope this agreement that human clinical study designed support involve compound being developed commercialized affiliate sublicensees their behalf solely with respect product specific patent within technology background technology conducting research development activity astrazeneca field except expressly provided clause this font style font size font family time roman section font foregoing license granted astrazeneca this font style font size font family time roman section font include right develop manufacture commercialize compound table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold cross license under collaboration intellectual property font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold enabling technology license from astrazeneca font subject term condition this agreement including exclusivity obligation under font style font size font family time roman section font astrazeneca hereby grant fully paid royalty free except otherwise provided under font style font size font family time roman section font font style font size font family time roman section font irrevocable worldwide exclusive sublicenseable license under astrazeneca collaboration intellectual property including astrazeneca interest jointly owned collaboration technology research develop manufacture have manufactured commercialize product other than designed bind exclusive target field table style text align justify style text align justify table zfbece ddccd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold enabling technology license from astrazeneca font subject term condition this agreement hereby grant astrazeneca fully paid royalty free irrevocable worldwide exclusive sublicenseable license under collaboration intellectual property including interest jointly owned collaboration technology research develop manufacture have manufactured commercialize product astrazeneca field table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold interaction license font avoidance doubt license granted font style font size font family time roman section font font style font size font family time roman section font intended undermine exclusivity covenant exclusive nature exclusive license granted party under this agreement royalty bearing license granted party other party under font style font size font family time roman section font font style font size font family time roman section font such party attempt exercise right granted under font style font size font family time roman section font font style font size font family time roman section font avoid complying with applicable exclusivity covenant paying milestone payment royalty other payment that would under this agreement result exercising right under license granted under font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table cddf class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold subcontracting font subject term this font style font size font family time roman section font each party will have right engage third party subcontractor perform certain obligation under this agreement subcontractor engaged party perform party obligation forth this agreement will meet qualification typically required such party performance work similar scope complexity subcontracted activity will enter into such party standard nondisclosure agreement consistent with such party standard practice party engaging subcontractor hereunder will remain responsible obligated such activity will grant right such subcontractor that interfere with right other party under this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold initial technology transfer font font style font size font family time roman font weight bold font extent previously provided within effective date will deliver otherwise make available through site visit access shared electronic portal astrazeneca licensed know relating program conducted prior effective date solely accordance with license granted under font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold technology transfer font collaboration target collaboration target basis after collaboration program exercise date will deliver astrazeneca following licensed know pursuant technology transfer plan mutually agreed astrazeneca table style text align justify style text align justify table zcdaf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold licensed know generally font copy licensed know other than manufacturing analytical know field possession that previously been provided hereunder solely accordance with license granted under font style font size font family time roman section font font style font size font family time roman section font astrazeneca together with regulatory documentation including draft related each product assist with transfer such licensed know will make personnel reasonably available astrazeneca during normal business hour total font style font size font family time roman font collaboration target collaboration target basis time under this agreement transfer such licensed know under this font style font size font family time roman section font thereafter requested astrazeneca will provide astrazeneca with reasonable level assistance connection with such transfer which astrazeneca will reimburse time incurred providing such assistance rate reasonable travel expense travel requested astrazeneca outside consultant cost consultant reasonable travel expense incurred agreed advance astrazeneca table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table fcfd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold manufacturing analytical know font solely astrazeneca affiliate third party acting astrazeneca behalf manufacture astrazeneca affiliate sublicensees astrazeneca affiliate mutually agreed licensed manufacturing facility copy manufacturing analytical know relating product possession that previously been provided hereunder which necessary exercise astrazeneca affiliate third party manufacturing right granted under font style font size font family time roman section font will make personnel reasonably available astrazeneca during normal business hour astrazeneca will reimburse time incurred performing such technology transfer rate reasonable travel expense travel requested astrazeneca outside consultant cost consultant reasonable travel expense incurred agreed advance astrazeneca table style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center development manufacturing commercialization style font size font family time roman font weight bold text align center style text align justify table bada class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca diligence font collaboration target collaboration target basis commencing collaboration program exercise date except expressly provided otherwise this agreement astrazeneca solely responsible development manufacture commercialization product with respect such collaboration target will solely responsible cost associated therewith with respect each licensed program astrazeneca will commercially reasonable effort develop product seek approval such product human following approval commercialize such product human develop commercialize product human worldwide outside extent consistent with global commercialization strategy effort astrazeneca would astrazeneca similar product same franchise develop commercialize each product substantially accordance with applicable table style text align justify style text align justify table ebfe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold specific performance milestone event font licensed program licensed program basis within after collaboration program exercise date astrazeneca will identify provide specific performance milestone event font style font size font family time roman font weight bold font style italic specific performance milestone event font first product from such licensed program based information then available astrazeneca then current practice case consistent with astrazeneca then current internal specific performance milestone event metric applicable astrazeneca franchise astrazeneca shall consider good faith will unreasonably refuse incorporate proposal comment made connection with such specific performance milestone event once specific performance milestone event astrazeneca given product such specific performance milestone event will attached hereto made part hereof font style font size font family time roman font variant small schedule font font style font size font family time roman font astrazeneca will commercially reasonable effort achieve specific performance milestone event regulatory development issue arise that impede commencement activity anticipated astrazeneca will notify requested meet discus such delay table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zfcec class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold integrated product plan font each licensed program astrazeneca will prepare global integrated product plan comparable document consistent with astrazeneca then current internal practice astrazeneca internal program outlining aspect development product being developed from such program well development proceeds such information available aspect worldwide regulatory strategy pricing market access strategy market launch commercialization each plan other such document font style font size font family time roman font weight bold font style italic integrated product plan font font style font size font family time roman font weight bold font style italic font astrazeneca will prepare each later than relevant product will contain high level information consistent with astrazeneca development commercialization plan similar product similar stage development commercialization same astrazeneca franchise once astrazeneca prepared astrazeneca will update consistent with astrazeneca standard practice including updated presented astrazeneca internal committee least annually will provide such update astrazeneca will meet through party otherwise agree annual basis discus draft astrazeneca will consider good faith proposal comment made incorporation table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold investigator brochure font subject font style font size font family time roman section font astrazeneca will keep reasonably informed with respect status activity progress development product licensed astrazeneca hereunder will provide updated version investigator brochure when requested more frequently than annually when development product result substantive change safety risk product table style text align justify style text align justify table aebb class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold competitive product font notwithstanding font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font product product basis independently with affiliate third party commences product ceased development such product same indication astrazeneca developing commercializing product commercializes product same indication astrazeneca developing commercializing product then astrazeneca discretion following written notice cease provide reduce information communication report plan provided pursuant this agreement affected product unless otherwise agreed astrazeneca will such affected product font style font size font family time roman font style italic provided however font that astrazeneca will continue provide information described under font style font size font family time roman section font internal safety database provide royalty report delivered accordance with font style font size font family time roman section font provide with advance notice under font style font size font family time roman section font material announcement regarding such product deliver annual basis high level summary such product meet with through exist with accordance with font style font size font family time roman section font collaboration program that involve such product table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table aaba deba class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold regulatory interaction font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold participation regulatory meeting font each party will provide other party with much advance written notice practicable meeting such party plan have with regulatory authority regarding approval approval matter product case invitee that relate antisense oligonucleotide platform subject font style font size font family time roman section font will allow representative invited party participate observer such meeting that font style font size font family time roman font meeting regarding cost associated with such observer attendance will invitee party except presence been specifically requested astrazeneca which case astrazeneca will reimburse time incurred attending rate extent that astrazeneca fully used available pursuant font style font size font family time roman section font font style font size font family time roman section font then astrazeneca will entitled allocate such activity performed pursuant this font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold regulatory communication font subject font style font size font family time roman section font each party will provide other party with copy document communication submitted including such draft providing party considers reasonably practicable include least finalization draft thereof received from regulatory authority that materially impact development commercialization product other party review comment submitting party will consider good faith including comment provided reviewing party such document communication table style text align justify style text align justify table zcbba class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold assistance with regulatory filing font collaboration target collaboration target basis after collaboration program exercise date upon astrazeneca written request will prepare report pertaining conducted activity required inclusion inds product astrazeneca will ordinate ensure that content such report suitable submission applicable regulatory authority using astrazeneca then current template product same franchise font style font size font family time roman font style italic long font able such template without incurring more than such template would require incur such cost connection with purchase software party shall discus agree appropriate format such report addition will assist astrazeneca preparing regulatory filing product including inds other regulatory filing except with respect regulatory filing related activity outlined font style font size font family time roman section font font style font size font family time roman section font such additional regulatory filing assistance will thereafter upon astrazeneca written request will provide such additional assistance preparing such regulatory filing product rate reasonable travel expense travel requested astrazeneca outside consultant cost consultant reasonable travel expense incurred agreed advance astrazeneca estimate such cost expense will provided astrazeneca before initiation agreed work table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table cfce dbea class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold class generic claim font extent astrazeneca intends make claim product label regulatory filing that class generic asos technology incorporated into product astrazeneca will provide such claim regulatory filing advance will consider good faith proposal comment made table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold applicable font each astrazeneca will perform activity pursuant this agreement compliance with good laboratory clinical practice cgmp each case applicable under regulation country state local government wherein such activity conducted table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold antisense safety database font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto maintains internal database that includes information regarding tolerability drug compound individually class including information discovered during clinical clinical development font style font size font family time roman font weight bold font style italic internal safety database font font style font size font family time roman font style italic provided that font astrazeneca obligation pursuant this font style font size font family time roman section font subject applicable particular astrazeneca will required disclose information contravention applicable relating data privacy effort maximize understanding safety profile pharmacokinetics compound astrazeneca will cooperate connection with populating internal safety database extent collected astrazeneca form which astrazeneca store such information purpose astrazeneca will provide with material information concerning toxicology pharmacokinetics safety pharmacology study serious adverse event other safety information related product licensed astrazeneca under this agreement soon practicable following date such information available astrazeneca later than after astrazeneca receipt such information connection with reported serious adverse event astrazeneca will provide serious adverse event report including initial interim follow amended final report addition with respect product astrazeneca will provide with copy annual safety update filed with each safety section final clinical study report furthermore astrazeneca will promptly provide with supporting data answer follow question reasonably requested conduct analysis keep partner informed regarding class generic property asos including with respect safety such information disclosed astrazeneca will astrazeneca confidential information font style font size font family time roman font style italic provided font font style font size font family time roman font style italic however font that long disclose identity product relevant target astrazeneca identity disclose such astrazeneca confidential information regulatory authority other partner pursuant font style font size font family time roman section font below such information regarding class generic property asos with respect partner such partner have agreed similar provision permitting disclosure their confidential information relating asos partner astrazeneca will deliver such information internal safety database pharmaceutical gazelle court carlsbad california attention chief medical officer such other address contact designated writing astrazeneca will also cause affiliate sublicensees comply with this font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto from time time utilizes information internal safety database conduct analysis keep partner informed regarding class generic property asos including with respect safety such when identifies safety other related issue that relevant product including potential class related toxicity will promptly inform astrazeneca such issue provide data supporting conclusion table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold manufacturing supply font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold initial supply astrazeneca font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto with respect licensed program support astrazeneca further development product such collaboration target upon astrazeneca written request least advance requested delivery date will manufacture supply product from each such licensed program requested astrazeneca will reasonable endeavor manufacture supply than notice extent available capacity table style text align justify style text align justify table zcde dbfa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will such within after astrazeneca receipt applicable invoice subject font style font size font family time roman section font request from astrazeneca manufacture under this font style font size font family time roman section font will submitted within after astrazeneca exercise collaboration program license right applicable product under this agreement table style text align justify style text align justify table bbfda class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca place order pursuant font style font size font family time roman section font prior exercise collaboration program license right given collaboration target will required deliver until after such exercise such circumstance invoice astrazeneca such when such order placed balance delivery font style font size font family time roman font style italic provided that font astrazeneca exercise collaboration program license right such collaboration target astrazeneca shall required continues development relevant product shall table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto after astrazeneca exercise collaboration program license right applicable product under this agreement addition supply forth this font style font size font family time roman section font will sell astrazeneca astrazeneca desire other inventory cgmp finished drug product possession table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold manufacturing service agreement font each party agrees acknowledges that mutually agreed manufacturing service agreement font style font size font family time roman font weight bold font style italic font required place govern supply arrangement under font style font size font family time roman section font which will negotiated good faith between party following effective date will form substantially similar that certain manufacturing service agreement between astrazeneca dated march party objective that will entered into within after effective date table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca responsible supplying finished drug product astrazeneca research development commercialization product under this agreement sixth each subsequent licensed program table style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center financial provision style font size font family time roman font weight bold text align center style text align justify table zbfa class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold front font within following effective date astrazeneca will front allocated follows table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto consideration exclusive license granted under font style font size font family time roman section font astrazeneca product table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto consideration table style text align justify style text align justify style text align justify table eaaabb class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold product license font collaboration program license right collaboration program license right basis collaboration program that program following astrazeneca written notice stating that astrazeneca exercising such collaboration program license right accordance with this agreement astrazeneca will license table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each such collaboration program within after astrazeneca receipt from invoice such license table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table fcef class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each subsequent collaboration program within after astrazeneca receipt from invoice such license table style text align justify style text align justify table zfdd class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold candidate drug designation milestone font font style font size font family time roman font weight bold font following astrazeneca written notice stating that astrazeneca exercising collaboration program license right with respect accordance with this agreement astrazeneca will milestone payment font style font size font family time roman font weight bold font style italic milestone font within after astrazeneca receipt from invoice such milestone payment table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold milestone payment achievement milestone event product font licensed program licensed program basis accordance with font style font size font family time roman section font astrazeneca will milestone payment forth font style font size font family time roman font variant small table font below when milestone event listed font style font size font family time roman font variant small table font first achieved astrazeneca affiliate sublicensees with respect product under such licensed program table table fbec style font size font family time roman border collapse collapse margin left width cellspacing cellpadding border style border solid border right solid vertical align middle border bottom solid border left solid colspan style font size font family time roman font variant small font weight bold text align center table style border solid border right solid vertical align middle border bottom solid border left solid width style font size font family time roman font weight bold text align left product milestone event style border solid border right solid vertical align middle border bottom solid border left solid width style font size font family time roman font weight bold text align center product milestone event payment style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align left style border solid border right solid vertical align middle border bottom solid border left solid width background color ffffff style font size font family time roman text align center table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify table aeed class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold limitation milestone payment exception notice font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each milestone payment forth font style font size font family time roman font variant small table font above will paid only once licensed program upon first achievement milestone event regardless many product such licensed program achieve such milestone event table style text align justify style text align justify table aecbbe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto milestone otherwise payable font style font size font family time roman font style italic font will payable unless until table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto particular milestone event achieved because development commercial activity transpired such that achievement such earlier milestone event unnecessary otherwise occur then upon achievement later milestone event milestone event payment applicable such earlier milestone event will also example party proceeds directly font style font size font family time roman font style italic font without achieving font style font size font family time roman font style italic font then upon achieving font style font size font family time roman font style italic font milestone event each font style font size font family time roman font style italic font font style font size font family time roman font style italic font font style font size font family time roman font style italic font milestone event payment additional example after achieving font style font size font family time roman font style italic font milestone event then both font style font size font family time roman font style italic font font style font size font family time roman font style italic font milestone event payment similarly party proceeds directly font style font size font family time roman font style italic font without achieving font style font size font family time roman font style italic font then upon achieving font style font size font family time roman font style italic font milestone event both font style font size font family time roman font style italic font font style font size font family time roman font style italic font milestone event payment table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto addition particular milestone event achieved contemporaneously connection with another milestone event then upon achievement such milestone event other milestone event will also deemed achieved milestone payment both milestone event example astrazeneca achieves font style font size font family time roman font style italic font milestone event that subject such milestone event then both font style font size font family time roman font style italic font font style font size font family time roman font style italic font milestone event payment similarly astrazeneca achieves font style font size font family time roman font style italic font milestone event that subject such milestone event then both font style font size font family time roman font style italic font font style font size font family time roman font style italic font milestone event payment table style text align justify style text align justify table accb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each time milestone event achieved under this font style font size font family time roman article font astrazeneca will send written notice thereof promptly later than business following date achievement such milestone event thereafter will promptly invoice astrazeneca achievement milestone event under this font style font size font family time roman article font such milestone payment will within after astrazeneca receipt such invoice table style text align justify style text align justify style text align justify table ddce class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold credit case termination program font table style text align justify style text align justify table edde class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic credit font program under font style font size font family time roman section font astrazeneca otherwise astrazeneca voluntarily terminated agreement with respect program then solely with respect next which astrazeneca exercise under font style font size font family time roman section font astrazeneca will have credit such that such will under font style font size font family time roman section font font style font size font family time roman font style italic provided however font astrazeneca timely exercise pursuant font style font size font family time roman section font party agree that this agreement will revert back status agreement immediately prior issuance such credit under this font style font size font family time roman section font astrazeneca such that payment will such exercise astrazeneca exercise exercised another such collaboration program will also under font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic program credit terminated certain event font time through style vertical align text line height font size smaller font size smaller vertical align text line height after date which applicable mean after period program such program terminated failure achieve such prior such program that occurs with respect participating such program with respect that cause astrazeneca regulatory authority require such terminated hold that otherwise precludes further development astrazeneca delivers written notice termination stating that astrazeneca terminating program occurrence item item above then table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca paid astrazeneca will obligated under font style font size font family time roman section font next which astrazeneca under this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca paid payment through payment listed font style font size font family time roman font variant small font font style font size font family time roman section font product font style font size font family time roman font variant small font astrazeneca will have credit such payment such that corresponding payment listed font style font size font family time roman font variant small font font style font size font family time roman section font that would otherwise under this agreement achievement product from next will hereunder table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align font weight bold font style italic text align justify width auto example credit mechanism under section table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto program terminated astrazeneca occurrence item item font style font size font family time roman section font above astrazeneca paid applicable payment product through payment program then next payable under font style font size font family time roman section font this agreement will payment will with respect next such payment will with respect next such table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zbabd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto program terminated astrazeneca occurrence item item above astrazeneca paid other then astrazeneca will have credit such payment such that next payable under font style font size font family time roman section font next will table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic credit refund font event that accordance with font style font size font family time roman section font determines that satisfies accordance with font style font size font family time roman section font astrazeneca decides exercise with respect then credit will accrue based program under circumstance will astrazeneca entitled refund credit under this font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold royalty payment font table style text align justify style text align justify table efcd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca full royalty font licensed program licensed program basis partial consideration right granted astrazeneca hereunder subject provision this font style font size font family time roman section font font style font size font family time roman section font astrazeneca will royalty annual worldwide sale product sold astrazeneca affiliate sublicensees country country product product basis each case amount follows font style font size font family time roman font variant small table font below font style font size font family time roman font weight bold font style italic astrazeneca full royalty font table table bfabb dcbadcaa style font size font family time roman border collapse collapse margin left width cellspacing cellpadding border style border solid border right solid vertical align border bottom solid border left solid colspan style font size font family time roman font variant small font weight bold text align center table style border solid border right solid vertical align border bottom solid border left solid width style font size font family time roman font weight bold text align center royalty style font size font family time roman font weight bold text align center tier style border solid border right solid vertical align border bottom solid text align left border left solid width style font size font family time roman font weight bold annual worldwide sale product from licensed program style border solid border right solid vertical align middle border bottom solid text align center border left solid width style font size font family time roman font weight bold royalty style font size font family time roman font weight bold rate style font size font family time roman font weight bold style border solid border right solid vertical align border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align border left solid width background color cceeff style font size font family time roman text align left portion annual worldwide sale style border solid border right solid vertical align border left solid width background color cceeff style font size font family time roman text align center style border right solid vertical align border bottom solid border left solid width background color cceeff style border right solid vertical align border bottom solid border left solid width background color cceeff style border right solid vertical align border bottom solid border left solid width background color cceeff style border solid border right solid vertical align border left solid width background color ffffff style font size font family time roman text align center style border solid border right solid vertical align border left solid width background color ffffff style font size font family time roman text align left portion annual worldwide sale font style font size font family time roman font style border solid border right solid vertical align border left solid width background color ffffff style font size font family time roman text align center style border right solid vertical align border bottom solid border left solid width style border right solid vertical align border bottom solid border left solid width style border right solid vertical align border bottom solid border left solid width style border solid border right solid vertical align border bottom solid border left solid width background color cceeff style font size font family time roman text align center style border solid border right solid vertical align border bottom solid border left solid width background color cceeff style font size font family time roman text align left portion annual worldwide sale font style font size font family time roman font style font size font family time roman text align left style border solid border right solid vertical align border bottom solid border left solid width background color cceeff style font size font family time roman text align center table style font size font family time roman text align justify subject font style font size font family time roman section font annual worldwide sale will calculated taking aggregate sale product under applicable licensed program country worldwide style font size font family time roman text align justify style text align justify table faaefafd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto during royalty period astrazeneca will royalty sale product arising from named patient other similar program under applicable astrazeneca will provide report payment consistent with font style font size font family time roman section font royalty sale product arising from compassionate other program providing delivery product cost sale product arising from named patient compassionate other similar program will considered first commercial sale purpose calculating royalty period determining whether approval milestone event listed font style font size font family time roman font variant small table font font style font size font family time roman font font style font size font family time roman section font been achieved table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman purpose clarification font product specific patent font style font size font family time roman assigned font astrazeneca forth font style font size font family time roman section font font style font size font family time roman will still considered font product specific patent font style font size font family time roman determining royalty term applicable royalty rate under this font font style font size font family time roman article font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold application royalty rate font royalty forth under font style font size font family time roman section font subject provision this font style font size font family time roman section font payable follows table style text align justify style text align justify table fdac class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold royalty period font astrazeneca obligation astrazeneca full royalty above with respect product will continue country country product product basis from date first commercial sale such product until later date expiration last valid claim within licensed patent covering such product country which such product made used sold data exclusivity period conferred applicable regulatory authority such country with respect such product font style font size font family time roman font such case orphan drug anniversary first commercial sale first product contain relevant compound such country such royalty period font style font size font family time roman font weight bold font style italic royalty period font font style font size font family time roman font style italic provided font following such anniversary such first commercial sale only remaining valid claim licensed patent covering such product country where such product made sold manufacturing analytical patent then astrazeneca will reduced royalty such product such country royalty rate equal font style font size font family time roman font variant small font until such manufacturing analytical patent expires table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold allocation reduction font party acknowledge that applicable royalty rate font style font size font family time roman font variant small table font font style font size font family time roman font dependent annual worldwide sale product royalty rate reduction proviso font style font size font family time roman section font applies country country product product basis party will apply appropriate mechanism apportion such reduction proportionally across royalty tier font style font size font family time roman font variant small table font font style font size font family time roman font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold limitation aggregate reduction astrazeneca royalty font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto offset under font style font size font family time roman section font apply event will aggregate royalty offset under font style font size font family time roman section font font style font size font family time roman section font reduce royalty payable sale product given period amount that than greater table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto offset under font style font size font family time roman section font applies event will aggregate royalty offset under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font reduce royalty payable sale product given period amount that than table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold royalty obligation font country country product product basis other than astrazeneca obligation make royalty payment hereunder such country will expiration royalty period such country sale product made after expiration royalty period such product country shall included annual worldwide sale purpose calculating royalty under font style font size font family time roman section font table style text align justify style text align justify table zeaee class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold compulsory license font court governmental agency competent jurisdiction requires astrazeneca affiliate sublicensees grant compulsory license third party each font style font size font family time roman font weight bold font style italic compulsory sublicensee font permitting such third party make sell product country such compulsory sublicensee will considered sublicensee purpose this agreement such grant will permitted deemed consented under font style font size font family time roman section font such time astrazeneca affiliate sublicensees enters into sublicense with compulsory sublicensee font style font size font family time roman font style italic provided that font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold third party payment obligation that relevant third party compound technology font third party obligation that become payable astrazeneca under agreement such party entered into license otherwise acquire third party patent right other intellectual property right each case that third party compound technology will paid party shared party expressly forth this font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold existing technology license agreement font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic existing technology license agreement font certain licensed technology that licensed astrazeneca under font style font size font family time roman section font licensed acquired under agreement with third party licensors seller listed font style font size font family time roman font variant small appendix font certain milestone royalty payment license maintenance become payable such third party under license agreement based development commercialization product astrazeneca affiliate sublicensee under this agreement such payment obligation arising under license agreement listed font style font size font family time roman font variant small appendix font font style font size font family time roman font extent applicable third party compound technology table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto they apply patent right know claiming each case licensed astrazeneca connection with applicable product will paid table style text align justify style text align justify table feee class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto they apply each case licensed astrazeneca connection with applicable product will paid table style text align justify style text align justify table ddfb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic astrazeneca existing license agreement font astrazeneca will solely responsible third party obligation that become payable astrazeneca third party under agreement arrangement astrazeneca with such third party effective date based development commercialization product astrazeneca affiliate sublicensee under this agreement such payment obligation will paid astrazeneca astrazeneca supported through cost under this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold licensed additional product specific patent font table style text align justify style text align justify table bcfb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold prior exercise collaboration program license right font collaboration target collaboration target basis prior astrazeneca exercise collaboration program license right obtains third party patent right necessary develop commercialize product where such patent right would have satisfied definition product specific patent controlled such patent right effective date then extent controlled will include such third party patent right license granted astrazeneca under font style font size font family time roman section font will consult with astrazeneca before entering into such third party agreement will take into consideration reasonable comment made astrazeneca such agreement astrazeneca such license agreement shall license agreement font style font size font family time roman font variant small appendix font font style font size font family time roman font shall updated accordingly table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold after exercise collaboration program license right font table style text align justify style text align justify margin left font style font size font family time roman font weight bold font font style font size font family time roman collaboration target collaboration target basis after astrazeneca exercise collaboration program license right astrazeneca case will promptly provide other party written notice additional third party patent right necessary practice product specific patent develop commercialize product font style font size font family time roman font weight bold font style italic additional product specific patent font belief identified astrazeneca will have first right obligation negotiate with obtain license from third party controlling such additional product specific patent astrazeneca obtains such additional product specific patent then third party obligation arising under such third party agreement will paid font style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify margin left font style font size font family time roman font weight bold font font style font size font family time roman however astrazeneca elect obtain such license such additional product specific patent astrazeneca will notify obtain such license such additional product specific patent will include such additional product specific patent license granted astrazeneca under font style font size font family time roman section font such agreement astrazeneca such license agreement shall license agreement font style font size font family time roman font variant small appendix font font style font size font family time roman font shall updated accordingly font style text align justify margin left style text align justify table befa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional core license agreement font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will promptly provide written notice intellectual property controlled third party that necessary that font style font size font family time roman font style italic font third party compound technology font style font size font family time roman font weight bold font style italic additional core font that astrazeneca belief identified will have first right obligation negotiate with obtain license from third party controlling such additional core clarity additional core include patent right claiming intellectual property related third party compound technology obtains such third party license will include such additional core license granted astrazeneca under font style font size font family time roman section font will financial obligation under such third party agreement provided that astrazeneca agreed term such agreement such agreement shall license agreement font style font size font family time roman font variant small appendix font font style font size font family time roman font shall updated accordingly table style text align justify style text align justify table efce class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto however elect obtain such license such additional core will notify astrazeneca astrazeneca obtain such third party license astrazeneca offset amount equal against table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold dispute regarding additional core font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto agree that certain intellectual property identified astrazeneca pursuant font style font size font family time roman section font additional core will send written notice such effect astrazeneca party will engage mutually agreed upon independent third party intellectual property lawyer with expertise patenting oligonucleotides appropriate professional credential relevant jurisdiction determine question whether such third party intellectual property additional core determination third party expert engaged under preceding sentence will binding party solely purpose determining whether cost third party expert engaged under this font style font size font family time roman section font will paid party against whose position third party lawyer determination made table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto notwithstanding determination third party lawyer under font style font size font family time roman section font third party controlling additional core awarded judgment from court competent jurisdiction arising from claim against astrazeneca asserting that astrazeneca will permitted table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold license agreement font license agreement existence execution date listed font style font size font family time roman font variant small appendix font font style font size font family time roman font after effective date font style font size font family time roman font variant small appendix font font style font size font family time roman font will updated accordance with font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font such update will collaboration target collaboration target basis identify relevant intellectual property right astrazeneca supported through cost supported through cost table style text align justify style text align justify table befa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic minimum third party payment font minimum third party payment astrazeneca obligated under this agreement will satisfied table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold third party compound technology font font style font size font family time roman font weight bold font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold existing third party compound technology font where astrazeneca agrees incorporate third party compound technology into under drug discovery plan accordance with font style font size font family time roman section font will include such technology license granted astrazeneca under font style font size font family time roman section font subject font style font size font family time roman section font will extent triggered manufacturing development commercialization product conduct drug discovery plan behalf astrazeneca table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional third party compound technology font order grant license astrazeneca third party compound technology that party agree incorporate into accordance with font style font size font family time roman section font necessary obtain license from third party controlling such third party compound technology time after party decide incorporate third party compound technology into pursuant font style font size font family time roman section font either party becomes aware intellectual property controlled third party that necessary practice such third party compound technology develop manufacture commercialize product then will consult with astrazeneca before entering into agreement with such third party access such third party compound technology such intellectual property necessary practice such third party compound technology will take into consideration reasonable comment made astrazeneca such agreement extent economic term such third party agreement third party obligation that will paid such economic term will prior executing such agreement with such third party such agreement such will include such technology license granted astrazeneca under font style font size font family time roman section font such license agreement shall license agreement font style font size font family time roman font variant small appendix font font style font size font family time roman font shall updated accordingly elect obtain such license third party compound technology will notify astrazeneca astrazeneca obtain such third party license table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will responsible paid with respect third party compound technology with respect third party compound technology triggered prior exercise applicable collaboration program exercise date astrazeneca will required such amount unless until such exercise table style text align justify style text align justify table aafc class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold payment font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold commencement font beginning with calendar quarter which first commercial sale product made each calendar quarter thereafter astrazeneca will make royalty payment under this agreement within following each such calendar quarter each royalty payment will accompanied report summarizing sale product during relevant calendar quarter calculation royalty thereon including country unit sale price exchange rate used royalty payable respect given calendar quarter astrazeneca will submit written royalty report indicating together with explanation such royalty payable addition beginning with calendar quarter which first commercial sale product made each calendar quarter thereafter within following each such calendar quarter astrazeneca will provide preliminary binding product sale estimate such calendar quarter table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold mode payment font payment under this agreement will payable full dollar regardless country which sale made made wire transfer immediately available fund account designated writing creditable except otherwise provided font style font size font family time roman section font font style font size font family time roman section font refundable whenever purpose calculating royalty payable under this agreement conversion from foreign currency will required amount will first calculated currency sale then converted into united state dollar astrazeneca accordance with rate exchange relevant month converting such other currency into dollar used astrazeneca internal accounting system which independently audited annual basis which accordance with generally accepted accounting principle fairly applied employed consistent basis throughout astrazeneca operation table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold record retention font commencing with first commercial sale product astrazeneca will keep complete accurate record pertaining sale product period after year which such sale occurred sufficient detail permit confirm accuracy sale royalty paid astrazeneca hereunder table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zfdfa class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold audit font during agreement term period thereafter request expense astrazeneca will permit independent certified public accountant nationally recognized standing appointed reasonably acceptable astrazeneca reasonable time upon reasonable notice case more than calendar year examine such record necessary purpose verifying accrual milestone payment calculation reporting sale correctness milestone royalty payment made under this agreement calculation contemplated font style font size font family time roman section font period within preceding condition examining record astrazeneca such auditor will sign nondisclosure agreement reasonably acceptable astrazeneca form substance record astrazeneca examined such independent certified public accountant will deemed astrazeneca confidential information upon completion audit accounting firm will provide both astrazeneca with written report disclosing whether milestone royalty payment calculation contemplated font style font size font family time roman section font made astrazeneca correct incorrect specific detail concerning discrepancy font style font size font family time roman font weight bold font style italic audit report font result inspection book record astrazeneca shown that astrazeneca payment under this agreement were more than milestone royalty amount which should have been paid then relevant party will make payment required made paying other party difference between such amount eliminate discrepancy revealed said inspection within receiving audit report with interest calculated accordance with font style font size font family time roman section font font style font size font family time roman font style italic provided however font that such payment astrazeneca will will such audit except that astrazeneca found have underpaid more than amount that should have been paid audited period astrazeneca will reimburse reasonable expense charged accounting firm audit table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font table style text align justify style text align justify table cbcb ecac class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold income font font style font size font family time roman font weight bold font each party alone will solely responsible paying other than withholding required applicable paid astrazeneca case levied account measured whole part reference income such party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold indirect font payment exclusive indirect indirect chargeable respect payment paying party will such indirect applicable rate respect such payment following receipt where applicable indirect invoice appropriate form issued receiving party respect those payment table style text align justify style font size font family time roman text align justify margin left party will issue invoice amount payable under this agreement consistent with indirect requirement irrespective whether netted settlement purpose such amount indirect refunded applicable governmental authority other fiscal authority subsequent payment party receiving such refund will transfer such amount paying party within receipt party agree reasonably cooperate provide information required party pursuing refund indirect paid style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold withholding font extent paying party required deduct withhold payment paying party will amount such proper governmental authority account receiving party remit amount receiving party timely manner paying party will promptly furnish receiving party with proof payment such documentation necessary order secure exemption from reduction withholding party will provide such documentation extent they entitled accordance with procedure forth font style font size font family time roman section font font style font size font family time roman section font receiving party will also indemnify paying party interest penalty imposed paying party paying party improperly reduces eliminates withholding based upon representation made receiving party will indemnify astrazeneca withholding incurred astrazeneca supported through cost paid astrazeneca that arises because these cost deemed beneficially owned table style text align justify style text align justify table fcac class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold cooperation font least prior date given payment under this agreement paying party will provide paying party with form that reasonably necessary order paying party lawfully withhold withhold reduced rate with respect such payment under applicable bilateral income treaty following paying party timely receipt such form from paying party paying party will withhold will withhold reduced rate under applicable bilateral income treaty appropriate under applicable paying party will provide such form paying party upon request advance date each party will provide other with reasonable assistance enable recovery permitted applicable withholding resulting from payment made under this agreement such recovery benefit party would have been entitled receive money application withholding under this font style font size font family time roman section font table style text align justify style font size font family time roman text align justify margin left provision this font style font size font family time roman section font read conjunction with provision font style font size font family time roman section font below style font size font family time roman text align justify margin left style text align justify table cbac class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold interest font undisputed payment made hereunder that paid before date such payment under this agreement payment that pending resolution dispute unless dispute ruled favor paying party will bear interest rate annum equal lesser rate announced bank america successor prime rate effect date that such payment would have been first plus maximum rate permissible under applicable table style font size font family time roman font weight bold text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center intellectual property style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold ownership font table style text align justify style text align justify table ccad class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold technology astrazeneca technology font between party will retain right title interest licensed know licensed patent astrazeneca will retain right title interest astrazeneca background intellectual property astrazeneca know astrazeneca patent subject assignment right license expressly granted party other party under this agreement clarity except otherwise expressly provided this agreement scope license granted astrazeneca under this agreement will include astrazeneca background intellectual property table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration technology font between party each party shall retain right title interest know that conceived discovered developed otherwise made behalf such party affiliate under connection with this agreement whether patented patentable patent right other intellectual property right with respect thereto table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold disclosure collaboration technology font table style text align justify style text align justify table zcdc fdcb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will promptly disclose will cause affiliate disclose discovery development creation astrazeneca collaboration intellectual property table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will promptly disclose astrazeneca will cause affiliate disclose discovery development creation collaboration intellectual property table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold jointly owned collaboration technology font party shall each equal undivided interest such know patent right that conceived discovered developed otherwise made jointly behalf party under connection with this agreement inventorship will determined accordance with font style font size font family time roman section font each party shall without additional compensation cooperate make necessary assignment fully effect ownership provided this font style font size font family time roman section font except expressly provided this agreement without limiting exclusive license granted under font style font size font family time roman section font exclusivity covenant under font style font size font family time roman section font neither party will have obligation account other profit with respect obtain consent other party license exploit jointly owned collaboration technology reason joint ownership thereof each party hereby waif right have under jurisdiction require such consent accounting font style font size font family time roman font style italic provided that font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold manager font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will appoint house patent attorney serve primary contact with respect intellectual property matter arising under this agreement font style font size font family time roman font weight bold font style italic manager font will cooperate with respect activity forth this font style font size font family time roman article font strategy will discussed with regard prosecution maintenance defense enforcement product specific patent astrazeneca product specific patent jointly owned collaboration patent that would licensed astrazeneca under font style font size font family time roman section font defense against allegation infringement third party patent right license third party patent right know each case extent such matter would reasonably likely have material impact this agreement license granted hereunder addition manager will ensure that patent right claiming font style font size font family time roman specific composition matter exact sequence chemistry prospective designated lead candidate development candidate method using such compound prophylactic therapeutic diagnostic will separated into their patent application separate from other subject matter ensure such claim initially licensed astrazeneca under font font style font size font family time roman section font font style font size font family time roman then assigned product specific patent under font font style font size font family time roman section font font style font size font family time roman font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto addition manager will responsible determination inventorship determination inventorship will made accordance with united state patent therefore this will determine invention solely jointly owned relevant party party extent reasonably requested either party manager will solicit involvement more senior member their respective legal department most senior intellectual property attorney where appropriate with respect critical issue escalate issue senior representative input resolution pursuant font style font size font family time roman section font each party manger will consider comment suggestion made other good faith either party deems reasonably advisable party will enter into mutually agreeable common interest agreement covering matter contemplated this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold prosecution maintenance patent font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent filing font party responsible prosecution maintenance patent right forth font style font size font family time roman section font font style font size font family time roman section font will endeavor obtain patent protection product prosecutes maintains other patent covering product development using counsel choice with respect patent right licensed astrazeneca under font style font size font family time roman section font counsel reasonably acceptable astrazeneca such country responsible party table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold licensed patent astrazeneca patent font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold core technology patent manufacturing analytical patent font during agreement term will control responsible aspect core technology patent manufacturing analytical patent table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold product specific patent jointly owned collaboration patent font collaboration target collaboration target basis following collaboration program exercise date long applicable license astrazeneca under font style font size font family time roman section font effect astrazeneca will control responsible aspect prosecution maintenance product specific patent jointly owned collaboration patent that core technology patent manufacturing analytical patent each case same extent right control responsible such prosecution maintenance immediately prior such license such milestone payment subject font style font size font family time roman section font table style text align justify style text align justify table zbdd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca patent font astrazeneca will control responsible aspect prosecution maintenance astrazeneca patent subject font style font size font family time roman section font font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold jointly owned collaboration patent font will control responsible aspect prosecution maintenance jointly owned collaboration patent that core technology patent manufacturing analytical patent that cover product collaboration target prior applicable collaboration program exercise date astrazeneca will control responsible aspect prosecution maintenance jointly owned collaboration patent licensed astrazeneca under font style font size font family time roman section font with respect following collaboration program exercise date that cover product core technology patent manufacturing analytical patent table style text align justify style text align justify table cadc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold other matter pertaining prosecution maintenance patent font table style text align justify style text align justify table zcbb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will keep other party informed through manager material development with respect prosecution maintenance product specific patent jointly owned collaboration patent which such party responsibility prosecution maintenance pursuant font style font size font family time roman section font font style font size font family time roman section font this font style font size font family time roman section font including providing copy material data arises office action office action response other correspondence that such party provides receives from patent office including notice interference reissue examination opposition request patent term extension patent related filing providing other party timely opportunity have reasonable input into strategic aspect such prosecution maintenance table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca elect file prosecute patent application jointly owned collaboration patent product specific patent that have been licensed assigned astrazeneca under this agreement astrazeneca product specific patent font style font size font family time roman font weight bold font style italic astrazeneca prosecuted patent font particular country continue prosecution including interference opposition reissue proceeding examination patent term extension adjustment restoration maintenance astrazeneca prosecuted patent particular country file prosecute patent application astrazeneca prosecuted patent particular country following written request from file prosecute such country then astrazeneca will notify promptly writing intention including reasonably detailed rationale doing good time enable meet deadline which action must taken establish preserve such patent right such country will have right obligation file prosecute maintain enforce otherwise pursue such astrazeneca prosecuted patent applicable country expense with counsel choice such case astrazeneca will cooperate with file continue prosecute maintain enforce otherwise pursue such astrazeneca prosecuted patent such country name only extent that astrazeneca required take position with respect such abandoned astrazeneca prosecuted patent that would reasonably likely adversely affect scope validity enforceability other patent right being prosecuted maintained astrazeneca under this agreement notwithstanding anything contrary this agreement assumes responsibility prosecution maintenance such astrazeneca prosecuted patent under this font style font size font family time roman section font will have obligation notify astrazeneca intends abandon such astrazeneca prosecuted patent table style text align justify style text align justify table efba class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party through manager will cooperate good faith determine when divisional continuation application will filed with respect jointly owned collaboration patent product specific patent where divisional continuation patent application filing would practical reasonable then such divisional continuation filing will made table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party responsible prosecution maintenance pursuant font style font size font family time roman section font intends abandon such jointly owned collaboration patent without first filing continuation substitution then such party will notify other party such intention least before such jointly owned collaboration patent will become abandoned such other party will have right obligation assume responsibility prosecution maintenance thereof expense subject font style font size font family time roman section font with counsel choice which case abandoning party will will cause affiliate assign other party such assignment possible grant fully paid exclusive license their right title interest such jointly owned collaboration patent party assumes responsibility prosecution maintenance such jointly owned collaboration patent under this font style font size font family time roman section font such party will have obligation notify other party intention such party abandon such jointly owned collaboration patent table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small text align left style text align justify table zaae class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto addition party will consult through manager take into consideration comment other party matter relating interference reissue examination opposition with respect those patent right which such other party ownership interest received license thereunder accordance with this agreement future accordance with this agreement obtain license sublicense thereunder table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent cost font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold jointly owned collaboration patent font unless party agree otherwise astrazeneca will share equally patent cost associated with prosecution maintenance jointly owned collaboration patent font style font size font family time roman font style italic provided that font either party decline share cost filing prosecuting maintaining jointly owned collaboration patent particular country particular country which case declining party will will cause affiliate assign other party such assignment possible grant fully paid exclusive license their right title interest such jointly owned collaboration patent table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold licensed patent astrazeneca patent font except forth font style font size font family time roman section font font style font size font family time roman section font each party will responsible patent cost incurred such party prior after effective date country prosecution maintenance patent right which such party responsible under font style font size font family time roman section font table style text align justify style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold defense claim brought third font font style font size font family time roman font weight bold party font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold product prior astrazeneca exercising collaboration program license right font third party initiate proceeding claiming patent right owned licensed such third party infringed development manufacture commercialization product with respect which astrazeneca exercised collaboration program license right will have first right obligation defend against such proceeding sole cost expense elect defend against such proceeding then will have sole right direct defense elect whether settle such claim font style font size font family time roman font style italic provided however font will settle such proceeding without prior written consent astrazeneca such consent unreasonably withheld conditioned delayed astrazeneca will reasonably assist defending such proceeding cooperate such litigation request expense will provide astrazeneca with prompt written notice commencement such proceeding that type described this font style font size font family time roman section font will keep astrazeneca apprised progress such proceeding elect defend against such proceeding then will notify astrazeneca writing within after first receives written notice initiation such proceeding astrazeneca will have right obligation defend against such proceeding sole cost expense thereafter astrazeneca will have sole right direct defense thereof including right settle such claim only with prior written consent which consent will unreasonably withheld delayed conditioned event party defending such proceeding will reasonably assist other party cooperate such litigation request expense party defending such proceeding each party expense with counsel join defense initiated directed other party under this font style font size font family time roman section font each party will provide other party with prompt written notice commencement such proceeding under this font style font size font family time roman section font such party will promptly furnish other party with copy each communication relating alleged infringement that received such party table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zcdbcd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold product after astrazeneca exercise collaboration program license right font third party initiate proceeding claiming patent right owned licensed such third party infringed development manufacture commercialization product being developed commercialized astrazeneca under license granted under font style font size font family time roman section font then astrazeneca will have first right obligation defend against such proceeding sole cost expense astrazeneca elect defend against such proceeding then astrazeneca will have sole right direct defense elect whether settle such claim only with prior written consent unreasonably withheld conditioned delayed will reasonably assist astrazeneca defending such proceeding cooperate such litigation request expense astrazeneca astrazeneca will provide with prompt written notice commencement such proceeding that type described this font style font size font family time roman section font astrazeneca will keep apprised progress such proceeding astrazeneca elect defend against proceeding then astrazeneca will notify writing within after astrazeneca first receives written notice initiation such proceeding will have right obligation defend against such proceeding sole cost expense thereafter will have sole right direct defense thereof including right settle such claim only with prior written consent astrazeneca which consent will unreasonably withheld delayed conditioned notwithstanding foregoing font style font size font family time roman font font style font size font family time roman font style italic provided however font font style font size font family time roman event font party defending such proceeding will reasonably assist other party cooperate such litigation request expense party defending such proceeding each party expense with counsel join defense initiated directed other party under this font style font size font family time roman section font each party will provide other party with prompt written notice commencement such proceeding under this font style font size font family time roman section font such party will promptly furnish other party with copy each communication relating alleged infringement that received such party table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold discontinued product font third party initiate proceeding claiming that patent right know owned licensed such third party infringed development manufacture commercialization discontinued product will have first right obligation defend against settle such proceeding sole cost expense astrazeneca will reasonably assist defending such proceeding cooperate such litigation request expense each party expense with counsel join defense directed other party will provide astrazeneca with prompt written notice commencement such proceeding allegation infringement which becomes aware that type described this font style font size font family time roman section font will promptly furnish astrazeneca with copy each communication relating alleged infringement received table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold interplay between enforcement defense third party claim font notwithstanding provision font style font size font family time roman section font font style font size font family time roman section font extent that party defense against third party claim infringement under this font style font size font family time roman section font involves enforcement other party know patent right defense invalidity claim with respect such other party know patent right then each case general concept font style font size font family time roman section font will apply enforcement such other party know patent right defense such invalidity claim font style font size font family time roman font each party right enforce intellectual property except that relevant commercializing party will have initial right extent provided font style font size font family time roman section font enforce such know patent right defend such invalidity claim other party will have step right extent provided font style font size font family time roman section font enforce such know patent right defend such invalidity claim table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold enforcement patent against competitive infringement font with respect infringement unauthorized misappropriation threatened infringement third party product specific patent reason development manufacture commercialization product that bind collaboration target field font style font size font family time roman font weight bold font style italic competitive infringement font prior applicable collaboration program exercise date will have sole right with obligation discus with astrazeneca obligation institute prosecute control proceeding with respect thereto with respect competitive infringement after applicable collaboration program exercise date party will handle such competitive infringement accordance with remainder this font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zbbd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold duty notify competitive infringement font either party learns competitive infringement third party which such party obligation confidentiality such party will promptly notify other party writing will provide such other party with available evidence such competitive infringement font style font size font family time roman font style italic provided however font that case competitive infringement under font style font size font family time roman section font below such written notice will given within table style text align justify style text align justify table ebfe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold control competitive infringement proceeding font competitive infringement with respect product licensed astrazeneca under font style font size font family time roman section font that occurs after applicable collaboration program exercise date long part such proceeding astrazeneca also enforces patent right controlled astrazeneca including product specific patent assigned astrazeneca under this agreement being infringed that cover such product then astrazeneca will have first right obligation institute prosecute control proceeding with respect thereto counsel choice expense will have right expense represented that action counsel choice font style font size font family time roman font style italic however font astrazeneca will have right control such litigation astrazeneca fails initiate proceeding within period after receipt written notice such competitive infringement subject extension conclude negotiation astrazeneca commenced good faith negotiation with alleged infringer elimination such competitive infringement within such period will have right initiate control proceeding with respect such competitive infringement counsel choice astrazeneca will have right represented such action counsel choice expense notwithstanding foregoing font style font size font family time roman font style italic provided however font font style font size font family time roman font table style text align justify style text align justify table cafe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold joinder font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party initiate proceeding accordance with this font style font size font family time roman section font other party agrees joined party plaintiff where necessary give first party reasonable assistance authority file prosecute proceeding subject font style font size font family time roman section font cost expense each party incurred pursuant this font style font size font family time roman section font will borne party initiating such proceeding font style font size font family time roman font style italic provided font astrazeneca will only requested join such proceeding such proceeding relates patent right product licensed astrazeneca under font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto party initiate proceeding accordance with this font style font size font family time roman section font other party join such proceeding party plaintiff where necessary such other party seek lost profit with respect such infringement table style text align justify style text align justify table fbefc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold share recovery font damage other monetary award recovered with respect proceeding brought pursuant this font style font size font family time roman section font will shared follows table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto amount such recovery will first applied party reasonable pocket cost incurred connection with such proceeding which amount will allocated font style font size font family time roman font style italic rata font insufficient cover totality such expense then table style text align justify style text align justify table fdfa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto remaining proceeds will allocated follows initiate control defense proceeding pursuant font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font astrazeneca initiate control defense proceeding pursuant font style font size font family time roman section font astrazeneca will receive retain remaining proceeds will receive retain remaining proceeds astrazeneca initiate control defense proceeding pursuant font style font size font family time roman section font font style font size font family time roman font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold settlement font notwithstanding anything contrary this font style font size font family time roman article font neither party enter settlement consent judgment other voluntary final disposition suit under this font style font size font family time roman article font that disclaims limit scope admits invalidity unenforceability grant license covenant similar immunity under patent right controlled other party without first obtaining written consent party that control relevant patent right table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold infringement font notwithstanding anything contrary this font style font size font family time roman section font solely with respect licensed patent that have been assigned astrazeneca under this agreement competitive infringement under time period forth font style font size font family time roman section font during which party will have initial right bring proceeding will shortened total that extent other party right pursuant such section initiate proceeding first party initiate proceeding such other party will have such right first party initiate proceeding within after such first party receipt written notice such competitive infringement table style text align justify style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold other infringement font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold jointly owned collaboration patent font with respect infringement field jointly owned collaboration patent which competitive infringement party will cooperate good faith bring suit together against such infringing party party decide permit party solely bring suit damage other monetary award recovered with respect proceeding brought pursuant this font style font size font family time roman section font will shared follows amount such recovery will first applied party reasonable pocket cost incurred connection with such proceeding which amount will allocated font style font size font family time roman font style italic rata font insufficient cover totality such expense party jointly initiate proceeding pursuant this font style font size font family time roman section font only party initiate proceeding pursuant this font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent solely owned font will retain right pursue infringement patent right solely owned which other than competitive infringement will retain recovery with respect thereto table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent solely owned astrazeneca font astrazeneca will retain right pursue infringement patent right solely owned astrazeneca which other than competitive infringement astrazeneca will retain recovery with respect thereto table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent listing font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca obligation font astrazeneca will promptly accurately completely list with applicable regulatory authority during agreement term applicable patent right that cover product licensed astrazeneca under font style font size font family time roman section font prior such listing party will meet through manager evaluate identify applicable patent right astrazeneca will have right review where reasonable original record relating invention which patent right being considered manager such listing notwithstanding preceding sentence astrazeneca will retain final decision making authority listing applicable patent right product that core technology patent manufacturing analytical patent regardless which party owns such patent right table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold obligation font will promptly accurately completely list with applicable regulatory authority applicable patent right that cover discontinued product prior such listing manager will meet evaluate identify applicable patent right will have right review where reasonable original record relating invention which patent right being considered manager such listing notwithstanding preceding sentence will retain final decision making authority listing applicable patent right such discontinued product applicable regardless which party owns such patent right table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold joint research agreement under leahy smith america invents font party intends invoke right under leahy smith america invents will notify other party neither party will make election under such provision when exercising right under this font style font size font family time roman article font without prior written consent other party such consent unreasonably withheld conditioned delayed party will reasonable effort cooperate coordinate their activity with such party with respect submission filing other activity support thereof party acknowledge agree that this agreement joint research agreement defined table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold obligation third party font notwithstanding foregoing each party right obligation with respect licensed technology under this font style font size font family time roman article font will subject third party right obligation under third party agreement restriction obligation which astrazeneca agreed under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font prior agreement such agreement effect date such collaboration target designated high interest target placed high interest target list with respect execution date such prior agreement amended thereafter license agreement such agreement effect date identified license agreement added font style font size font family time roman font variant small appendix font font style font size font family time roman font accordance with font style font size font family time roman section font have been disclosed astrazeneca prior such date form disclosed astrazeneca prior such date such license agreement amended thereafter unless such amendment made with astrazeneca prior written consent font style font size font family time roman font style italic provided font font style font size font family time roman font style italic however font that extent that transferable right prosecute maintain enforce patent right licensed astrazeneca hereunder this agreement purport grant such right astrazeneca will such regard with respect such patent right astrazeneca direction table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional right exception font notwithstanding provision this font style font size font family time roman article font subject font style font size font family time roman section font retains sole right prosecute maintain core technology patent manufacturing analytical patent during agreement term control enforcement core technology patent manufacturing analytical patent will take lead such enforcement solely extent that scope validity patent right controlled covering core technology patent manufacturing analytical patent risk table style text align justify style text align justify table aaedca class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold patent term extension font font style font size font family time roman font weight bold font party will cooperate with each other gaining patent term extension wherever applicable product astrazeneca will determine which product specific patent will extended clarity with respect product specific patent which astrazeneca exclusive license under font style font size font family time roman section font between astrazeneca third party granted license outside field under such product specific patent astrazeneca will determine which product specific patent will extended table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font with respect product specific patent astrazeneca will have right determine whether again unified patent court system requested astrazeneca will promptly thing reasonably necessary execute document required give effect such decision font style font size font family time roman font style italic provided that font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify confidential style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center representation warranty style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold representation warranty covenant both party font each party hereby represents warrant effective date covenant other party that table style text align justify style text align justify table cbcdb bcdd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto power authority legal right enter into this agreement perform obligation hereunder that taken necessary action part required authorize execution delivery this agreement performance obligation hereunder table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation such party enforceable against accordance with term subject effect bankruptcy insolvency other general application affecting enforcement creditor right judicial principle affecting availability specific performance general principle equity whether enforceability considered proceeding equity table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto necessary consent approval authorization regulatory authority other party required obtained such party connection with execution delivery this agreement performance obligation hereunder have been obtained table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto execution delivery this agreement performance such party obligation hereunder conflict with violate requirement applicable provision certificate incorporation bylaw similar instrument such party applicable material conflict with violate breach constitute default require consent already obtained under contractual obligation court administrative order which such party bound table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto employee consultant contractor except academic collaborator third party under permitted license prior agreement relation astrazeneca affiliate third party appointed term agreement described font style font size font family time roman section font such party affiliate performing development activity hereunder behalf such party such party hereby covenant other party that they will obligated assign right title interest invention developed them whether patentable such party affiliate respectively sole owner thereof table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto such party will such party hereby covenant other party that will perform activity pursuant this agreement compliance with good laboratory clinical practice cgmp applicable each case applicable under regulation country state local government wherein such activity conducted with respect care handling development activity hereunder human animal behalf such party will time comply will ensure compliance subcontractor with applicable national federal state local regulation ordinance performing obligation under this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto such party debarred under united state federal food drug cosmetic comparable applicable will during agreement term employ service person entity debarred connection with development manufacture commercialization product either party becomes aware debarment threatened debarment person entity providing service such party including party itself affiliate sublicensees which directly indirectly relate activity under this agreement other party will immediately notified writing table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold representation warranty covenant font hereby represents warrant astrazeneca effective date that table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto owner otherwise right grant right license purport grant astrazeneca with respect licensed technology under this agreement compound identified before effective date collaboration program they exist effective date table style text align justify style text align justify table beab class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge licensed patent have been filed maintained properly correctly material respect table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto previously entered into agreement whether written oral with respect otherwise assigned transferred licensed conveyed otherwise encumbered right title interest licensed technology including granting covenant with respect thereto such make representation forth font style font size font family time roman section font true will enter into such agreement grant such right title interest person that inconsistent with right license granted astrazeneca under this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge each licensed patent properly identifies each every inventor claim thereof determined accordance with jurisdiction which such patent right issued such application pending table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table abca class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto received written claim alleging have knowledge fact circumstance indicating that licensed patent invalid unenforceable including licensed patent required order conduct obligation under collaboration plan they exist effective date applicable bring down date each case with respect collaboration target compound product identified before effective date table style text align justify style text align justify table eecd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto received written claim alleging have knowledge fact circumstance indicating that activity relating collaboration target compound product identified before effective date infringe intellectual property right third party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge license agreement license granted under license agreement full force effect received written notice knowledge breach party license agreement performance obligation under this agreement including collaboration plan they exist effective date applicable bring down date will constitute breach obligation under license agreement license granted thereunder table style text align justify style text align justify table ceadb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge require additional license other intellectual property right order conduct obligation under collaboration plan they exist effective date applicable bring down date each case with respect collaboration target compound identified before effective date table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge respect pending united state patent application included licensed patent submitted material prior which aware accordance with requirement united state patent trademark office table style text align justify style text align justify table ffab deddc bced class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto knowledge neither affiliate owns control patent right know covering formulation delivery technology effective date there additional license beyond those that would granted astrazeneca under font style font size font family time roman section font upon exercise collaboration program license right collaboration target under intellectual property owned controlled affiliate effective date each case that would necessary useful order astrazeneca further develop manufacture commercialize compound contemplated under collaboration plan they exist effective date applicable bring down date table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font variant small appendix font prior agreement complete accurate list license agreement agreement between third party effective date with respect exclusive target included this agreement effective date that create material third party obligation that affect right granted astrazeneca under this agreement prior agreement have been materially amended extended since first being placed data room which astrazeneca given access during negotiation this agreement subject redaction represent true complete accurate copy thereof such redaction information necessary disclose understand implication such prior agreement this agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table aaafdf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto conducted clinical study with compound conducted required contractor consultant conduct preclinical study related compound compliance with good laboratory clinical practice cgmp applicable each case applicable under regulation country state local government wherein such activity were conducted table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold update warranty font collaboration target collaboration target basis time delivers lead candidate data package under font style font size font family time roman section font time during evaluation period with respect such target each font style font size font family time roman font weight bold font style italic bring down date font knowledge that representation warranty forth font style font size font family time roman section font true accurate such bring down date with respect such target then existing compound such target including identified after effective date will notify astrazeneca relevant fact circumstance soon practicable later than before applicable collaboration program license right deadline table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold additional covenant font font style font size font family time roman font hereby covenant astrazeneca that during agreement term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will promptly amend font style font size font family time roman font variant small appendix font font style font size font family time roman font core technology patent font style font size font family time roman font variant small appendix font font style font size font family time roman font manufacturing analytical patent font style font size font family time roman font variant small appendix font font style font size font family time roman font product specific patent submit such amended appendix astrazeneca becomes aware that core technology patent manufacturing analytical patent product specific patent properly identified such appendix table style text align justify style text align justify table zbbc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will promptly notify astrazeneca becomes aware agreement that should have been identified prior agreement license agreement shall provide astrazeneca with copy such agreement with astrazeneca written consent font style font size font family time roman font variant small appendix font font style font size font family time roman font license agreement font style font size font family time roman font variant small appendix font font style font size font family time roman font prior agreement will amended include such omitted agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will maintain breach license agreement other agreement with third party entered into after execution date that provide grant right from such third party that controlled licensed that belief become subject license from astrazeneca exclusive target lead candidate product will amend modify terminate such agreement manner that would adversely affect astrazeneca right hereunder without first obtaining astrazeneca written consent which consent withheld astrazeneca sole discretion table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align font weight bold text align justify width auto font style font size font family time roman disclaimer warranty font except express warranty forth this font style font size font family time roman article font astrazeneca make representation grant warranty express implied either fact operation statute otherwise astrazeneca each specifically disclaim warranty whether written oral express implied including warranty quality merchantability fitness particular purpose warranty validity patent right infringement intellectual property right third party table style text align justify margin left style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center indemnification insurance style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold indemnification astrazeneca font astrazeneca agrees defend affiliate their respective director officer stockholder employee agent their respective successor heir assigns collectively font style font size font family time roman font weight bold font style italic indemnitees font will indemnify hold harmless indemnitees from against liability loss cost damage expense payable third party reasonable attorney other legal expense with respect thereto collectively font style font size font family time roman font weight bold font style italic loss font arising claim action lawsuit other proceeding third party collectively font style font size font family time roman font weight bold font style italic third party claim font brought against indemnitee resulting from occurring result activity conducted astrazeneca employee consultant contractor performance astrazeneca conducted activity development manufacture commercialization product astrazeneca affiliate sublicensees distributor compulsory sublicensees only extent astrazeneca indemnified such compulsory sublicensee contractor breach astrazeneca representation warranty covenant pursuant this agreement negligence willful misconduct astrazeneca astrazeneca affiliate sublicensee performance this agreement font style font size font family time roman font style italic except font such case extent such loss result from negligence willful misconduct indemnitee breach representation warranty covenant obligation pursuant this agreement breach applicable indemnitee table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold indemnification font agrees defend astrazeneca affiliate their respective director officer stockholder employee agent their respective successor heir assigns collectively font style font size font family time roman font weight bold font style italic astrazeneca indemnitees font will indemnify hold harmless astrazeneca indemnitees from against loss arising third party claim brought against astrazeneca indemnitee resulting from occurring result activity conducted employee consultant contractor performance conducted activity breach representation warranty covenant pursuant this agreement negligence willful misconduct indemnitee contractor performance this agreement development manufacture commercialization discontinued product affiliate sublicensees distributor contractor font style font size font family time roman font style italic except font such case extent such loss result from negligence willful misconduct astrazeneca indemnitee breach astrazeneca representation warranty covenant obligation pursuant this agreement breach applicable astrazeneca indemnitee table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold notice claim font indemnification claim provided font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font will made solely such party this agreement font style font size font family time roman font weight bold font style italic indemnified party font indemnified party will give indemnifying party prompt written notice font style font size font family time roman font weight bold font style italic indemnification claim notice font loss discovery fact upon which indemnified party intends base request indemnification under font style font size font family time roman section font font style font size font family time roman section font event will indemnifying party liable loss extent such loss result from delay providing such notice each indemnification claim notice must contain description claim nature amount such loss extent that nature amount such loss known such time indemnified party will furnish promptly indemnifying party copy paper official document received respect loss third party claim table style text align justify style text align justify table aafa bdad class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold defense settlement cooperation expense font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold control defense font option indemnifying party assume defense third party claim giving written notice indemnified party within after indemnifying party receipt indemnification claim notice assumption defense third party claim indemnifying party will construed acknowledgment that indemnifying party liable indemnify indemnified party respect third party claim will constitute waiver indemnifying party defense assert against indemnified party claim indemnification upon assuming defense third party claim indemnifying party appoint lead counsel defense third party claim legal counsel selected indemnifying party event indemnifying party assumes defense third party claim indemnified party will soon reasonably possible deliver indemnifying party original notice document including court paper received indemnified party connection with third party claim should indemnifying party assume defense third party claim except provided this font style font size font family time roman section font indemnified party will responsible legal cost expense subsequently incurred such indemnified party connection with analysis defense settlement third party claim table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold right participate defense font without limiting font style font size font family time roman section font indemnified party will entitled participate control defense such third party claim employ counsel choice such purpose font style font size font family time roman font style italic provided however font that such employment will indemnified party cost expense unless employment thereof been specifically authorized indemnifying party writing indemnifying party failed assume defense employ counsel accordance with font style font size font family time roman section font which case indemnified party will control defense interest indemnified party indemnifying party with respect such third party claim sufficiently adverse prohibit representation same counsel both party under applicable ethical rule equitable principle which case indemnifying party will responsible such cost expense counsel indemnified party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold settlement font with respect third party claim relating solely payment money damage connection with third party claim that will admit liability violation part indemnified party result indemnified party becoming subject injunctive other relief otherwise adversely affecting business indemnified party manner such granting license admitting invalidity patent right controlled indemnified party which indemnifying party will have acknowledged writing obligation indemnify indemnified party hereunder indemnifying party will have sole right consent entry judgment enter into settlement otherwise dispose such loss such term indemnifying party sole discretion will deem appropriate with respect other loss connection with third party claim where indemnifying party assumed defense third party claim accordance with font style font size font family time roman section font indemnifying party will have authority consent entry judgment enter into settlement otherwise dispose such loss provided obtains prior written consent indemnified party which consent will unreasonably withheld indemnifying party will liable settlement consent entry judgment other disposition loss indemnified party that reached without written consent indemnifying party regardless whether indemnifying party chooses defend prosecute third party claim indemnified party will admit liability with respect settle compromise discharge third party claim without prior written consent indemnifying party such consent unreasonably withheld table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold cooperation font regardless whether indemnifying party chooses defend prosecute third party claim indemnified party will will cause each other indemnified party cooperate defense prosecution thereof will furnish such record information testimony provide such witness attend such conference discovery proceeding hearing trial appeal reasonably requested connection therewith such cooperation will include access during normal business hour afforded indemnifying party reasonable retention indemnified party record information that reasonably relevant such third party claim making indemnified party other employee agent available mutually convenient basis provide additional information explanation material provided hereunder indemnifying party will reimburse indemnified party reasonable pocket cost expense connection therewith table style text align justify style text align justify table zafa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold cost expense font except provided above this font style font size font family time roman section font cost expense including attorney expense incurred indemnified party connection with claim will reimbursed calendar quarter basis indemnifying party without prejudice indemnifying party right contest indemnified party right indemnification subject refund event indemnifying party ultimately held obligated indemnify indemnified party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold insurance font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold insurance obligation font will maintain cost reasonable insurance against liability other risk associated with activity contemplated this agreement including limited indemnification obligation herein such amount such term customary prudent practice biotech company similar size with similar resource pharmaceutical industry activity conducted under this agreement taking into account scope development product will furnish astrazeneca evidence insurance required under this font style font size font family time roman section font upon request table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca insurance obligation font astrazeneca hereby represents warrant that will maintain cost reasonable insurance against liability other risk associated with activity contemplated this agreement including product liability including limited indemnification obligation herein such amount such term customary prudent practice large company pharmaceutical industry activity conducted astrazeneca under this agreement astrazeneca will maintain such insurance self insurance throughout agreement term five year thereafter will furnish evidence such insurance upon request table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table zaebc class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold limitation consequential damage font font style font size font family time roman font weight bold except claim third party that subject indemnification under this font font style font size font family time roman font weight bold article font font style font size font family time roman font weight bold font font style font size font family time roman font weight bold section font font style font size font family time roman font weight bold claim arising party willful misconduct party breach font font style font size font family time roman font weight bold article font font style font size font family time roman font weight bold breach font font style font size font family time roman font weight bold section font font style font size font family time roman font weight bold astrazeneca affiliate claim arising party breach confidentiality obligation under this agreement neither party affiliate will liable other party this agreement affiliate incidental consequential special punitive other indirect damage lost imputed profit royalty lost data cost procurement substitute good service whether liability asserted contract tort including negligence strict product liability indemnity contribution irrespective whether that party representative that party been advised otherwise might have anticipated possibility such loss damage font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold anti bribery corruption compliance font table style text align justify style text align justify table zfbc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party agrees behalf itself officer director employee behalf affiliate that will will diligent effort procure that agent representative consultant subcontractor hired activity undertaken connection with performance this agreement together with such party font style font size font family time roman font weight bold font style italic party representative font performance obligation hereunder table style text align justify style font size font family time roman text align justify margin left party representative will directly indirectly offer promise authorize payment money give offer promise give authorize giving anything else value style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto government official order influence official action table style text align justify style text align justify table bdbf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto person whether government official influence such person breach duty good faith impartiality trust acting improperly reward such person acting improperly where such person would acting improperly receiving money other thing value table style text align justify style text align justify table ccdcf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto other person while knowing having reason know that portion money other thing value will paid offered promised given will otherwise benefit government official order influence official action against either party connection with matter that subject this agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto person reward that person acting improperly induce that person improperly table style text align justify style text align justify table bfaaeab class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will will diligent effort procure that party representative will directly indirectly solicit receive agree accept payment money anything else value violation anti corruption table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party acknowledges that undertaking given font style font size font family time roman section font font style font size font family time roman font material other party entering into relationship with such party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party behalf itself party representative represents warrant other party that term this agreement year thereafter will will diligent effort procure that party representative keep maintain accurate book reasonably detailed record connection with performance obligation under this agreement including record required establish compliance with font style font size font family time roman section font font style font size font family time roman font above table style text align justify style text align justify table cfbfe class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will promptly provide other party with written notice following event upon becoming aware material breach violation party representative representation warranty undertaking forth font style font size font family time roman section font font style font size font family time roman font upon receiving formal notification that target formal investigation relevant authority material anti corruption violation upon receipt information from party representative connected with this agreement that them target formal investigation relevant authority material anti corruption violation table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto term this agreement year thereafter each party will purpose auditing monitoring performance compliance with agreement particularly this font style font size font family time roman section font permit other party affiliate auditor them regulatory authority have access premise such party extent that such party able secure such access party representative each case used connection with this agreement together with right access personnel record that relate this agreement font style font size font family time roman font weight bold font style italic audit font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party will responsible breach representation warranty undertaking this font style font size font family time roman section font anti corruption party representative table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party disclose term this agreement action taken under this font style font size font family time roman section font prevent potential violation continuing violation applicable anti corruption including identity other party payment term governmental authority such party determines upon advice counsel that such disclosure necessary table style font size font family time roman font weight bold text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center term termination style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold agreement term expiration font this font style font size font family time roman section font font style font size font family time roman article font font style font size font family time roman article font this agreement will become effective execution date remainder this agreement will become effective effective date unless earlier terminated pursuant other provision this font style font size font family time roman article font will continue full force effect until this agreement expires follows table style text align justify style text align justify table ebca class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto where there collaboration target designated under font style font size font family time roman section font later expiration disease research term last date which former high interest target could become collaboration target pursuant font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto where there development candidate designated under font style font size font family time roman section font later expiration collaboration program term last date which exercise carryover option could occur table style text align justify style text align justify table zecf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto where collaboration program license right including those that could arise pursuant font style font size font family time roman section font font style font size font family time roman section font have expired unexercised table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto country country product product basis date expiration payment obligation astrazeneca under this agreement with respect such product such country table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto entirety upon expiration payment obligation astrazeneca under this agreement with respect last product country pursuant font style font size font family time roman section font table style text align justify style font size font family time roman text align justify margin left period from effective date until date expiration this agreement pursuant this font style font size font family time roman section font earlier termination this agreement pursuant font style font size font family time roman section font font style font size font family time roman font weight bold font style italic agreement term font antitrust clearance required accordance with font style font size font family time roman section font obtained december this agreement including this font style font size font family time roman section font font style font size font family time roman article font font style font size font family time roman article font will automatically expire style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination agreement font table style text align justify style text align justify table fabbdecc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca termination convenience change control font table style text align justify style text align justify table zfaa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination convenience with respect font time following payment astrazeneca upfront under font style font size font family time roman section font subject font style font size font family time roman section font below astrazeneca will entitled terminate this agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto entirety part collaboration target collaboration target basis convenience providing written notice such termination table style text align justify style text align justify table adbd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto with respect program forth font style font size font family time roman section font written notice such termination table style text align justify style text align justify table cfed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold change control event font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto prior collaboration program license right deadline collaboration target astrazeneca will have right terminate this agreement whole part with respect more collaboration target which astrazeneca exercised collaboration program license right immediately upon written notice provided time within business following notification astrazeneca closing change control event will obliged give notice such closing event fails astrazeneca right terminate exercised within business such closing coming astrazeneca knowledge such closing occurs during collaboration program term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca discretion astrazeneca decides terminate this agreement with respect particular collaboration target pursuant this font style font size font family time roman section font following closing change control event during collaboration program term then subject below provision this font style font size font family time roman section font astrazeneca obligation under font style font size font family time roman article font perform relevant program such collaboration target will remain successor will commercially reasonable effort perform relevant program such collaboration target accordance with this agreement while extent reasonably practicable maintaining confidentiality astrazeneca confidential information from entity acquiring result change control event soon reasonably possible after public announcement such change control event successor astrazeneca will meet discus good faith successor will continue perform obligation under this agreement with respect collaboration target which astrazeneca exercised collaboration program license right that astrazeneca consider whether exercise right termination under this font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca exercise right termination astrazeneca will have right providing with written notice within business following notification astrazeneca closing change control event require that cease performing certain activity operate take such measure requested ensure prompt smooth transition such activity astrazeneca designee astrazeneca will entitled deduct amount equal from next applicable milestone license payment applicable without prejudice foregoing requested astrazeneca such measure will include technology transfer pursuant provision font style font size font family time roman section font font style font size font family time roman section font either case without charge astrazeneca table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto furthermore surviving entity following such change control event clinically developing commercializing product that directly competing with product under this agreement then subject font style font size font family time roman section font development commercialization such directly competing product such surviving entity will violation exclusivity covenant under font style font size font family time roman section font such product being developed commercialized acquiring party prior change control event solely with respect product that subjected such competition font style font size font family time roman section font shall apply table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination material breach font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold astrazeneca right terminate font astrazeneca reason believe that material breach this agreement other than with respect failure commercially reasonable effort under font style font size font family time roman article font which governed font style font size font family time roman section font below then astrazeneca deliver notice such material breach breach curable will have cure such breach fails cure such breach within period breach subject cure astrazeneca terminate this agreement entirety such breach relates this agreement entirety relevant part product product collaboration target collaboration target basis such breach relate this agreement entirety providing written notice table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold right terminate font reason believe that astrazeneca material breach this agreement other than with respect failure commercially reasonable effort under font style font size font family time roman article font font style font size font family time roman section font which governed font style font size font family time roman section font below then deliver notice such material breach astrazeneca breach curable astrazeneca will have cure such breach except extent such breach involves failure make payment when which breach must cured within following such notice astrazeneca fails cure such breach within period applicable breach subject cure terminate this agreement entirety such breach relates this agreement entirety relevant part product product collaboration target collaboration target basis such breach relate this agreement entirety providing written notice astrazeneca table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold remedy failure commercially reasonable effort font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto fails commercially reasonable effort contemplated font style font size font family time roman article font determined accordance with font style font size font family time roman section font astrazeneca will notify within thereafter astrazeneca will meet confer discus resolve matter good faith attempt devise mutually agreeable plan address outstanding issue related commercially reasonable effort font style font size font family time roman article font following such meeting fails commercially reasonable effort contemplated font style font size font family time roman article font such failure constitutes material breach this agreement then subject font style font size font family time roman section font below astrazeneca will have right sole discretion terminate this agreement whole part collaboration target collaboration target basis table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca fails commercially reasonable effort contemplated font style font size font family time roman article font font style font size font family time roman section font determined accordance with font style font size font family time roman section font will notify astrazeneca within thereafter astrazeneca will meet confer discus resolve matter good faith attempt devise mutually agreeable plan address outstanding issue related astrazeneca commercially reasonable effort font style font size font family time roman article font font style font size font family time roman section font following such meeting astrazeneca fails commercially reasonable effort contemplated font style font size font family time roman article font font style font size font family time roman section font such failure constitutes material breach this agreement then subject font style font size font family time roman section font below will have right sole discretion terminate this agreement part collaboration target collaboration target basis table style text align justify style text align justify table fbee class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold dispute regarding material breach font notwithstanding foregoing breaching party font style font size font family time roman section font font style font size font family time roman section font dispute good faith existence materiality failure cure such breach which payment breach provides notice breaching party such dispute within respectively such cure period notice period breaching party will have right terminate this agreement accordance with font style font size font family time roman section font font style font size font family time roman section font unless until been determined accordance with font style font size font family time roman section font that this agreement materially breached breaching party breaching party fails cure such breach within following such determination understood acknowledged that during pendency such dispute term condition this agreement will remain effect party will continue perform their respective obligation hereunder including satisfying payment obligation table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination licensed program font once astrazeneca exercised collaboration program license right with respect collaboration target neither party shall entitled terminate that licensed program pursuant font style font size font family time roman section font font style font size font family time roman font unless material breach failure commercially reasonable effort with respect such licensed program such breach failure shall determined licensed program licensed program basis table style text align justify style text align justify table faca class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination insolvency font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto either party terminate this agreement time other party file court agency pursuant statute regulation state country petition bankruptcy insolvency appointment receiver trustee party substantially asset other party proposes written agreement composition extension substantially debt other party will served with involuntary petition against filed insolvency proceeding such petition will dismissed within after filing thereof other party will propose party dissolution liquidation other party will make assignment substantially asset benefit creditor table style text align justify style text align justify table fffa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto right license granted under pursuant section this agreement will otherwise deemed purpose font style font size font family time roman section font title united state code font style font size font family time roman font weight bold font style italic bankruptcy code font analogous provision applicable outside license right intellectual property defined font style font size font family time roman section font bankruptcy code analogous provision applicable outside party will retain fully exercise their respective right election under bankruptcy code analogous provision applicable outside upon commencement bankruptcy proceeding party bankrupt party will further entitled complete duplicate complete access such intellectual property embodiment which already possession will promptly delivered bankrupt party upon written request table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold termination patent challenge font terminate this agreement astrazeneca dispute assist third party dispute validity licensed patent patent examination inter partes review post grant other patent office proceeding opposition litigation other court proceeding within written notice from astrazeneca fails rescind such action font style font size font family time roman font style italic provided however font that nothing this clause prevents astrazeneca from taking action referred this clause font style font size font family time roman font style italic provided further font that will have right terminate astrazeneca table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table cade class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto asserts invalidity defense court proceeding brought asserting infringement licensed patent table style text align justify style text align justify table cbca class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto acquires third party that existing challenge whether court administrative proceeding against licensed patent table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto license product which existing challenge whether court administrative proceeding against licensed patent table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold consequence expiration termination this agreement font table style text align justify style text align justify table fead class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold consequence termination this agreement font this agreement terminated party accordance with font style font size font family time roman section font entirety collaboration target collaboration target basis time reason following term will apply such termination only extent such termination font style font size font family time roman font with respect terminated collaboration program licensed program font style font size font family time roman font weight bold font style italic terminated program font target font style font size font family time roman font weight bold font style italic terminated target font product under such terminated program termination date font style font size font family time roman font weight bold font style italic discontinued product font entirety table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold license font license granted astrazeneca under this agreement will terminate astrazeneca affiliate subject font style font size font family time roman section font sublicensees will cease selling discontinued product under such license font style font size font family time roman font style italic provided that font astrazeneca affiliate sublicensees will have right sell remaining inventory discontinued product over period greater than month after effective date such termination astrazeneca will royalty accordance with font style font size font family time roman section font sale such inventory such product extent already paid there clinical study being conducted date termination astrazeneca shall entitled continue developing manufacturing compound product extent period necessary effect orderly transfer wind down such clinical study timely manner accordance with applicable table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration program license right font exercised prior date termination astrazeneca collaboration program license right will terminate with respect terminated target table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold exclusivity font neither party will have further obligation under font style font size font family time roman section font this agreement insofar relates terminated target table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold collaboration plan font except expressly stated survive under font style font size font family time roman section font neither party will have further obligation with respect terminated program under collaboration plan table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold responsibility discontinued product font product becomes discontinued product except expressly provided this font style font size font family time roman section font astrazeneca will have further obligation responsibility with respect such product except activity undertaken astrazeneca affiliate sublicensees distributor pursuant font style font size font family time roman section font prior date termination will responsible liability relating development manufacture commercialization discontinued product behalf affiliate sublicensees distributor following date such termination table style text align justify style text align justify table fbba class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold return information material font font style font size font family time roman font weight bold font party will return destroy directed other party data file record other material containing comprising other party confidential information which retain right under surviving provision this agreement notwithstanding foregoing party will permitted retain copy such data file record other material archival legal compliance purpose font style font size font family time roman font weight bold font each party will also permitted retain such additional copy computer record file containing other party confidential information that have been created solely automatic archiving back procedure extent created retained manner consistent with retaining party standard archiving back procedure other purpose confidential information shall continue subject term this agreement period forth font style font size font family time roman section font table style text align justify style text align justify table cedbc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold accrued right font font style font size font family time roman font weight bold font termination this agreement reason will without prejudice right financial compensation that will have accrued benefit party prior such termination such termination will relieve party from obligation that expressly indicated survive termination this agreement purpose clarification milestone payment under font style font size font family time roman article font accrue date applicable milestone event achieved even payment that time table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table eccedb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold survival font following provision this agreement will survive expiration earlier termination this agreement font style font size font family time roman section font process designating high interest target collaboration target only with respect party right obligation related restoring target this agreement collaboration target exclusivity covenant effect date such expiration earlier termination this agreement font style font size font family time roman section font core research term only with respect license other right granted therein font style font size font family time roman section font disease research term only with respect provision font style font size font family time roman section font referenced therein font style font size font family time roman section font process designating development candidate only with respect party right obligation related restoring target compound this agreement license other right granted therein exclusivity covenant effect date such expiration earlier termination this agreement font style font size font family time roman section font expiration collaboration program term only with respect provision font style font size font family time roman section font referenced therein font style font size font family time roman section font exclusive right obtain maintain exclusive license development candidate only with respect development candidate restored this agreement font style font size font family time roman section font exercise only with respect license other right granted therein astrazeneca exclusivity covenant effect date such expiration earlier termination this agreement font style font size font family time roman section font effect termination sublicenses font style font size font family time roman section font consequence natural expiration this agreement font style font size font family time roman section font implied license font style font size font family time roman section font grant back product specific patent font style font size font family time roman section font exclusive technology license grant astrazeneca font style font size font family time roman section font cross license under collaboration intellectual property font style font size font family time roman section font interaction license font style font size font family time roman section font royalty obligation font style font size font family time roman section font record retention font style font size font family time roman section font audit font style font size font family time roman section font font style font size font family time roman section font interest font style font size font family time roman section font technology astrazeneca technology font style font size font family time roman section font collaboration technology font style font size font family time roman section font jointly owned collaboration technology font style font size font family time roman section font jointly owned collaboration patent subject font style font size font family time roman section font applicable font style font size font family time roman section font jointly owned collaboration patent subject font style font size font family time roman section font applicable font style font size font family time roman article font indemnification insurance excluding font style font size font family time roman section font font style font size font family time roman section font consequence expiration termination this agreement font style font size font family time roman article font confidentiality font style font size font family time roman article font miscellaneous font style font size font family time roman font variant small appendix font definition extent definition embodied foregoing listed article section table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold special consequence certain termination font astrazeneca terminates agreement under font style font size font family time roman section font terminates this agreement under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font then addition term forth font style font size font family time roman section font following additional term will also apply only with respect terminated program terminated target discontinued product table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto subject font style font size font family time roman section font font style font size font family time roman section font astrazeneca will hereby grant table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left strong style font weight normal confidential strong style text align justify style text align justify margin left font style font size font family time roman font weight bold font font style font size font family time roman sublicensable worldwide exclusive license sublicense case under astrazeneca technology excluding astrazeneca background intellectual property controlled astrazeneca date such reversion that cover discontinued product developed commercialized astrazeneca affiliate such date font style text align justify margin left style text align justify margin left font style font size font family time roman font weight bold font font style font size font family time roman sublicensable worldwide exclusive license sublicense case under astrazeneca background intellectual property controlled astrazeneca date such reversion that cover discontinued product developed commercialized astrazeneca affiliate such date font style text align justify margin left style font size font family time roman text align justify margin left each case solely develop make have made sell offer sale have sold import otherwise commercialize discontinued product field such license will sublicensable accordance with font style font size font family time roman section font font style font size font family time roman font style italic mutatis mutandis font font style font size font family time roman font style italic provided that font will accordance with font style font size font family time roman article font indemnify hold harmless astrazeneca affiliate sublicensees from loss arising third party claim with respect exploitation such discontinued product responsible extent paid astrazeneca indemnify hold harmless astrazeneca affiliate licensing cost payment payable third party technology used discontinued product which astrazeneca made aware unless notifies astrazeneca that wish license under such technology cease such technology prior such notification each case with respect exploitation such discontinued product under such license that accrue after date such termination style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will assign back patent right that relate discontinued product previously assigned astrazeneca under this agreement table style text align justify style text align justify table dbfe ebfea class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will transfer with respect development commercialization discontinued product know data result regulatory information pricing market access strategy information health economic study information material communication with payors filing file possession astrazeneca copy thereof date such termination reversion that relate solely such discontinued product table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca will grant exclusive royalty free fully paid license under trademark that specific discontinued product solely with such discontinued product font style font size font family time roman font style italic provided however font that event will astrazeneca have obligation license trademark used astrazeneca both connection with product connection with sale other product service including astrazeneca astrazeneca formative mark table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table edfc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will control responsible aspect prosecution maintenance jointly owned collaboration patent astrazeneca will provide with will instruct counsel provide with information record astrazeneca counsel possession related prosecution maintenance such jointly owned collaboration patent each case only respect discontinued product table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto upon written request pursuant mutually agreed supply agreement astrazeneca will sell bulk finished product astrazeneca possession related compound that subject termination time such termination price equal astrazeneca cost time such material produced table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto affiliate sublicensees commercializes discontinued product which astrazeneca paid license under font style font size font family time roman section font with respect milestone product then each such case following first commercial sale such discontinued product affiliate sublicensees will astrazeneca royalty annual worldwide sale such discontinued product until table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto there licensed right granted astrazeneca under font style font size font family time roman section font party will negotiate good faith regarding reasonable royalty such discontinued product exceed annual worldwide sale such discontinued product paid astrazeneca discontinued product covered such licensed right with such royalty payment beginning date ending earlier table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto purpose clause sale shall mean sale affiliate sublicensees font style font size font family time roman font style italic provided that font definition sale agreed sublicensee length sublicense agreement commercialization discontinued product will used calculate sale such discontinued product sold sublicensees which royalty payable astrazeneca hereunder table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto clarity license granted astrazeneca pursuant this font style font size font family time roman section font include intellectual property right relating compound that compound table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align font weight bold text align justify width auto astrazeneca special consequence certain termination table style text align justify style text align justify table fbcdb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca terminates this agreement under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font provision font style font size font family time roman section font will apply font style font size font family time roman font style italic except that font astrazeneca affiliate sublicensees distributor will have right sell remaining inventory product astrazeneca will royalty accordance with font style font size font family time roman section font sale such inventory such product extent already paid table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca right terminate this agreement under font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font elect continue agreement following provision which will effective upon astrazeneca notice such election will apply table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto astrazeneca require that cease performing activity operate take such measure requested ensure prompt smooth transition such activity astrazeneca designee require that cease participate without prejudice foregoing requested astrazeneca such measure will include technology transfer pursuant provision font style font size font family time roman section font font style font size font family time roman section font either case without charge astrazeneca table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto money damage that awarded astrazeneca arising from circumstance which gave rise right terminate cost amount such cost mutually agreed good faith party incurred astrazeneca connection with transition responsibility under this agreement astrazeneca designee against monies owed astrazeneca provided font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto provision this font style font size font family time roman section font will preclude party from pursuing right remedy have hereunder equity with respect breach this agreement prejudice party right obtain performance obligation font style font size font family time roman font style italic provided that font assessing remedy available right transferred following termination this agreement entirety with respect termination program discontinued product shall taken into account party acknowledge agree that only right that permit party terminate this agreement this font style font size font family time roman article font table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center confidentiality style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold confidentiality exception font except extent expressly authorized this agreement otherwise agreed writing party agree that during agreement term five year thereafter receiving party font style font size font family time roman font weight bold font style italic receiving party font affiliate will keep confidential will publish otherwise disclose purpose other than provided this agreement confidential information disclosed other party affiliate font style font size font family time roman font weight bold font style italic disclosing party font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold prior confidentiality agreement font mutual confidential disclosure agreement executed astrazeneca april including amendment thereto font style font size font family time roman font weight bold font style italic font will govern disclosure confidential information defined between party prior execution date connection with subject matter this agreement confidential information exchanged between party after execution date under this agreement will subject term this font style font size font family time roman article font table style text align justify style text align justify table adfee class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold authorized disclosure font except expressly provided otherwise this agreement receiving party affiliate disclose third party confidential information disclosing party follows solely connection with performance obligation exercise right granted reserved this agreement under confidentiality provision restrictive than those this agreement font style font size font family time roman font style italic provided font that confidential information disclosed receiving party governmental entity agency without requiring such entity agency enter into confidentiality agreement extent reasonably necessary file prosecute patent copyright trademark application subject font style font size font family time roman section font below complying with applicable governmental regulation obtaining approval conducting clinical study clinical study marketing product otherwise required applicable regulation rule legal process including rule stock exchange font style font size font family time roman font style italic provided however font that receiving party affiliate required regulation make such disclosure disclosing party confidential information will except where impracticable necessary disclosure give reasonable advance notice disclosing party such disclosure requirement will reasonable effort secure confidential treatment such confidential information required disclosed communication with actual potential lender investor merger partner acquirer sublicensees consultant professional advisor need know basis each case under confidentiality provision restrictive than those this agreement extent such disclosure required comply with existing expressly stated contractual obligation owed such party affiliate licensor with respect intellectual property licensed other party under this agreement subject term protective order disclosing party using protect confidential information prosecute defend litigation permitted this agreement mutually agreed writing party table style text align justify style text align justify table bedb class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold licensed know font acknowledges astrazeneca interest maintaining confidentiality confidential information that know specific exclusive target product will take reasonable step protect such confidential information from unauthorized disclosure table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold press release publication disclosure agreement font table style text align justify style text align justify table fafb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold public announcement generally font promptly after each execution date effective date party will issue joint press release announcing existence this agreement form substance agreed writing party except extent required comply with applicable regulation rule legal process otherwise permitted accordance with this font style font size font family time roman section font each party agrees issue other press release other public statement disclosing other information relating this agreement term this agreement transaction contemplated hereby without prior written consent other party which consent will unreasonably withheld delayed table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold name font font style font size font family time roman font weight bold font except forth font style font size font family time roman section font neither party will other party name press release other publication without first obtaining prior consent party named table style text align justify style text align justify table zaaabf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold notice significant event font each party will promptly notify where advance warning provide advance notice other significant event related product major market including data regulatory advice approval reimbursement decision that party analyze need desirability publicly disclosing reporting such event notwithstanding font style font size font family time roman section font above press release other similar public communication related product will submitted astrazeneca review approval least three business advance such proposed public disclosure which approval will unreasonably withheld delayed astrazeneca related product efficacy safety data result regulatory advice approval reimbursement decision major market will submitted review shall subject approval least three business advance such proposed public disclosure table style text align justify style text align justify table bacb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold disclosure information related product font party that primary control product font style font size font family time roman font effective date with respect product which astrazeneca exercised collaboration program license right with respect licensed program astrazeneca sole right consistent with practice with other product issue press release other similar public communication disclose progress result regarding such product public order satisfy disclosure obligation under applicable remain consistent with normal public disclosure practice clarity connection with collaboration program such disclosure would involve disclosing collaboration target development candidate until such development candidate phase study font style font size font family time roman font style italic provided that font proposed press release other similar public communication such controlling party disclosing regulatory discussion efficacy safety data result related product such controlling party will submit such proposed communication controlling party review least business advance such proposed public disclosure controlling party will have right review recommend change such communication controlling party will good faith consider change that timely recommended controlling party addition time during such business review period other party informs such party that proposed public disclosure discloses invention made either party course research development under this agreement that have been protected through filing patent application public disclosure could expected have material adverse effect patent right know solely owned controlled such other party then such party will either delay such proposed publication period time reasonably necessary permit timely preparation first filing patent application information involved extent permitted applicable remove identified information prior disclosure while party acknowledge that interpreted that there overlap between this font style font size font family time roman section font font style font size font family time roman section font clarity party intend this font style font size font family time roman section font address public disclosure that primarily scientific scholarly nature which meant disclosed accordance with font style font size font family time roman section font below rather this font style font size font family time roman section font designed address more urgent disclosure required under applicable provide investor with material information regarding product this agreement timely manner that they make informed investment decision astrazeneca stock table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold scientific clinical presentation font regarding proposed scientific publication public presentation related summary result from collaboration plan clinical study generated astrazeneca product party acknowledge that scientific lead time element value product under this agreement further agree commercially reasonable effort control public scientific disclosure result research development activity under this agreement prevent potential adverse effect premature public disclosure such result example without limitation intellectual property protection competitive intelligence prejudicing optimal presentation major meeting clarity connection with collaboration program such disclosure would involve disclosing collaboration target development candidate until such development candidate phase study unless agreed otherwise party manager will establish procedure publication review each party will first submit other party manger early draft such publication presentation whether they presented orally written form least prior submission publication including facilitate publication summary clinical study data result required clinical trial registry each respective party each party will review such proposed publication order avoid unauthorized disclosure party confidential information preserve patentability invention arising from collaboration plan during such period other party informs such party that proposed publication contains confidential information other party then such party will delete such confidential information from proposed publication addition time during such period other party informs such party that proposed publication discloses invention made either party course research development under this agreement that have been protected through filing patent application public disclosure such proposed publication could expected have material adverse effect patent right know solely owned controlled such other party then such party will either delay such proposed publication from date other party informed such party objection proposed publication permit timely preparation first filing patent application information involved remove identified disclosure prior publication table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table cced class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold filing font each party will give other party reasonable opportunity review material filing with describing term this agreement prior submission such filing will give consideration reasonable comment filing party relating such filing table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold subsequent disclosure font notwithstanding foregoing extent information regarding this agreement product already been publicly disclosed either party affiliate subsequently disclose same information public without consent other party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold acknowledgment font each party will acknowledge press release public presentation publication regarding collaboration font style font size font family time roman font product other party role discovering developing product font style font size font family time roman font discontinued product applicable that product under license from otherwise acknowledge contribution from other party each party stock ticker symbol font style font size font family time roman font nasdaq nyse include product identify astrazeneca partner product drug pipeline table style text align justify style font size font family time roman font weight bold text align center article style font size font family time roman font weight bold text align center miscellaneous style font size font family time roman font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold dispute resolution font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold resolution senior representative font party will seek settle amicably dispute controversy claim arising connection with this agreement dispute between party including failure reach consensus matter within decision making authority will promptly presented executive vice president astrazeneca innovative medicine early development imed biotech unit chief operating officer font style font size font family time roman font weight bold font style italic senior representative font their respective designees resolution such senior representative their respective designees will meet person teleconference soon reasonably possible thereafter their good faith effort mutually agree upon resolution dispute controversy claim table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto request arbitration after negotiating good faith pursuant font style font size font family time roman section font party fail after good faith discussion undertaken within reasonable promptness reach amicable agreement within then either party upon written notice other submit binding arbitration pursuant font style font size font family time roman section font below provided that dispute within decision making authority whether resolved senior representative will subject arbitration statement made either party during such discussion will used other party admissible arbitration other subsequent proceeding resolving dispute table style text align justify style text align justify table zffc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold expert determination development candidate font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto fails designate development candidate belief that lead compound from program satisfies success criterion such that astrazeneca entitled benefit described font style font size font family time roman section font such dispute font style font size font family time roman font weight bold font style italic dispute font resolved senior representative accordance with font style font size font family time roman section font either party initiate expedited dispute resolution expert defined below resolve matter serving written notice thereof other party font style font size font family time roman font weight bold font style italic referral notice font table style text align justify style text align justify table edcaae class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto within following referral notice party will engage service independent scientist with than year experience drug discovery font style font size font family time roman font weight bold font style italic expert font font style font size font family time roman font style italic provided that font party unable agree will appointed expert within such period either party request international chamber commerce font style font size font family time roman font weight bold font style italic font appoint expert table style text align justify style text align justify table efed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto expert will directed review lead candidate data package provided determine within being provided such package whether lead compound from program satisfies success criterion table style text align justify style text align justify table bfdc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto expert will expert arbitrator decision expert shall final binding both party legal dispute regarding scope legal effect validity determination shall subject arbitration procedure font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party shall bear counsel cost disbursement arising dispute cost third party expert engaged under this font style font size font family time roman section font will paid party against whose position expert determination made table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align font weight bold text align justify width auto font style font size font family time roman arbitration font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto subject font style font size font family time roman section font font style font size font family time roman section font dispute claim controversy arising from related this agreement interpretation application breach termination validity thereof including claim inducement this agreement fraud otherwise resolved under provision font style font size font family time roman section font will resolved final binding arbitration conducted accordance with term this font style font size font family time roman section font arbitration will held york york according rule arbitration arbitration will conducted panel three arbitrator with significant experience pharmaceutical industry unless otherwise agreed party appointed accordance with applicable rule arbitration herewith will conducted english language maximum extent possible arbitrator will render written decision later than month following selection arbitrator including basis damage awarded statement damage were calculated award will promptly paid dollar free deduction offset each party agrees abide award rendered arbitration conducted pursuant this font style font size font family time roman section font with respect money damage nothing contained herein will construed permit arbitrator court other forum award punitive exemplary damage except case breach font style font size font family time roman article font entering into this agreement arbitrate party expressly waive claim punitive exemplary damage except case breach font style font size font family time roman article font each party will legal cost related arbitration including witness expert judgment award rendered will final entered court having jurisdiction thereof table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party hereto waif right trial issue jury each party hereto waif claim attorney cost prejudgment interest from other table style text align justify style text align justify table eeed class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold court action font nothing contained this agreement will deny either party right seek injunctive other equitable relief from court competent jurisdiction context font style font size font family time roman font style italic bona fide font emergency prospective irreparable harm such action filed maintained notwithstanding ongoing dispute resolution discussion arbitration proceeding addition either party bring action court competent jurisdiction resolve dispute pertaining validity construction scope enforceability infringement other violation patent other proprietary intellectual property right such claim will subject arbitration pursuant font style font size font family time roman section font table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold governing jurisdiction equitable relief loss remedy font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto this agreement will governed construed enforced accordance with state york without reference rule conflict clarification dispute relating scope validity enforceability infringement patent will governed construed enforced accordance with patent applicable jurisdiction table style text align justify style text align justify table dbcf dbfaa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party acknowledges agrees that restriction forth font style font size font family time roman section font this agreement reasonable necessary protect legitimate interest other party that other party would have entered into this agreement absence such restriction that breach threatened breach these provision will probably result irreparable injury other party which there will adequate remedy event breach threatened breach such provision each party will authorized entitled obtain from court competent jurisdiction equitable relief whether preliminary permanent specific performance equitable accounting earnings profit other benefit arising from such breach which right will cumulative addition other right remedy which such party entitled equity each party agrees waive requirement that other party post bond other security condition obtaining such relief show irreparable harm balancing harm consideration public interest inadequacy monetary damage remedy nothing this font style font size font family time roman section font intended should construed limit party right equitable relief other remedy breach other provision this agreement except offset credit explicitly forth font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font amount awarded paid party other panel arbitrator final binding arbitration proceeding adjudicated under font style font size font family time roman section font offset undisputed unpaid amount under this agreement neither party will have right amount owed belief owed against payment payable other party under this agreement table style text align justify style text align justify table acfcc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto neither party will entitled recover loss relating matter arising under provision this agreement extent that such party already recovered loss with respect such matter pursuant other provision this agreement including recovery under font style font size font family time roman section font font style font size font family time roman section font offset under font style font size font family time roman section font table style text align justify style text align justify table cdaeb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto provision this agreement that describe payment refundable shall without prejudice either party right bring claim breach this agreement misrepresentation other claim permissible under applicable including seeking recovery payment made damage loss table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold assignment successor font neither this agreement obligation party hereunder assigned either party without consent other which will unreasonably withheld delayed conditioned except that each party assign this agreement right obligation interest such party whole part including with respect licensed program without other party consent affiliate purchaser substantially asset which this agreement relevant part relates successor corporation resulting from merger consolidation share exchange other similar transaction font style font size font family time roman font style italic provided font party transfer assigns this agreement part hereof described this agreement then such transferring party such affiliate font style font size font family time roman font weight bold font style italic transferring party font font style font size font family time roman font style italic font will that transferring party obligated transferring party font style font size font family time roman font weight bold font style italic transferring party font under font style font size font family time roman article font such that transferring party receives addition assign transfer right receive payment under this agreement liability without astrazeneca consent affiliate third party connection with payment factoring transaction font style font size font family time roman font style italic provided however font that will provide astrazeneca advance notice such proposed payment factoring transaction giving astrazeneca reasonable opportunity provides comment which will consider good faith purported assignment transfer made contravention this font style font size font family time roman section font will null void table style text align justify style font size font family time roman text align justify margin left extent transferring party utilizes year transferring party will transferring party assist transferring party determining when pursuant foregoing sentence beginning with first annual return year which transferring party payment under this font style font size font family time roman section font each year thereafter including clarity year which transferring party transferring party will provide transferring party with transferring party annual return federal state year which transferring party utilizes supporting documentation such style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold change control event involving astrazeneca font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic change control event initial meeting font astrazeneca will provide written notice within following closing change control event involving astrazeneca such notice will identify third party acquiring company font style font size font family time roman font weight bold font style italic astrazeneca acquirer font contact information person astrazeneca acquirer with whom will work schedule meeting between astrazeneca acquirer within following closing such change control event astrazeneca acquirer will meet with mutually agreed date time facility within before date such meeting astrazeneca acquirer will provide detailed written plan showing astrazeneca acquirer will meet astrazeneca obligation under this agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic change control event right first negotiation font case change control event involving astrazeneca within such change control event astrazeneca acquirer approached third party regarding elect offer third party opportunity acquire license otherwise right develop commercialize product then astrazeneca acquirer will provide written notice together with after date astrazeneca exercised applicable collaboration program license right extent previously provided will then have notify astrazeneca acquirer writing whether interested negotiating with astrazeneca acquirer obtain such right develop commercialize such product upon such written notice astrazeneca acquirer will negotiate good faith including least determine mutually acceptable term condition conveying such right notify astrazeneca acquirer within such period that interested negotiating with astrazeneca acquirer obtain right develop commercialize such product astrazeneca acquirer unable reach agreement within after astrazeneca acquirer receipt such notice from then astrazeneca acquirer will free grant right develop commercialize such product alone with third party font style font size font family time roman font style italic provided that font such grant right made astrazeneca third party within last offer shall term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold font style italic change control event effect carryover provision font case change control event involving astrazeneca within after closing such change control event delivers written notice astrazeneca that would like activate provision this font style font size font family time roman section font font style font size font family time roman font weight bold font style italic activation notice font then following will apply astrazeneca right under font style font size font family time roman section font restore designate former high interest target this agreement collaboration target astrazeneca carryover option under font style font size font family time roman section font will terminate limitation restriction obligation under font style font size font family time roman section font related astrazeneca carryover option under font style font size font family time roman section font will terminate applicable restriction astrazeneca affiliate right exploit asos under font style font size font family time roman section font font style font size font family time roman section font will terminate table style text align justify style text align justify style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold antitrust filing font table style text align justify style text align justify table eeaef class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party agrees prepare make cause prepared made appropriate filing under other antitrust requirement relating this agreement transaction contemplated under this agreement within business after execution date each party agrees cooperate antitrust clearance process including furnishing other party such necessary information reasonable assistance other party request connection with preparation filing submission that necessary under other antitrust requirement furnish promptly with united state federal trade commission font style font size font family time roman font weight bold font style italic font antitrust division united state department justice font style font size font family time roman font weight bold font style italic font other antitrust authority information reasonably requested them connection with such filing each party shall furnish copy subject reasonable redaction privilege confidentiality concern shall otherwise keep other party apprised status communication with inquiry request additional information from other antitrust authority shall comply promptly with such inquiry request each party shall give other party opportunity review advance shall consider good faith other party reasonable comment connection with proposed filing communication with other antitrust authority each party shall consult with other party extent practicable advance participating substantive meeting discussion with other antitrust authority with respect filing investigation inquiry extent permitted such antitrust authority give other party opportunity attend participate thereat neither party shall withdraw filing under agree delay effective date without prior written consent other party party right obligation hereunder apply only they relate agreement transaction contemplated under agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table fddcf class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party shall commercially reasonable effort obtain expiration early termination other clearance required under other antitrust requirement relating agreement transaction contemplated under agreement commercially reasonable effort used this font style font size font family time roman section font will include proposing negotiating committing effecting consent decree hold separate order otherwise sale divestiture disposition licensing sublicensing party affiliate asset property business behavioral limitation conduct restriction commitment with respect such asset property business right obligation party under this agreement defending through litigation claim asserted court party that would restrain prevent delay effective date table style text align justify style text align justify table cdcbc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto other than provision font style font size font family time roman section font font style font size font family time roman article font font style font size font family time roman article font which shall apply execution date right obligation party under this agreement will become effective until waiting period under been terminated expired other timeline required another antitrust authority there proceeding order injunction judgment relating thereto pending before governmental authority which sought restrain prohibit transaction contemplated hereby upon occurrence effective date other provision this agreement shall become effective automatically without need further action party table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto each party shall responsible cost associated with preparation submission required notification report form under other antitrust authority provision supplemental information other antitrust authority including legal incurred such party connection with such party obligation pursuant this font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold force majeure font party will held responsible other party deemed default under breach provision this agreement failure delay performing obligation this agreement when such failure delay force majeure without fault negligence party failing delaying purpose this agreement force majeure mean cause beyond reasonable control party which include regulation government terrorism civil commotion fire flood earthquake tornado tsunami explosion storm pandemic epidemic failure public utility common carrier such event party failing delaying will immediately notify other party such inability period which such inability expected continue party giving such notice will excused from such obligation under this agreement thereby disabled from performing long disabled maximum after which time party will negotiate good faith modification term this agreement that necessary arrive equitable solution unless party giving such notice reasonable timeframe plan resolve effect such force majeure executes such plan within such timeframe extent possible each party will reasonable effort minimize duration force majeure table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold notice font notice request required permitted given under connection with this agreement will deemed have been sufficiently given writing personally delivered sent facsimile transmission receipt verified internationally recognized overnight express courier service signature required prepaid party which such notice intended address forth such party below table table style font size border medium none font family time roman border right medium none border collapse collapse border bottom medium none margin left border left medium none width cellspacing cellpadding border style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left addressed style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left pharmaceutical style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left gazelle court style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left carlsbad style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align white space nowrap border bottom medium none border left medium none width style font size font family time roman text align left attention chief operating officer style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left with copy style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left pharmaceutical style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left gazelle court style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left carlsbad style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left attention general counsel style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential table cafab style font size border medium none font family time roman border right medium none border collapse collapse border bottom medium none margin left border left medium none width cellspacing cellpadding border style border medium none border right medium none vertical align white space nowrap border bottom medium none border left medium none width style font size font family time roman text align left astrazeneca addressed style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left astrazeneca style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left molndal style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left sweden style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left attention legal department style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left with copy style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left astrazeneca style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align white space nowrap border bottom medium none border left medium none width style font size font family time roman text align left scientific partnering alliance style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left molndal style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left sweden style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align white space nowrap border bottom medium none border left medium none width style font size font family time roman text align left attention business development director cvmd style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align left table style font size font family time roman text align justify margin left such other address such party will have specified like notice other party font style font size font family time roman font style italic provided that font notice change address will effective only upon receipt thereof delivered personally facsimile transmission date delivery will deemed date which such notice request given sent internationally recognized overnight express courier service date delivery will deemed second business after such notice request deposited with such service understood agreed that this section intended govern business communication necessary between party performing their duty course under term this agreement style font size font family time roman text align justify margin left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold export clause font each party acknowledges that regulation united state restrict export export commodity technical data united state origin each party agrees that will export export restricted commodity technical data other party form without appropriate united state foreign government license table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold waiver font neither party waive release right interest this agreement except writing failure either party assert right hereunder insist upon compliance with term condition this agreement will constitute waiver that right excuse similar subsequent failure perform such term condition waiver either party condition term more instance will construed continuing waiver subsequent waiver such condition term another condition term table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold severability font provision this agreement held illegal invalid unenforceable court competent jurisdiction such adjudication will affect impair whole part validity enforceability legality remaining portion this agreement remaining portion will remain full force effect original agreement been executed without invalidated unenforceable illegal part table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold entire agreement modification font this agreement including attached appendix exhibit schedule forth constitutes entire agreement understanding between party with respect subject matter hereof prior agreement understanding promise representation whether written oral with respect thereto superseded hereby each party confirms that relying representation warranty other party except specifically forth herein amendment modification release discharge will binding upon party unless writing duly executed authorized representative both party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold relationship party font expressly agreed that party will independent contractor another that relationship between party will constitute partnership joint venture agency table style text align justify style text align justify table ecaf class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold interpretation font except otherwise explicitly specified contrary reference section appendix exhibit schedule mean section appendix schedule exhibit this agreement unless another agreement specified word including various form mean including without limitation word will shall have same meaning reference particular statute regulation include rule regulation thereunder predecessor successor statute rule regulation each case amended otherwise modified from time time reference particular person include such person successor assigns extent prohibited this agreement unless otherwise specified reference united state dollar heading contained this agreement exhibit schedule this agreement table content this agreement convenience only will affect construction taken into consideration interpreting this agreement context otherwise requires word used inclusive sense table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold book record font book record maintained under this agreement party affiliate sublicensees will maintained accordance with generally accepted accounting principle case united state sale other applicable accounting standard consistently applied table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold further action font each party will execute acknowledge deliver such further instrument such other necessary appropriate order carry expressly stated purpose clear intent this agreement table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold construction agreement font font style font size font family time roman font weight bold font term provision this agreement represent result negotiation between party their representative each which been represented counsel choosing neither which acted under duress compulsion whether legal economic otherwise accordingly term provision this agreement will interpreted construed accordance with their usual customary meaning each party hereto hereby waif application connection with interpretation construction this agreement rule effect that ambiguous conflicting term provision contained this agreement will interpreted construed against party whose attorney prepared executed draft earlier draft this agreement table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table cdbffa class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold supremacy font event express conflict inconsistency between this agreement schedule exhibit appendix hereto term this agreement will apply party understand agree that schedule appendix hereto intended final complete embodiment term provision this agreement updated from time time during agreement term appropriate accordance with provision this agreement table style text align justify style text align justify table fabdecd class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold counterpart font this agreement signed counterpart each which will deemed original notwithstanding variation format file designation which result from electronic transmission storage printing copy this agreement from separate computer printer facsimile signature signature transmitted electronic mail format will treated original signature table style text align justify style text align justify table feca class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto font style font size font family time roman font weight bold compliance with font each party will will ensure that affiliate sublicensees will comply with relevant regulation exercising right fulfilling obligation under this agreement table style font size font family time roman font style italic text align center style font size font family time roman font style italic text align center signature page follows style font size font family time roman font style italic text align center style font size font family time roman text align center style font size font family time roman text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify text indent font style font size font family time roman font weight bold witness whereof font party have caused this agreement executed their representative thereunto duly authorized execution date table style font size font family time roman border collapse collapse width cellspacing cellpadding border style vertical align colspan style font size font family time roman font weight bold text align justify astrazeneca publ style vertical align width style vertical align width style vertical align width style vertical align width style vertical align width style font size font family time roman text align justify style vertical align border bottom black solid width style font size font family time roman text align justify marcus schindler style vertical align width style vertical align colspan style vertical align width style vertical align colspan style font size font family time roman text align justify name marcus schindler style vertical align width style vertical align colspan style vertical align width style vertical align colspan style font size font family time roman text align justify title vice president head cvmd imed style vertical align width table style font size font family time roman font variant small font weight bold text align center signature page strategic collaboration agreement style font size font family time roman font variant small font weight bold text align left dspfpagebreakarea style margin bottom clear both margin dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify text indent font style font size font family time roman font weight bold witness whereof font party have caused this agreement executed their representative thereunto duly authorized execution date style font size font family time roman text align justify text indent table style font size border medium none font family time roman border right medium none border collapse collapse border bottom medium none border left medium none width cellspacing cellpadding border style border medium none border right medium none vertical align border bottom medium none border left medium none colspan style font size font family time roman font weight bold text align justify pharmaceutical style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none colspan style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none width style font size font family time roman text align justify style border medium none border right medium none vertical align border bottom solid border left medium none width style font size font family time roman font variant normal font weight normal font style normal text align justify lynne parshall style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none colspan style font size font family time roman text align justify name lynne parshall style border medium none border right medium none vertical align border bottom medium none border left medium none width style border medium none border right medium none vertical align border bottom medium none border left medium none colspan style font size font family time roman text align justify title chief operating officer style border medium none border right medium none vertical align border bottom medium none border left medium none width table style font size font family time roman font variant small font weight bold text align center signature page strategic collaboration agreement dspfpagebreakarea style margin bottom clear both margin dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center list appendix schedule exhibit style font size font family time roman font weight bold text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font definition style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font font style font size font family time roman font variant small font lead candidate checklist style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font font style font size font family time roman font variant small font license agreement style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font core technology patent style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font manufacturing analytical patent style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font product specific patent style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small appendix font prior agreement style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font preliminary core research plan style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font preliminary disease research plan style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font criterion activity achieve target sanction style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font draft drug discovery plan style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font criterion activity development candidate designation style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font variant small font development pipeline execution date style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font variant small font governance style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font alliance management activity style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font work plan report style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font bioethics policy style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font variant small font specific performance milestone event style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small schedule font font style font size font family time roman font variant small font fully absorbed cost good methodology style font size font family time roman text align left style font size font family time roman text align left font style font size font family time roman font variant small exhibit font font style font size font family time roman font variant small font astrazeneca framework style font size font family time roman text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font weight bold text align center definition style font size font family time roman font weight bold text align center style font size font family time roman text align justify purpose this agreement following capitalized term will have following meaning style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font mean lawful currency united state style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic acceptance filing font mean with respect jnda cnda bdrp filed product united state receipt written notice from accordance with that such officially font style font size font family time roman font style italic filed font european union receipt astrazeneca affiliate sublicensee written notice validation such under centralized european procedure accordance with feedback received from european regulatory authority font style font size font family time roman font style italic provided that font centralized filing procedure used then acceptance filing will determined upon validation such applicable regulatory authority major market japan receipt astrazeneca affiliate sublicensee written notice acceptance filing such jnda from koseisho font style font size font family time roman font font style font size font family time roman font font style font size font family time roman font style italic font japanese ministry health welfare successor agency thereto china receipt astrazeneca affiliate sublicensee written notice acceptance filing such cnda from relevant regulatory authority china china food drug administration provincial level food drug regulatory authority regulation require successor agency thereto brazil receipt astrazeneca affiliate sublicensee written notice from brazilian national health surveillance agency anvisa successor agency thereto confirming that bdrp been received style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic acquiring party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic activation notice font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic additional core font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic additional product specific patent font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic affiliate font entity mean corporation firm partnership other entity which directly indirectly through more intermediary control controlled under common control with party this agreement applicable time during term entity will deemed control another entity owns directly indirectly least outstanding voting security capital stock such lesser percentage which maximum allowed owned foreign corporation particular jurisdiction such other entity other comparable ownership interest with respect entity other than corporation power whether pursuant contract ownership security otherwise direct management policy entity style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic agreement font meaning forth preamble this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic agreement font font style font size font family time roman font weight bold font style italic term font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic alliance manager font meaning forth font style font size font family time roman section font style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic annual font font style font size font family time roman font weight bold font style italic annually font mean period covering calendar year occurring once calendar year context requires style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic anti corruption font mean foreign corrupt practice amended bribery amended other applicable anti corruption prevention fraud racketeering money laundering terrorism style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean bulk active pharmaceutical ingredient manufactured accordance with cgmp unless expressly stated otherwise product quantity will gross mass after lyophilization font style font size font family time roman font including such amount water impurity salt heavy metal within limit forth specification before release retention stability characterization sample removed needed style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic applicable font font style font size font family time roman font weight bold font style italic font mean applicable statute rule regulation other pronouncement having effect federal national multinational state provincial county city other political subdivision agency other body domestic foreign including applicable rule regulation guideline other requirement regulatory authority that effect from time time style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic approval font mean with respect product approval from applicable regulatory authority least member state sufficient manufacture distribution marketing sale such product either pricing approval such jurisdiction accordance with applicable been obtained first commercial sale product occurred with respect product regulatory jurisdiction other than approval sufficient manufacture distribution marketing sale such product such jurisdiction accordance with applicable style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic approval astrazeneca internal decision body initiate phase study font mean with respect product that internal governing body within astrazeneca responsible authorizing commencement phase study granted such authorization commence such phase study style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean single stranded double stranded oligonucleotide compound analog variant mimic mimetic thereof having sequence that between hundred nucleotide long designed hybridize nucleic acid transcript binding partially wholly such compound nucleic acid transcript style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca font meaning forth preamble this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca acquirer font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font font style font size font family time roman font weight bold font style italic astrazeneca background intellectual property font font style font size font family time roman font font style font size font family time roman font weight bold font font style font size font family time roman mean know patent right that were controlled astrazeneca prior effective date controlled astrazeneca after effective date that were created acquired connection with performance collaboration plan connection with exploitation product which patent know necessary font develop manufacture commercialize product field font style font size font family time roman font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca collaboration intellectual property font mean font style font size font family time roman know patent right that were font discovered developed invented created font style font size font family time roman connection with performance collaboration plan behalf astrazeneca including astrazeneca interest font jointly owned collaboration technology style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca conducted activity font mean under collaboration plan research clinical clinical activity that conducted activity style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca field font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca full royalty font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca indemnitees font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca know font mean know owned used developed licensed astrazeneca affiliate other than from pursuant this agreement connection with astrazeneca performance obligation under this agreement each case extent controlled astrazeneca affiliate time during agreement term that font style font size font family time roman necessary font develop manufacture commercialize product field such know constitute astrazeneca background intellectual property style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca patent font mean patent right owned used developed licensed astrazeneca affiliate other than from pursuant this agreement that invented astrazeneca affiliate licensors connection with astrazeneca performance obligation under this agreement each case extent controlled astrazeneca affiliate time during agreement term that necessary develop manufacture commercialize product field such patent constitute astrazeneca background intellectual property style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca product specific patent font mean font style font size font family time roman font product specific patent owned used created developed licensed astrazeneca affiliate other than from pursuant this agreement effective date arising time during agreement term font style font size font family time roman font each case extent controlled astrazeneca affiliate connection with performance obligation under this agreement such product specific patent constitute astrazeneca background intellectual property style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca prosecuted patent font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca supported through cost font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic astrazeneca technology font mean astrazeneca interest astrazeneca collaboration intellectual property astrazeneca product specific patent astrazeneca know astrazeneca patent including astrazeneca background intellectual property trademark described font style font size font family time roman section font owned used developed licensed astrazeneca affiliate other than from pursuant this agreement that necessary used astrazeneca develop manufacture commercialize product style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic audit font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic audit report font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic bankruptcy code font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic bdrp font mean drug registration petition filed with brazilian national health surveillance agency anvisa after completion necessary clinical study obtain approval market product brazil style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic breaching party font mean party that believed breaching party material breach this agreement style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic business font mean other than saturday sunday which banking institution york london england open business style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic calendar quarter font mean period three consecutive calendar month ending last march june september december respectively will also include period beginning effective date ending last calendar quarter which effective date fall style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic calendar year font mean year beginning january with respect effective date ending december style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic candidate drug font mean compound nominated further development astrazeneca accordance with astrazeneca internal process style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic candidate failure date font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic cardiovascular disease font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic carryover option font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic carryover period font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic cgmp font mean current good manufacturing practice specified united state code federal regulation guideline equivalent rule regulation applicable regulatory authority time manufacture style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic change control event font mean direct indirect acquisition substantially asset party direct indirect acquisition person group person acting concert more voting equity interest party tender offer exchange offer that result person group person acting concert beneficially owning more voting equity interest party merger consolidation other business combination similar transaction involving party pursuant which person owns substantially consolidated asset revenue income party taken whole which result holder voting equity interest party immediately prior such merger consolidation business combination similar transaction ceasing hold more combined voting power surviving purchasing continuing entity immediately after such merger consolidation other business combination similar transaction case where such transaction entered into with person other than other party this agreement affiliate style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic claim font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic clinical study font font style font size font family time roman font weight bold font style italic clinical study font mean phase study phase study phase study phase study such other font style font size font family time roman study human that conducted accordance with good clinical practice designed generate data support maintenance jnda other similar marketing application font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic cnda font font style font size font family time roman font style italic font mean chinese equivalent filed with china food drug administration provincial level food drug regulatory authority regulation require successor agency thereto style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean third party primarily engaged providing contract manufacturing service primarily engaged drug discovery development commercialization asos pharmaceutical product style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration plan font mean core research plan disease research plan drug discovery plan including drug discovery plan style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration program font mean discovery research program focused discovering optimizing least designed bind collaboration target that suitable selection development candidate accordance with applicable drug discovery plan style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration program exercise date font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration program license right font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration program license right deadline font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration program term font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration target font mean high interest target that designated under font style font size font family time roman section font subject collaboration program thereafter astrazeneca exercise collaboration program license right with respect such high interest target style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic commercialize font font style font size font family time roman font weight bold font style italic commercialization font font style font size font family time roman font weight bold font style italic commercializing font mean activity directed marketing promoting detailing distributing importing having imported exporting having exported holding transporting selling offering sell product following receipt approval product applicable country including conducting post approval activity including study reasonably required increase market potential product study provide improved formulation product delivery launching promoting product each country style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic commercializing party font mean astrazeneca with respect product that being developed commercialized behalf astrazeneca affiliate sublicensees hereunder with respect discontinued product that being developed commercialized behalf affiliate sublicensees hereunder style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic commercially reasonable effort font with respect style font size font family time roman text align justify style font size font family time roman text align justify margin left astrazeneca mean that level effort resource relevant point time commonly used pharmaceutical industry product similar commercial potential similar commercial space similar stage lifecycle taking into consideration relative safety efficacy product profile competitiveness marketplace market potential relative profitability product including pricing reimbursement status other relevant factor including technical legal scientific medical factor style font size font family time roman text align justify margin left style font size font family time roman text align justify margin left mean level effort resource relevant time that consistent with normal practice would dedicate activity when seeking achieve particular result similar timeframe benefit without limiting foregoing commercially reasonable effort applies research development product hereunder includes commercially reasonable effort perform conducted activity under each collaboration plan accordance with timeline forth therein style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic competitive infringement font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic competitive font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic complete font font style font size font family time roman font weight bold font style italic completed font font style font size font family time roman font weight bold font style italic completion font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic compound font mean that designed bind collaboration target where such discovered prior date which such target becomes high interest target with respect effective date performance collaboration plan each case salt hydrate solvate drug thereof clarity asos will different compound they have different sequence nucleotide different modified nucleotide including different backbone sugar moiety base modification they employ different conjugate technology such galnac style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic confidential information font mean confidential font style font size font family time roman font proprietary information material patentable otherwise form written oral photographic electronic magnetic otherwise which disclosed disclosing party otherwise received accessed receiving party course performing obligation exercising right under this agreement including trade secret know invention discovery proprietary information formula process technique information relating past present future marketing financial research development activity product potential product useful technology disclosing party affiliate pricing thereof font style font size font family time roman font style italic confidential information font include information that style font size font family time roman text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto lawful knowledge possession receiving party affiliate prior time disclosed learned receiving party affiliate otherwise developed independently receiving party affiliate evidenced written record kept ordinary course business other documentary proof actual receiving party affiliate table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto generally available public otherwise part public domain time disclosure receiving party affiliate table style text align justify style text align justify table fdec class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto became generally available public otherwise part public domain after disclosure other than through omission receiving party affiliate breach this agreement table style text align justify style text align justify table dbac class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto disclosed receiving party affiliate other than under obligation confidentiality third party obligation disclosing party affiliate disclose such information others table style text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic conjugate technology font mean chemistry designed enhance targeting uptake antisense drug specific tissue cell conjugate technology includes acetylgalactosamine galnac ligand conjugate capable binding asialoglycoprotein receptor asgp enhancing targeting uptake antisense drug liver style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic control font font style font size font family time roman font weight bold font style italic controlled font mean possession ability grant license sublicense hereunder without violating term agreement with third party font style font size font family time roman font style italic provided however font that party right grant license sublicense with respect item intellectual property other party only upon payment compensation including milestone royalty third party font style font size font family time roman font weight bold font style italic third party compensation font other than case license astrazeneca supported through cost astrazeneca supported through cost then first party will deemed have font style font size font family time roman font style italic control font relevant item intellectual property only other party agrees bear cost such third party compensation notwithstanding anything contrary under this agreement with respect third party that becomes affiliate party after effective date including third party acquirer intellectual property such third party will included license granted hereunder virtue such third party becoming affiliate such party style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic core research plan font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic core research program font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic core research term font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic cover font font style font size font family time roman font weight bold font style italic covered font font style font size font family time roman font weight bold font style italic covering font mean with respect patent that right granted person under such patent making using selling such person would infringe valid claim included such patent case patent that patent application would infringe valid claim such patent application were issue patent style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic develop font font style font size font family time roman font weight bold font style italic developing font font style font size font family time roman font weight bold font style italic development font mean with respect product discovery characterization preclinical including enabling toxicology study clinical regulatory activity with respect product seek approval including submission necessary filing with applicable regulatory authority support such preclinical clinical activity approval including human clinical trial conducted after approval product seek approval additional indication such product including importing having imported exporting having exported holding transporting connection with activity prior approval style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic development candidate font mean with respect collaboration program compound that meet development candidate success criterion otherwise designated astrazeneca under font style font size font family time roman section font with respect designated expert accordance with font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic development candidate success criterion font mean success criterion development candidate such program applicable drug discovery plan unless otherwise agreed such success criterion will include item checklist effective date when reviewing potential development candidate approval attached hereto font style font size font family time roman appendix font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic disclosing party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic discontinued product font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic disease research plan font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic disease research program font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic disease research term font meaning forth font style font size font family time roman section font style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic distributor font font style font size font family time roman font weight bold font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean antitrust division united state department justice style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic drug discovery plan font font style font size font family time roman mean drug discovery plan collaboration program focused particular collaboration target amended from time time accordance with this agreement font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic effective date font mean date that necessary authorization consent order approval declaration filing with expiration waiting period under applicable consummation transaction contemplated this agreement have been received authorized permitted expired style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic eligible target font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean european medicine agency successor entity thereto style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic european union font font style font size font family time roman font weight bold font style italic font mean each every country territory that officially part european union from time time style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic evaluation period font font style font size font family time roman font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic exclusion criterion font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic exclusive target font mean reserved target high interest target collaboration target term font style font size font family time roman font weight bold font style italic exclusive target font mean collectively reserved target high interest target collaboration target style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic execution date font meaning forth preamble this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic exploit font mean research develop manufacture commercialize font style font size font family time roman font weight bold font style italic exploiting font font style font size font family time roman font weight bold font style italic exploitation font have corresponding meaning purpose this agreement reference term font style font size font family time roman font style italic exploit font context compound product will read include list activity definition font style font size font family time roman font style italic exploit font relevant supporting defined term font style font size font family time roman font style italic mutatis mutandis font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic failed candidate font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean united state food drug administration successor entity thereto style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic field font mean with respect practice core technology patent manufacturing analytical patent prophylactic therapeutic form administration human animal product indication with respect practice product specific patent prophylactic therapeutic diagnostic form administration human animal product indication other case prophylactic therapeutic diagnostic form administration human animal product indication style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic first commercial sale font mean first sale product astrazeneca affiliate sublicensee third party particular country after approval such product been obtained such country style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean antitrust division united state department justice dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean effort more employee equivalent effort full time employee year case than full time dedicated person full time equivalent person year based upon total thousand seven hundred hour year work development program style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic rate font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic fully absorbed cost good font mean cost incurred determined using methodology forth font style font size font family time roman font variant small schedule font font style font size font family time roman font variant small font fairly applied employed consistent basis throughout operation font style font size font family time roman font variant small font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic government official font font style font size font family time roman font weight bold font style italic font mean person employed acting behalf government government controlled entity public international organization political party party official candidate person hold performs duty appointment office position created custom convention person hold himself authorized intermediary foregoing style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic high interest target font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic high interest target list font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean united state hart scott rodino antitrust improvement amended from time time style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean investigational drug application defined food drug cosmetic amended filed with foreign counterpart style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic enabling toxicology study font mean pharmacokinetic toxicology study required meet requirement filing including manufacturing support such activity style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic indemnification claim notice font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic indemnified party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic indication font mean style font size font family time roman text align justify style font size font family time roman text align left font style font size font family time roman font weight bold font style italic indirect font mean value added sale consumption other similar required disclosed invoice style font size font family time roman text align left style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic initiation font font style font size font family time roman font weight bold font style italic initiate font mean with respect clinical study dosing first human subject such clinical study style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic integrated product plan font font style font size font family time roman font weight bold font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic manager font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font meaning forth preamble this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic background intellectual property font mean font style font size font family time roman know patent right that were controlled prior effective date controlled after effective date that were created acquired connection with performance collaboration plan connection with exploitation product each case which patent know necessary font practice collaboration intellectual property style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic collaboration intellectual property font mean font style font size font family time roman know patent right that were font discovered developed invented created font style font size font family time roman connection with performance collaboration plan behalf including interest font jointly owned collaboration technology style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic conducted activity font mean research development activity which designated responsible under collaboration plan style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic core technology patent font mean patent right owned used developed licensed affiliate other than from astrazeneca pursuant this agreement each case extent controlled affiliate effective date time during agreement term claiming subject matter generally applicable asos other than product specific patent manufacturing analytical patent font style font size font family time roman list font core technology patent font style font size font family time roman font effective date font style font size font family time roman forth font font style font size font family time roman font variant small appendix font font style font size font family time roman attached hereto font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic field font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic license agreement font mean agreement listed font style font size font family time roman font variant small appendix font font style font size font family time roman font updated accordance with font style font size font family time roman section font otherwise with astrazeneca written consent style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic indemnitees font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic internal safety database font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic know font mean know including interest jointly owned collaboration know owned used developed licensed affiliate other than from astrazeneca pursuant this agreement each case extent controlled affiliate effective date time during agreement term that font style font size font family time roman necessary useful font develop manufacture commercialize product field know include manufacturing analytical know style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic manufacturing analytical know font mean know including interest jointly owned collaboration know that relates synthesis analysis product regardless sequence chemical modification owned used developed licensed affiliate other than from astrazeneca pursuant this agreement each case extent controlled affiliate effective date time during agreement term manufacturing analytical know include know style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic manufacturing analytical patent font mean patent right including interest jointly owned collaboration patent that claim method material used synthesis analysis product regardless sequence chemical modification owned used developed licensed affiliate other than from astrazeneca pursuant this agreement each case extent controlled affiliate effective date time during agreement term font style font size font family time roman list font manufacturing analytical patent font style font size font family time roman font effective date font style font size font family time roman forth font font style font size font family time roman font variant small appendix font font style font size font family time roman attached hereto font manufacturing analytical patent include product specific patent core technology patent style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic product specific patent font mean font style font size font family time roman font product specific patent each case extent controlled affiliate effective date time during agreement term font style font size font family time roman list font product specific patent font style font size font family time roman font effective date font style font size font family time roman forth font font style font size font family time roman font variant small appendix font font style font size font family time roman attached hereto font style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic supported through cost font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic japan font font style font size font family time roman font weight bold font style italic jnda font mean font style font size font family time roman japanese equivalent font font style font size font family time roman filed with font koseisho font style font size font family time roman font font style font size font family time roman font style italic font japanese ministry health welfare successor agency thereto font style font size font family time roman font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic jointly owned collaboration know font mean know discovered developed invented created jointly performance collaboration plan behalf both party their respective affiliate third party acting their behalf that font style font size font family time roman necessary useful font develop manufacture commercialize product field style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic jointly owned collaboration patent font mean patent right that claim cover jointly owned collaboration know style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic jointly owned collaboration technology font mean jointly owned collaboration know jointly owned collaboration patent style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic kidney disease font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic know font mean invention technical information know material including technology data composition formula biological material assay reagent construct compound discovery procedure process practice protocol method technique result experimentation testing knowledge trade secret skill experience each case whether patentable copyrightable each case that covered issued patent right style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic knowledge font mean good faith actual understanding fact information party affiliate executive officer their attorney employed their legal department patent department effective date bring down date applicable font style font size font family time roman font style italic provided that font with respect information regarding status patent right other intellectual property right font style font size font family time roman font style italic knowledge font mean good faith actual understanding fact information party affiliate executive officer their attorney employed their legal department patent department effective date bring down date applicable after performing diligent investigation with respect such fact information customary conduct business with respect such patent right other intellectual property right clarity diligent investigation solely connection with this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font font style font size font family time roman font weight bold font style italic lead candidate font font style font size font family time roman font style italic font mean case collaboration program compound identified being lead candidate such program style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic lead candidate data package font mean with respect collaboration program style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic lead compound font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic licensed font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic licensed know font mean manufacturing analytical know know clarity execution date licensed know include know covering formulation technology delivery device unless such know included jointly owned collaboration know style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic licensed patent font mean product specific patent core technology patent manufacturing analytical patent interest jointly owned collaboration patent clarity execution date licensed patent include patent right claiming formulation technology delivery device unless such patent right included jointly owned collaboration patent style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic licensed program font mean collaboration program following exercise applicable collaboration program license right long license under font style font size font family time roman section font such program effective style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic licensed technology font mean licensed patent licensed know trademark described font style font size font family time roman section font extent necessary useful research develop manufacture commercialize product field style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic loss font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font font style font size font family time roman font weight bold font style italic font font style font size font family time roman mean marketing authorization application filed with font font style font size font family time roman after completion font clinical study font style font size font family time roman obtain font approval font style font size font family time roman font product font style font size font family time roman under centralized european filing procedure centralized font font style font size font family time roman filing procedure used filed using applicable procedure with applicable regulatory authority font european union font style font size font family time roman country font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic approval font mean grant marketing authorization font style font size font family time roman european commission font font style font size font family time roman font product european union style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic major market font mean following country style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic manufacture font font style font size font family time roman font weight bold font style italic manufactured font font style font size font family time roman font weight bold font style italic manufacturing font mean activity involved relating manufacturing quality control testing including process release stability testing releasing packaging importing keeping clinical clinical purpose product finished form style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic material anti corruption violation font mean violation anti corruption relating subject matter this agreement which would were publicly known reasonable view astrazeneca have material adverse effect reputation astrazeneca because relationship with style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic metabolic disorder font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic minimum third party payment font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font font style font size font family time roman font weight bold font style italic font font style font size font family time roman font font style font size font family time roman font weight bold font font style font size font family time roman mean font drug application font style font size font family time roman filed with font font style font size font family time roman after completion font clinical study font style font size font family time roman obtain font approval font style font size font family time roman font product font style font size font family time roman united state font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic sale font mean gross invoiced amount sale product behalf astrazeneca affiliate sublicensees third party which third party will include distributor after deduction following amount extent taken style font size font family time roman text align justify style text align justify table fbca class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto normal customary trade quantity prompt settlement discount including initial launch stocking discount chargebacks allowance actually allowed table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto amount repaid credited reason rejection return recall good rebate font style font size font family time roman font style italic bona fide font price reduction determined astrazeneca affiliate sublicensees good faith table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style text align justify style text align justify table ffefd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto rebate similar payment made with respect sale paid governmental regulatory authority such illustration limitation party right hereunder federal state medicaid medicare similar state program united state equivalent governmental program other country table style text align justify style text align justify table dfaa class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto invoiced amount which collected astrazeneca affiliate sublicensees including debt table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto excise value added sale consumption other similar excluding income franchise withholding custom duty custom levy import imposed sale importation distribution product including paid pursuant section patient protection affordable care that astrazeneca affiliate their sublicensees applicable allocable sale such product accordance with astrazeneca affiliate their sublicensees standard policy procedure consistently applied across product applicable table style text align justify style text align justify table faafc class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto portion administrative paid during relevant time period group purchasing organization pharmaceutical benefit manager relating such product table style text align justify style text align justify table efafd class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto service payable under wholesaler agreement distribution service agreement inventory management agreement other similar agreement table style text align justify style text align justify table zcbb class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto other similar customary deduction including card that consistent with united state generally accepted accounting principle case united state sale other applicable accounting standard table style text align justify style text align justify table dcdad class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto allowance transportation cost distribution expense special packaging related insurance charge equal amount arrived after application deduction under clause above table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family time roman vertical align width align right style font size font family time roman vertical align text align justify width auto actual cost paid astrazeneca affiliate sublicensees each unit device table style text align justify style font size font family time roman text align justify sale including deduction will calculated using astrazeneca internal audited system used report such sale adjusted item above taken into account such system each case which accordance with generally accepted accounting principle fairly applied employed consistent basis throughout astrazeneca operation deduction pursuant subsection above will taken calendar quarter which such sale longer recorded receivable used above term font style font size font family time roman font style italic device font mean device approved regulatory authority with product that necessary administer product patient without such device product delivered accordance with approval style font size font family time roman text align justify style font size font family time roman text align justify product sold part combination product defined below sale from such product purpose determining royalty payment will determined multiplying sale determined without reference this paragraph combination product fraction where standard sale price ready sale form product containing same amount compound sole active ingredient combination product question given country when sold separately finished form standard sale price ready sale form product containing same amount other therapeutically active ingredient that contained combination product question given country each during applicable royalty period sale compound occur such period then most recent royalty reporting period event however that specific country either both compound other therapeutically active ingredient such combination product sold separately such country market price such product such other active ingredient will negotiated party good faith purpose performing calculation above determine royalty payment sale from such combination product used above term font style font size font family time roman font weight bold font style italic combination product font mean product that includes least additional therapeutically active ingredient whether coformulated copackaged compound style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic third party compound technology font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic breaching party font mean party that belief breaching party material breach this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic transferring party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic other lead font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic party font font style font size font family time roman font weight bold font style italic party font mean astrazeneca individually collectively style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic party representative font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic patent cost font mean reasonable expense paid outside legal counsel filing maintenance other reasonable pocket expense paid third party incurred connection with prosecution maintenance patent right style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic patent right font mean patent patent application similar government issued right protecting invention country jurisdiction however denominated priority application divisionals continuation substitution continuation part similar application claiming priority foregoing patent similar government issued right protecting invention issuing foregoing application together with registration reissue renewal examination confirmation supplementary protection certificate extension style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean gene style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic carryover option font mean carryover option exercised with respect style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic milestone font font style font size font family time roman font weight bold font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic compound font mean that designed bind where such discovered prior effective date discovered performance program clarity asos will different compound they have different sequence nucleotide different modified nucleotide including different backbone sugar moiety base they employ different conjugate technology such galnac style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic drug discovery plan font mean drug discovery plan program draft which attached hereto font style font size font family time roman font variant small schedule font font style font size font family time roman font adopted thereafter updated from time time accordance with this agreement style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic program font mean research development program product under this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic product font mean each compound product containing such compound active pharmaceutical ingredient including salt hydrate solvate drug thereof style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic program font mean drug discovery program product under this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic success criterion font mean development candidate success criterion program drug discovery plan style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic permitted license font mean license granted before after effective date third party under core technology patent manufacturing analytical patent manufacturing analytical know under product specific patent oligonucleotides supply oligonucleotides user solely conduct clinical research enable such third party manufacture formulate oligonucleotides contract manufacturer where such third party primarily engaged providing contract manufacturing service primarily engaged drug discovery development commercialization therapeutic assist such third party identify discover make product material transfer agreement with academic collaborator profit institution connection with conducted activity approved astrazeneca such approval unreasonably withheld delayed style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic person font mean corporation limited general partnership limited liability company joint venture trust unincorporated association governmental body authority bureau agency other entity body individual style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic phase study font mean first clinical study conducted human font style font size font family time roman font style italic phase study font includes clinical study designated under font style font size font family time roman font style italic phase study phase study font font style font size font family time roman font style italic phase trial font font style font size font family time roman font style italic phase trial font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic phase study font mean first clinical study where protocol anticipates that patient participating study will administered product more than eight week clarity continuation treatment patient more than eight week open label phase study will result that study being deemed phase study font style font size font family time roman font style italic phase study font includes clinical study designated under font style font size font family time roman font style italic phase study font font style font size font family time roman font style italic phase study font font style font size font family time roman font style italic phase study font font style font size font family time roman font style italic phase trial font font style font size font family time roman font style italic phase trial font font style font size font family time roman font style italic phase trial font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic phase study font mean further phase study product same indication that intended identify definite dose range efficacy primary endpoint that indication style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic phase study font mean clinical study human performed gain evidence statistical significance efficacy product target patient population obtain expanded evidence safety such product that needed evaluate overall benefit risk relationship such product provide adequate basis obtaining regulatory approval including physician labeling described equivalent outside united state font style font size font family time roman font style italic phase study font includes clinical study designated under font style font size font family time roman font style italic phase study font font style font size font family time roman font style italic phase trial font font style font size font family time roman font style italic pivotal study font font style font size font family time roman font style italic registration study font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic clinical study font mean font style font size font family time roman font style italic vitro font font style font size font family time roman font style italic vivo font study more compound human including those study conducted whole animal other test system designed determine toxicity bioavailability pharmacokinetics product whether product desired effect style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic primary disease font meaning forth recital font style font size font family time roman font style italic primary disease font include neurology disease ocular disease associated with primary disease font style font size font family time roman font diabetic retinopathy style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic prior agreement font mean agreement listed font style font size font family time roman font variant small appendix font font style font size font family time roman font attached hereto style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic proceeding font mean action suit proceeding style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic product font mean each compound product containing such compound active pharmaceutical ingredient including salt hydrate solvate drug thereof product style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic product specific patent font mean patent right controlled party affiliate after effective date claiming specific composition matter product method using such product prophylactic therapeutic diagnostic style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic prosecution maintenance font font style font size font family time roman font weight bold font style italic prosecute maintain font mean with regard patent right preparing filing prosecuting maintenance such patent right well handling examination reissue request patent term extension with respect such patent right together with conduct interference defense opposition other similar proceeding with respect particular patent right clarification font style font size font family time roman font style italic prosecution maintenance font font style font size font family time roman font style italic prosecute maintain font will include other enforcement action taken with respect patent right style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font font style font size font family time roman font weight bold font style italic receiving party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic regulatory authority font mean governmental authority including koseisho font style font size font family time roman font font style font size font family time roman font style italic font japanese ministry health welfare successor agency thereto that responsibility regulating otherwise exercising authority with respect development manufacture marketing sale other commercialization product country style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic regulatory documentation font font style font size font family time roman font weight bold font style italic font mean regulatory submission notification registration approval other filing correspondence made with regulatory authority country jurisdiction other record required applicable maintained that necessary useful develop manufacture market sell otherwise commercialize product field style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic release notice font mean written notice delivered astrazeneca within after target failure date candidate failure date applicable pursuant which astrazeneca release from obligation restore former high interest target former collaboration target together with asos designed bind such former high interest target former collaboration target collaboration pursuant font style font size font family time roman section font font style font size font family time roman font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic relevant authority font mean court government body whether national supra national federal state local foreign provincial including political subdivision thereof including department commission board bureau agency other regulatory administrative governmental authority instrumentality further including quasi governmental person entity exercising function these style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic research font mean conducting research activity with compound including clinical research lead optimization font style font size font family time roman font style italic specifically excluding font development commercialization when used verb font style font size font family time roman font style italic researching font mean engage research style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic research collaboration font mean conduct disease research program core research program collaboration program accordance with this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic reserved target font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic reserved target list font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic font mean research management committee successor committee style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic royalty period font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic senior representative font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic service provider font mean third party conducting original revised study under collaboration plan style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic specific performance milestone event font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic sublicensee font mean third party whom party affiliate sublicensees granted sublicense license under licensed technology case astrazeneca astrazeneca technology case case licensed such party accordance with term this agreement style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic target font mean mrna mrna gene target coding style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic target failure date font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic target sanction font mean style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic target sanction data package font mean with respect high interest target style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic terminated program font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic terminated target font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic third party font mean person entity other than party their respective affiliate style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic third party claim font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic third party obligation font mean financial financial encumbrance obligation restriction limitation imposed agreement between party third party that relate product exclusive target including field territory restriction covenant milestone payment diligence obligation sublicense revenue royalty other payment style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic transferring party font meaning forth font style font size font family time roman section font style font size font family time roman text align justify style font size font family time roman text align justify style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic united state font font style font size font family time roman font weight bold font style italic font mean fifty state united state america territory possession district columbia style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic valid claim font mean claim issued unexpired united state foreign patent right which will country issuance have been donated public disclaimed held invalid unenforceable court competent jurisdiction unappealed unappealable decision united state foreign patent application within patent right which will country question have been cancelled withdrawn abandoned been pending more than seven year including calculating such seven year period time which such application interference opposition similar proceeding time which decision examiner being appealed notwithstanding foregoing country country basis patent application pending more than seven year will considered have valid claim purpose this agreement unless until patent meeting criterion forth clause above with respect such application issue style font size font family time roman text align justify style font size font family time roman text align justify font style font size font family time roman font weight bold font style italic work plan report font meaning forth font style font size font family time roman section font style font size font family time roman text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font weight bold text align center lead candidate checklist style font size font family time roman font weight bold text align center style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center license agreement style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center core technology patent style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center manufacturing analytical patent style font size font family time roman font weight bold text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font weight bold text align center product specific patent style font size font family time roman font variant small font weight bold text align center relevant style font size font family time roman font variant small font weight bold text align center style font size font family time roman font variant small text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center appendix style font size font family time roman font weight bold text align center prior agreement style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center margin left margin right text indent dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center schedule style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center preliminary core research plan style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center schedule style font size font family time roman font weight bold text align center outline preliminary disease research plan style font size font family time roman font weight bold text align center style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center font style font size font family time roman font variant small schedule font font style font size font family time roman font style font size font family time roman font weight bold text align center criterion activity achieve target sanction style font size font family time roman font weight bold text align center style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left margin left text indent confidential style font size font family time roman font weight bold text align left margin left text indent style font size font family time roman font weight bold text align center margin left text indent font style font size font family time roman font variant small schedule font font style font size font family time roman font style font size font family time roman font weight bold text align center margin left text indent draft drug discovery plan style font size font family time roman font variant small text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center font style font size font family time roman font variant small schedule font font style font size font family time roman font style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center criterion activity development candidate designation style font size font family time roman font weight bold text align center style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center schedule style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center development pipeline execution date style font size font family time roman font weight bold text align center style text align center image style text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center font style font size font family time roman schedule font font style font size font family time roman font style font size font family time roman font variant small font weight bold text align center governance style font size font family time roman font variant small font weight bold text align center style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto will determine operating procedure including frequency meeting least quarterly location meeting responsibility agenda minute will codify these operating procedure written minute first meeting table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto hold meeting person audio video conference determined least meeting year will person held facility other held astrazeneca facility outside alliance manager will attend meeting participating member addition upon prior approval other party each party invite employee consultant attend meeting including subject matter expert with valuable knowledge relevant exclusive target table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto chair will responsible ensuring that activity occur forth this agreement including ensuring that meeting occur recommendation properly reflected minute dispute given prompt attention resolved accordance with font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font font style font size font family time roman section font applicable table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto member from same party will collectively have vote will strive make recommendation with approval both member astrazeneca member record such recommendation minute applicable meeting table style text align justify style text align justify table dfedc class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto form subcommittee working group determines order carry activity under this agreement which will dissolve when dissolve table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center font style font size font family time roman schedule font font style font size font family time roman font style font size font family time roman font weight bold text align center alliance management activity style font size font family time roman font weight bold text align center style font size font family time roman text align left each alliance manager will primary point contact party regarding their collaboration under this agreement will responsible style font size font family time roman text align left style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto promoting overall health relationship between party table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto developing mutually agreed alliance launch plan covering activity system that party need implement within first after effective date support collaboration plan table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto organizing each meeting including agenda drafting minute publishing final minute table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto supporting chair with organization meeting information exchange meeting minute facilitating dispute resolution necessary table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto preparing status progress report above determined necessary ensuring that report produced maintained sufficient quality table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto assisting with completing work plan report under font style font size font family time roman section font ensuring that such report provided astrazeneca table style text align justify style text align justify table eacb bcda class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto ensuring compliance maintaining internal safety database outlined font style font size font family time roman section font table style text align justify style text align justify table fefa class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto ensuring proper approval publication prior submission required font style font size font family time roman section font table style text align justify style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style font size font family time roman vertical align font weight bold width align right style font size font family time roman vertical align text align justify width auto review material transfer agreement keeping record creation supply material table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always text align left style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center font style font size font family time roman schedule font font style font size font family time roman font style font size font family time roman font variant small font weight bold text align center work plan report style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font weight bold text align left style font size font family time roman font weight bold text align center font style font size font family time roman font font style font size font family time roman font variant small chedule font font style font size font family time roman font style font size font family time roman font weight bold text align center astrazeneca bioethics policy style font size font family time roman text align justify astrazeneca bioethics policy applicable everyone involved activity including third party behalf style font size font family time roman text align justify astrazeneca bioethics policy defines principle behaviour ethical standard governing research development worldwide while many topic covered existing national regulation this policy commitment beyond ordinary legal compliance astrazeneca third party acting astrazeneca behalf style font size font family time roman text align justify further information using animal research study astrazeneca available site font style font size font family time roman http astrazeneca responsibility research ethic animal research font style font size font family time roman text align justify astrazeneca considers responsible animal ethically appropriate biomedical research product safety testing where suitable alternative available following principle apply animal study conducted astrazeneca third party conduct animal study behalf breeding supplying animal such study style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family symbol serif vertical align width align right style font size font family time roman vertical align text align justify width auto humane approach must adopted care treatment animal greatest consideration given their health welfare consistent with meeting necessary scientific objective astrazeneca committed principle replacement reduction refinement table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family symbol serif vertical align width align right style font size font family time roman vertical align text align justify width auto animal study must carefully considered justified ensure that study scientifically necessary there practicable alternative animal replacement only minimum number appropriate specie animal will used achieve scientific objective reduction that study designed undertaken minimise pain distress animal involved refinement table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family symbol serif vertical align width align right style font size font family time roman vertical align text align justify width auto astrazeneca committed sharing knowledge good practice achievement both throughout astrazeneca group company wider scientific community table style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family symbol serif vertical align width align right style font size font family time roman vertical align text align justify width auto must ensure that facility animal welfare programme well those third party conduct animal study behalf comply with policy animal study must undertaken compliance with relevant local national regulation with principle guide care laboratory animal edition institute laboratory animal research wherever possible preference work with third party accredited association assessment accreditation laboratory animal care international aaalac international table dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style text align justify table class dspflisttable style font size font family time roman width cellspacing cellpadding style width style font size font family symbol serif vertical align width align right style font size font family time roman vertical align text align justify width auto astrazeneca conduct resource work using wild caught human primate great specie rare case where there credible alternative model develop treatment serious disease exception considered decision progress requires rigorous secondary ethical scientific review challenge need study followed astrazeneca board level approval table style text align justify dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center schedule style font size font family time roman font variant small font weight bold text align center style font size font family time roman font weight bold text align center specific performance milestone event style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center font style font size font family time roman font variant small font added after collaboration program license right exercise font style font size font family time roman font variant small font style font size font family time roman font weight bold text align left dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center schedule style font size font family time roman font weight bold text align center fully absorbed cost good methodology style font size font family time roman text align center cost estimate cost kilogram style font size font family time roman text align center style font size font family time roman text align center dspfpagebreakarea style margin bottom clear both margin dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font dspfpagebreak style page break after always style border left width height border right width border bottom width color clear both margin border width width background color noshade noshade style font size font family time roman font variant small font weight normal font style normal text align left confidential style font size font family time roman font variant small font weight bold text align left style font size font family time roman font variant small font weight bold text align center exhibit style font size font family time roman font weight bold text align center astrazeneca framework style font size font family time roman font weight bold text align center style font size font family time roman font weight bold text align center dspfpagenumberarea style text align center font dspfpagenumber style font size font family time roman font weight normal font style normal font style height color text align center margin left auto background color margin right auto noshade noshade body html text document